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ABSTRACT
Observational studies have suggested that the transmission o f the human immunodeficiency virus 
(HIV) is enhanced in the presence o f other sexually transmitted diseases (STDs). Based on this 
STD/HTV co-factor hypothesis it has been suggested that interventions aimed at reducing the 
prevalence of STDs may be able to reduce the incidence o f HTV infection.
This thesis presents the results of a community based randomised controlled trial of the impact of 
improved STD case management on the incidence o f HTV infection. The trial was earned  out in 
the Mwanza Region o f North-Western Tanzania between 1991 and 1995. It involved 12 rural 
communities which were formed into six matched pairs. Within each pair, one community was 
randomised to receive the intervention which comprised improved STD case management 
services integrated into the existing primary health care (PHC) structure, and health education 
campaigns to improve treatment seeking behaviour for STDs.
The impact of the intervention was studied in a cohort of about 1000 adults aged 15 to  54 years 
from each o f the communities. Over the 2 years o f follow-up, there were 130 HIV 
seroconversions, 48 (1.16%) in the intervention group and 82 (1.86%) in the comparison group, 
equivalent to annual incidences o f 0.58% and 0.93%. The crude relative risk (RR) for 
seroconversion in intervention compared to comparison communities was 0.57 (95%  Cl 0.42- 
0.76, p=0.004) After adjustment for potential confounders, the RR was 0.62 (95%  Cl 0.45- 
0 85, p=0.013), equivalent to a reduction of 38%.
There was also a reduction in the prevalence o f active syphilis (adjusted RR = 0.67; 95% Cl: 
0 47-0.96, p=0.04 at RPR titre o f >=1:8), and o f symptomatic urethritis in men (adjusted RR = 
0.51, 95%C1: 0.25-1.03,p=0.06). No impact was observed for gonococcal / chlamydial infection 
or overall urethritis in men. There was no impact on the prevalence of STDs in pregnant women, 
studied by means of two consecutive cross-sectional studies at antenatal clinics.
The results o f this trial provide additional strong evidence for the STD/H1V co-factor hypothesis, 
and demonstrate that improving STD services can substantially reduce the incidence of HTV 
infection in populations with high STD prevalences. They suggest that the control o f  STDs 
should form an important component of HIV prevention programmes Reliable drug supply and 
frequent support supervision to health facilities are essential prerequisites for such ST D  control 
programmes.
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Chapter 1 Introduction: Scope of the thesis
This thesis concerns a community-based randomised controlled trial which investigated the 
hypothesis that sexually transmitted diseases (STDs) enhance the transmission of the human 
immunodeficiency virus (HTV), and that the improved case management of STDs will reduce the 
incidence o f HIV in the general population. This research, the Mwanza STD/HIV Intervention 
Trial, was conducted in north-western Tanzania from 1991 to 1995.
Chapter 2 presents a review o f  the relevant literature on the epidemiology and public health 
importance o f STDs in sub-Saharan Africa, on the options available to control them, and on the 
association between STDs and HTV infection. Emphasis is laid on methodological issues 
encountered when studying the link between the two types o f diseases A synopsis o f the 
epidemiology and the public health relevance o f HIV infection and AIDS is provided. This is 
kept very brief, as STDs, their control and their possible association with HIV infection are the 
main focus o f the thesis.
The literature review is followed in chapter 3 by a description of the background to the trial, 
which includes information on the study area, the organisation and management o f the trial and 
on the collaborating institutions which contributed to its implementation.
Chapters 4 to 6 describe the aims, the design and the results o f the trial, respectively. Chapter 7 
discusses the methodology and findings of the study and the implications of the results.
The thesis ends in chapter 8 with a series o f conclusions and recommendations. T he latter 
include policy and programmatic recommendations, as well as recommendations for future 
research.
The Mwanza trial has also been used to study a variety of related issues, for example patterns of 
sexual behaviour, risk factors for STDs and HIV infection, the performance o f risk scores as a 
screening tool for the detection o f  cervical infections in women, the performance of a screening 
tool to detect urethritis in men, the adult mortality due to HIV infection, and the performance of 
a verbal autopsy tool. These related studies are not discussed in this thesis. A full list of 
publications from the Mwanza STD/HIV Intervention and Research Programme and related 
studies is given in Annex 5.
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Chapter 2: Literature review
2.1 Sexually transmitted diseases and reproductive tract infections
2.1.1 Definitions
Sexually transmitted diseases
Sexually transmitted diseases (STDs) is the collective term for a whole group o f infectious 
disorders fo r which sexual intercourse is an important route o f infection. The group includes 
bacterial, viral, protozoal, mycotic and parasitic infections (Mabey and Richens 1996). Many are 
associated w ith genital symptoms and signs; for example gonorrhoea or chancroid. Others do not 
usually lead to pathologic changes o f  the genital organs; for example HTV infection or hepatitis 
B In the context of this thesis, the term STDs is used for infections which frequently cause 
genital symptoms or signs, and mostly refers to viral, bacterial, mycotic or protozoal infections.
Reproductive tract infections
The term reproductive tract infections (RTls) is restricted to diseases o f the genital system. Not 
all infections o f the genital tract require sexual transmission. Some, such as bacterial vaginosis 
or infection with Candida albicans, appear spontaneously, although sexual transmission may 
also occur. Therefore, the terms STDs and RTIs are not synonymous. However, this thesis is 
concerned w ith a programme for the control of STDs, and in line with common terminology in 
this programmatic context, candidiasis and bacterial vaginosis may be included under the term 
STDs (WHO 1994).
STD syndromes
Different ST D  aetiologies often lead to a similar pattern of pathology. Such a set o f symptoms 
and signs is called a syndrome, and from a clinical point of view it is convenient to categorise 
different ST D s by the syndrome they may cause (Meheus et al 1990). Important syndromes with 
which this thesis is concerned are the vaginal discharge syndrome, the urethral discharge 
syndrome, th e  lower abdominal pain syndrome and the genital ulcer syndrome
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The vaginal discharge syndrome (VDS) in women and the urethral discharge syndrome (LIDS) in 
men, which together form the group o f genital discharge syndromes (GDS) (M osha et al 1993), 
are all characterised by an excretion of watery or purulent exudate. Infections o f  the female 
genital tract may also involve the urethra, but urethritis in women is usually mild, and the term 
UDS is normally used as a synonym for GDS in men therefore.
In women, infection with Neisseria gonorrhoeae and Chlamydia trachomatis are primarily 
located in the cervix o f the uterus and are frequently asymptomatic (Hook and Handsfield 1990, 
Stamm and Holmes 1990). If they lead to a noticeable amount of inflammatory cervical exudate, 
this appears as VDS.
The proportion o f women complaining of VDS in whom a microbiological aetiology can be 
identified, seems to vary widely between different parts o f the world and seems to be very low in 
some countries, for example in a rural population in Bangladesh (Sarah Hawkes, personal 
communication 1998). The fact that many women who complain o f VDS are not infected with an 
RTI or STD may be o f concern for the design o f STD control programmes.
As a frequent complication of some infections in women, bactena may ascend to the upper 
reproductive tract and involve the Fallopian tubes, the ovaries and the pelvic cavity. The 
resulting syndrome is defined as pelvic inflammatory disease (PID) or, because the inflammation 
can clinically only be suspected, as lower abdominal pain (LAP) syndrome (WHO 1994).
A variety o f STD aetiologies are associated with the genital ulcer syndrome (GUS), which is 
defined by a disruption o f the integrity of the skin or the mucosal membranes of the reproductive 
organs (Plot and Plummer 1990). The appearance o f the ulcers can be extremely variable, 
making a clinical diagnosis unreliable in the absence o f diagnostic tests (De Schryver and 
Mcheus 1992, Ndinya-Achola et al 1996).
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2.1.2 Synopsis of STDs and RTIs frequently seen in East Africa
Infections leading to GDS
G onorrhoea: This is an acute infectious disease of the epithelium of the urethra and cervix 
caused b y  Neisseria gonorrhoeae (NG). The infection may ascend into the upper genital tract, 
and lead to  epididymitis in men, or to endometritis, salpingitis and PID in women. The infection 
may occasionally involve the rectum or other areas of the body and give rise to bacteraemia, 
resulting in metastatic complications (Hook and Handsfield 1990). NG is a gram-negative 
diplococcus which can be diagnosed microscopically in a gram-stained smear, or, with higher 
sensitivity, by culture. The bacterium has a tendency to develop antimicrobial resistance rather 
quickly, and has become resistant already to many of the drugs used for the treatment of 
gonorrhoea (Piot and Islam 1993, West et al 1995).
Infection with Chlamydia trachomatis: Location of the infection, symptoms, signs and typical 
complications are similar to gonorrhoea Different strains of Chlamydia trachomatis (CT) exist. 
GDS is mainly caused by serovars D - K, whilst serovars A - C are found in trachoma, and 
serovars L I - L3 in lymphogranuloma venereum (Mabey and Richens 1996). Diagnosis o f the 
small gram-negative bacteria by microscopy or culture, by polymerase chain reaction (PCR) or 
ligase chain reaction (LCR) is highly sensitive and specific, but is possible only in specialised 
laboratories. Methods which are simpler to use, such as an antigen-detection enzyme 
immunoassay (E1A) are still too costly and sophisticated to be employed routinely in developing 
countries (Noble 1997). Treatment is possible with a variety of antibiotic drugs including 
doxycvcline (Mabey and Richens 1996).
Trichomoniasis: Infection with the flagellate protozoan Trichomonas vaginalis (TV) is one o f 
the most frequent aetiologies of VDS, and may also lead to urethral discharge in men (Rein and 
Mueller 1990). There are many asymptomatic infections, particularly in men. In a cross- 
sectional survey in a rural community of Mwanza Region, 11% of the men were found to be 
infected (Buve et al 1996). The vaginal discharge caused by TV is typically copious, greenish- 
yellow and  frothy, but this sign is not specific. The diagnosis is made by microscopy o f a wet 
preparation of the vaginal or urethral excretion, or by culture For treatment, metronidazole is 
the drug o f  choice (Rein and Mueller 1990).
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Genital candidiasis: The yeast infection of the genital tract is caused by Candida albicans 
(CA), which may be transmitted sexually or spread from the intestine (M abey and Richens 
1996). The discharge may contain cheesy material adhering to the surface o f  the vaginal wall or 
glans penis. In men, the infection leads to balanitis (Stolz et al 1990). Asymptomatic infections 
occur in men more often than women. An immediate diagnosis can be made microscopically by 
wet preparation or a gram-stained smear. Treatment options include antimycotic pessaries and 
creams such as nystatin, or the use o f antimicrobial dyes such as Gentian violet.
Non-specific urethritis: A variety o f  bacteria are responsible for non-gonococcal, non- 
chlamydial and non-trichomonal urethral infections in men'. The type o f  discharge is not 
pathognomonic. A species specific diagnosis is difficult, and the diagnosis is usually based on 
the presence o f polymorpho-nuclear cells in the gram-stained urethral sm ear and exclusion of 
NG or CT infection. The infection usually responds to treatment w ith tetracycline or 
erythromycin (Bowie 1990).
Bacterial vaginosis (BV): This condition is characterised by vaginal discharge associated with 
an increase of vaginal pH, decrease o f  the physiologic lactobacilli flora and the presence o f a 
variety of bacterial species including Gardnerella vaginalis, Mycoplasma hominis and 
anaerobic bacteria such as Baclerioides spp. Peptostreptococcus spp, Prevotella spp and 
Mobiluncus spp., usually without an inflammatory tissue response of the vaginal wall (Spiegel 
CA 1991). Asymptomatic BV occurs frequently. Diagnosis has been based on the combination 
o f microscopic presence o f vaginal epithelial cells coated with bacteria (clue cells), increase in 
pH and fishy odour in the KOH test (Easmon et al 1991). More recently, a standardised 
quantitative morphological classification system has been introduced, using gram-stained smears 
o f the vaginal flora (Hillier 1993). BV can be treated with clindamycin or metronidazole.
Infections leading to G US
Syphilis: This systemic disease is caused by the spirochete Treponema pallidum , and is 
characterised by periods o f florid manifestations and years o f symptomless latency. Primary and 
sometimes secondary signs and symptoms involve the genital tract, but in principle the disease is
1 Chlamydia infection and trichomoniasis of the male urethra are sometimes also summarised under the 
term ‘non-specific urethritis’. Strictly speaking, the term should be limited to infections where the 
causative agent cannot be identified by means of routine laboratory methods
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systemic. The infection is usually transmitted sexually, but vertical transmission from mother to 
foetus occurs frequently. Primary syphilis is characterised by a usually painless ulcer (chancre) 
appearing usually within 3 weeks of infection. This chancre heals within 4 to 8 weeks. Secondary 
syphilis appears 6 to 12 weeks after infection, and is characterised by cutaneous rashes of 
different parts o f the body, which heal spontaneously after some time, but relapses occur. One 
genital manifestation of secondary syphilis is the extremely infectious condylomata lata, 
characterised by hypertrophic flat papules. The secondary stage is followed by latent 
(asymptomatic) syphilis which may last a few years or the rest o f the patient’s life. During this 
stage, syphilis may continue to smoulder as a systemic infection involving bones, viscera, the 
vascular system or the central nervous system. Clinical manifestations o f this process are defined 
as  tertiary syphilis (Sparling 1990).
Clinical diagnosis is not always straightforward. Neither the primary ulcer nor the secondary 
manifestations are pathognomonic, except for condylomata lata. Primary syphilis can be 
diagnosed through demonstration of T. pallidum  by darkfield microscopy o f  ulcer exudate This 
method is highly specific, but its sensitivity is low.
Diagnosis can be assisted by a variety of serological tests The tests used in the studies described 
in this thesis are the Treponema Pallidum Haemagglutination Assay (TPHA) and the Rapid 
Plasma Reagin (RPR) test The latter is similar to the Venereal Disease Research Laboratory 
(VDRL) test, but does not require the use of a microscope. A patient becomes TPHA positive 1 
to  4 weeks after infection, and usually remains positive for decades even if effectively treated 
(Larsen et al 1995). The test is highly specific, but cross-reaction occurs with non-syphilitic 
treponemal infections such as yaws (Schulz et al 1990, Arya 1996).
Seroconversion to the RPR test occurs 1 to 2 weeks after that for the TPHA test. The test turns 
negative some months after treatment, but stays positive in untreated patients. However, if 
treatment is given during the late latent phase, the test often remains positive, usually at a lower 
titre (Larsen et al 1995, Goeman et al 1995). The RPR test is non-specific, and false positive 
results may be observed in pregnant women, and in patients with malaria or some other 
conditions. The combination of a positive TPHA and a positive RPR test result suggests 
untreated or recently treated syphilis, and is often referred to as ‘active syphilis’ in 
epidemiological studies (Mabey 1986, Mosha et al 1993). A positive TPHA test result alone can 
be interpreted as indicating past or present syphilis. The combination o f a positive TPHA and a 
negative RPR test result indicates a syphilis infection which was treated successfully in one of
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the early stages. For the treatment o f syphilis, benzathine-penicillin, a long-acting penicillin is 
used (Musher 1991). So far, no cases of antimicrobial resistance have been described.
Chancroid: This is a localised disease, characterised by genital ulcers and often by suppuration 
of the inguinal lymphatic nodes, and is caused by Haemophilus ducreyi, a  slender gram-negative 
♦ bacterium. In contrast to the syphilitic chancre, chancroid ulcers are usually non-indurated,
painful and may be multiple. However, clinical misclassification as syphilis or herpes infection 
occurs, as do mixed infections (De Schryver and Meheus 1992, Ndinya-Achola et al 1996). 
Untreated infections may lead to phagedenic ulcers with massive tissue destruction. Diagnosis 
can be made by culture or PCR, both of which require a specialised laboratory. Recommended 
treatments include erythromycin, ciprofloxacin and trimethoprim-sulfamethoxazole (Ronald and 
Albritton 1990).
Genital herpes: Infection with Herpes simplex virus type-2 (HSV-2) is sexually transmitted. 
Infection is lifelong, symptomatic episodes occur at irregular intervals, and the recurrent lesions 
are always infectious. The periods between the manifestation of genital lesions are defined as 
latency. Latency can be established after both symptomatic and asymptomatic initial infection. 
Recrudescent productive infection with viral shedding is usually associated with genital lesions, 
but may be clinically asymptomatic (Corey 1990). Genital lesions start as grouped vesicles 
which erode and usually form painful ulcers which coalesce. Identical genital lesions can be 
caused by Herpes simplex virus type-1 (HSV-1). Diagnosis is possible using a specific antigen- 
detection enzyme immunoassay on ulcer exudate. Cure is not possible, but the size of the lesions 
and the duration o f the episode may be mitigated by systemic therapy w ith acyclovir (Corey 
1990).
Lymphogranuloma venereum (LGV): This disease, also known as lymphogranuloma 
inguinale, is caused by a subgroup o f Chlamydia trachomatis (serovars L1-L3). The 
symptomatology starts with a transient vesicular lesion, which ulcerates and quickly heals. This 
is followed by usually unilateral painful enlargement of inguinal lymphatic nodes, which turn 
into fluctuant abscesses and erupt. Healing with scarification may occur after a prolonged 
interval; chronic inflammation may lead to blockage of the lymphatic vessels with resulting 
oedema and possibly genital elephantiasis (Perine and Osoba 1990). The disease is 
comparatively rare in East Africa. It can be diagnosed with a chlamydia antigen detection EIA 
using material from the discharging abscess or serologically. Treatment is possible with 
tetracycline or erythromycin.
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Other common RTIs
Genital w arts and human papilloma virus infection: Genital warts often appear as small 
moist pedunculated growths (condylomata accuminata). They are usually caused by human 
papilloma virus (HPV) types 6 and 11. They occur most commonly in the coronal sulcus and the 
subpreputial area in men, and on the vulva, vaginal wall and the perineum in women. Genital 
warts can be treated topically with podophyllum, or through surgical intervention (Oriel 1990).
HPV type 16, more often than types 6 and 11, is associated with cervical carcinomas (Oriel 
1990). These seem to occur frequently in sub-Saharan Africa, and cervical intraepithelial 
neoplasms with proven HPV infection were repeatedly observed at the STD reference clinic in 
Mwanza (Philippe Mayaud, personal communication 1995). However, the issue of genital 
carcinoma is not subject to this thesis.
Balanoposthitis: Inflammation o f the glans penis and the preputium may be caused by a variety 
o f  aetiologic factors including lack of hygiene or a tight prepuce, but can also accompany 
candidiasis, trichomoniasis, gonorrhoea or ulcers o f the preputium (Stolz et al 1990).
2.1.3 Global epidemiology and public health importance of STDs
The burden o f STDs in the world, and particularly in developing countries, is enormous. The 
World Health Organization estimated that in 1995, 333 million new cases o f  syphilis, 
gonorrhoea, chlamy dial infection, and trichomoniasis occurred world-wide (WHO 1995).
According to the World Development Report 1993, the burden of disease in women of child 
bearing age caused by STDs (without HTV infection) is the second highest o f all groups of 
diseases, surpassed only by maternity related disorders. The annual loss o f Disability Adjusted 
Life Years (DALYs) in women due to STD related mortality and morbidity has been estimated at 
17.2 million (World Bank 1993).
It is their complications and sequelae rather than the acute episodes which make STDs such an 
important public health problem for women and their offspring: acute and chronic pelvic 
inflammatory disease, infertility, puerperal sepsis, ectopic pregnancy, abortion, stillbirth, low-
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birthweight and blind or diseased children (Wasserheit 1989, Laga 1994). These are discussed 
further in section 2.1.5.
Available data on the prevalence and/or incidence of STDs in developing countries are limited 
and confined to selected groups and often samples of convenience (O ver and Piot 1993). The 
estimates given above are not accurate therefore. However, there is much evidence that the 
proportion o f the population at risk is increasing in many developing countries. The spread o f 
STDs is strongly influenced by social and economic factors. Poverty and urbanisation are 
growing rapidly in many developing countries, are often associated with migrant labour and 
increased demand for prostitution, and are frequently the driving forces behind both STD and 
HTV epidemics (Laga 1994).
By contrast, in many industrialised countries, STD prevalences and incidences were declining 
until the end of the last decade and mostly remain at a very low level thanks to more favourable 
economic and social conditions, the existence o f a functional health care infrastructure, and 
effective control measures. For example, in 1989 the incidence of gonorrhoea was around 40 per 
100,000 in Denmark, whilst it was estimated at 3000 - 10,000 per 100,000 in large cities in 
Africa (De Schryver and Meheus 1990). On the other hand, high incidences of STDs have been 
reported from some populations of the US, with particularly high rates o f syphilis and 
gonorrhoea in the southern states Annual notification rates of primary and secondary syphilis 
are rising and exceed 60 per 100 000 in some places In these areas, the epidemic is concentrated 
in the poor heterosexual black population (Mushinski 1995, Nakashima et al 1996). Since about 
1990, almost all countries o f the former Soviet Union are experiencing a  major STD epidemic. 
For example, in the Russian Federation, the annual notification rate o f  syphilis has risen from 4 
per 100 000 in 1988 to 263 per 100 000 in 1996, equivalent to 62-fold increase (Trichonova et 
al 1997)
2.1.4 Epidemiology of STDs in sub-Saharan Africa
STDs are a public health problem all over Africa, but are much m ore common in countries 
situated south of the Sahara than in the north o f the continent. The STD related burden o f  disease 
per 100,000 women has been estimated as being more than 7-fold higher in sub-Saharan Africa 
than in North African and Middle East countries (World Bank 1993). The reasons for this 
difference are not fully understood (Piot et al 1990). Doubts remain concerning the quality of the
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data from North Africa, so that definite conclusions are difficult to draw. In sub-Saharan Africa, 
the overall combined incidence of syphilis, gonorrhoea, chlamydial infection, and trichomoniasis 
has been estimated at 254 per 1000 person years at risk (WHO 1995).
However, as in developing countries elsewhere, these figures reflect only estimates, generated by 
extrapolation of data from patchy sources. Many STD patients do not report to official facilities, 
diagnosis is mostly not based on laboratory results, and in most countries there is no compulsory 
registration or reporting o f STDs (Adler 1996).
Most epidemiological studies have been conducted in groups which are comparatively easy to 
reach, such as antenatal clinic (ANC) attenders (table 2.1), or certain high risk behaviour groups 
(table 2.2). The paucity o f studies performed in general populations is striking (table 2.3).
The available studies in various countries show high prevalences of most STDs even in low risk 
populations, and as one would expect higher prevalences in sex workers. For low risk 
populations, the prevalence of active syphilis frequently ranges between 4 and 12%, but levels as 
high as 18% have been observed in war-tom Mozambique (Lindstrand et al 1993, Vuylsteke et 
al 1993iii). Infections with Neisseria gonorrhoeae and Chlamydia trachomatis have frequently 
been observed in 2 - 10 % of the population, although again extraordinarily high levels have 
been reported, exceeding 15% in some communities (Arya 1973, Vuylsteke et al 1993iii). Cost- 
effective treatment of gonorrhoea has become difficult, as high levels o f  antimicrobial resistance 
against many drugs has been reported (Lind 1990, West et al 1995). More than 30% of the 
women in a population commonly have at least one type of RTI, and sometimes the prevalence 
exceeds 50% (Vuylsteke et al 1993iii, Mayaud et al 1995). Many STDs in both men and 
women, particularly those caused by gonococcal, chlamydial and syphilitic infections are 
asymptomatic (Arya 1973, Piot and Islam 1994, Grosskurth et al 1996). Asymptomatic 
infections with Haemophilus ducreyi occur as well, and may contribute to the transmission o f 
chancroid (D'Costa et al 1985). Observations from Tanzania are in line with findings in other 
countries in sub-Saharan Africa (tables 2.1 and 2.3).
In sex workers, the prevalence of active syphilis ranges between 14% and more than 70% (table 
2.2). Prevalences o f trichomoniasis, candidiasis and chlamydial infection are mostly similar to 
those observed in low risk population studies, but gonorrhoea and genital ulcers usually occur 
much more frequently, which underlines the importance of this group for STD control 
programmes (Over and Piot 1993).
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Table 2.1: Prevalences of various STDs from selected studies among pregnant women
in sub-Saharan Africa
Population C ountry STD N Prevalence Reference
Urban Ethiopia Active syphilis 337 11% Friedmann et al 
1977
Rural The Gambia Active syphilis 100 1% Mabey et al 1984
NG 6.7%
CT 6.9%
TV 32%
CA 35%
HSV-2 (cult ) 0%
Urban South Africa NG 1200 11.7% Welgemoed et al 
1986
Rural South Africa Active syphilis 193 12% O’Farrell et al
NG 5.7% 1989
CT 11%
TV 49%
CA 38%
BV 6.2%
Rural Zambia Active syphilis 925 8.0% Hira et al 1990
Rural Mozambique Active syphilis 15% Vuylsteke et al
N G /C T 16% 1993 (iii)
GUS 6%
Anv STD 201 51%
Urban Mozambique Active syphilis 202 18% Lindstrand et al 
1993
Urban Burkina Faso Any STD 645 32% Meda et al 1997
Active syphilis 3.6%
NG 1.6%
CT 3.1%
TV 14%
CA 14%
BV 13%
GUS 0.8%
Genital warts 3.0%
Rural Tanzania1 Active syphilis 964 10.1% Mavaud et al
NG 2.1% 1995
CT 6.6%
NG/CT 8.4%
TV 27.4%
CA 14.3%
GUS 0.9%
Any STD 39.2%
Anv RTI 49.1%
Active syphilis: combination of positive TPHA or FTA with RPR or VDRL tests,
NG Neisseria gonorrhoeae, CT Chlamydia trachomatis, TV Trichomonas vaginalis, 
CA Candida albicans, HSV Herpes simplex virus-2, GUS Genital ulcer syndrome,
1 Mwanza Region 1992
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Table 2.2: Prevalences of various STDs from selected studies among high risk behaviour
groups in sub-Saharan Africa
Population Country STD N Prevalence Reference
Urban sex workers Kenya NG
high income 71 16% D’Costa et al
intermediate 51 28% 1985
low income 71 46%
Urban sex workers Kenya Active syphilis
high income 71 14%
intermediate 51 31%
low income 71 52%
Urban sex workers Kenya GUS
high income 71 2.8%
intermediate 51 11.8%
low income 71 8.5%
Urban sex workers Kenya Chancroid or
high income carrier of 71 0%
intermediate Haemophilus 51 7.8%
low income ducreyi 71 8.5%
Urban sex workers The Gambia Active syphilis 31 71% Mabey 1986
Urban sex workers Zaire Active syphilis 1233 16% Nzila et al
GUS 5% 1991
NG 23%
CT 13%
TV 22%
CA 10%
Genital warts 3%
Anv STD 75%
Urban promiscuous Djibouti Active svphilis 105 14% Fox et al 1989
men NG 34%
CT 6%
Legend: see table 2.1
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Table 2.3: Prevalences of various STDs from community based studies in sub-Saharan Africa
Population Country STD N Prevalence Reference
Rural men Uganda1 NG 166 4 2% Arya et al 1973
Rural women NG 168 2.3%
Rural men NG 270 8.9%
Rural women NG 295 18%
Rural men Somalia Active syphilis 187 4.2% Osman et al
CT 6.0% 1990
NG 0%
Rural women Somalia Active syphilis 200 16%
CT 18%
NG 0%
Rural villagers Uganda Active syphilis 294 11% Wagner et al
HD antibodies 10% 1994
HSV-2 68%
antibody
Rural Nigeria Active syphilis 158 2.6% Brabin et al
adolescent girls (Rivers State) CT 10.5% 1994
(aged 17-19 y) NG 1.9%
TV 8 3%
CA 35.9%
Any STD 20.9%
Anv RTI 43.8%
Urban men Tanzania2 Active syphilis 597 9.3% Mosha et al
GUS4 0.2% 1993
GDS4 1.0%
Urban women Tanzania2 Active syphilis 590 12.4%
GUS4 1.0%
GDS4 1.0%
Rural men Tanzania3 Active syphilis 978 7.0
GUS4 1.7
GDS4 2.6
Rural women Tanzania3 Active syphilis 1046 7.9
GUS4 0.4
GDS4 2.1
Rural men Tanzania' NG4 5876 2.2% Grosskurth et al
CT4 0.7% 1996
NG/CT4 2.7%
A ctne syphilis: combination of positive TPHA or FTA with RPR or VDRL tests.
NG Neisseria gonorrhoeae, CT Chlamydia trachomatis, TV Trichomonas vaginalis, CA Candida 
albicans, HSV-2 Herpes simplex virus type-2, GUS Genital ulcer syndrome. GDS Genital discharge 
syndrome,
'Two different rural communities 2Mwanza town 1990/91, ’Mwanza Region 1990/91, ^Minimum 
prevalences (self reported and clinically confirmed infections), 5Mwanza Region 1992
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2.1.5 The epidemiology and public health importance of STD sequelae
Many STDs may lead to serious complications, particularly in women and their off-spring. 
Epidemiological data about the incidence of these events in sub-Saharan Africa are scarce, but it 
is expected that the risk is at least as high as in industrialised countries (Wasserheit 1989). The 
data given below refer to observations from industrialised countries, except where specific 
reference to developing countries is made.
Pelvic inflammatory disease: About 10 - 15% of women with untreated chlamydial cervicitis 
and up to 20% of women with untreated gonococcal cervicitis develop PID (De Schryver and 
Meheus 1992, Wasserheit 1989). The bacterial flora seen in BV can often also be recovered 
from peritoneal fluid and tubal specimens o f women with PID, suggesting that BV may 
frequently be the antecedent o f pelvic infection. The risk of PID is particularly high in 
intrauterine device users and in women with cervical infection in whom abortion is performed 
{Wasserheit 1989).
PID frequently results in tubal blockage or tubal scarring, both intraluminal and peritubal, 
leading to complications which have devastating consequences for the health of women in 
countries with insufficient health care systems. These complications include infertility, chrome 
pelvic pain, and ectopic pregnancy. The risk o f these complications increases with increasing 
numbers of PID episodes (Wasserheit 1989).
Chronic pelvic pain: The chronic lower abdominal pain following peritubal scarring is often so 
severe that it may have a debilitating effect on women. This condition develops in 15 - 20% of 
women who had PID (Wasserheit 1989).
Infertility: The prevalence o f infertility seems to be higher in sub-Saharan Africa than in all 
other continents, often exceeding 20% and reaching a level of 50% in some communities (Muir 
and Belsey 1980, Rosenberg et al 1986). It has been estimated that 80% o f infertility in Africa is 
attributable to STDs (Belsey 1976). Infertility may result from gonococcal but even more often 
from chlamydial infection (Mabey et al 1985), probably because acute gonococcal PID is more 
severe and patients are more likely to seek treatment. The social consequences o f infertility for 
women may be severe in societies where much o f the social value of an individual is attached to 
the capability' to reproduce (Wasserheit 1989). Infertility and pregnancy wastage may result in 
divorce, or prostitution in order to survive (Laga 1994).
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STDs are also associated with male infertility. Untreated or inadequately treated gonococcal or 
chlamydial infection in men frequently leads to epididymitis which is the leading cause of male 
infertility in Africa (De Schryver and M eheus 1992). In a study o f  infertile couples in Lagos, 
Nigeria, 40% of the husbands had oligo- o r  azoospermia, and most o f  them reported a history o f 
untreated or undertreated urethritis (Osoba 1984). In a community based study in Uganda, 29% 
o f the men in the general population had evidence o f chronic orchitis or epididymitis, 22% of 
which was bilateral (Arya et al 1973). T he commonest late complication of urethritis is urethral 
stricture which may also represent a considerable handicap to conception (Osoba 1984).
E c to p ic  p r e g n a n c y :  The risk of ectopic pregnancy has been estimated to be increased up to 
tenfold in women who had one or m ore episodes o f PID, as compared to women without a 
history of PID, and postinfectious ectopic pregnancy occurs more often in developing than in 
industrialised countries (Muir and Belsey 1980). Because diagnostic and therapeutic possibilities 
are far more limited in developing countries, the mortality of ectopic pregnancy is also much 
higher (Wasserheit 1989). Precise epidemiological data are lacking, however.
P u e r p e r a l  u p p e r  r e p r o d u c t iv e  t r a c t  i n f e c t io n s :  Deliveries conducted in the presence o f  an 
STD. notably cervical infections and bacterial vaginosis, can frequently lead to endometritis and 
generalised sepsis (Plummer et al 1987, Brunham et al 1990).
A b o r t io n  a n d  s t i l lb i r th :  Pregnancy wastage is frequently associated with STDs. Early 
spontaneous abortion is associated with gonococcal and Herpes simplex virus type-2 infection, 
and 2nd and 3rd trimester abortion and stillbirth with syphilis (Schulz et al 1987, Wasserheit
1989) . In various African studies it has been shown that 20% to 40%  of pregnancies in women 
with untreated syphilis result in perinatal death (Ratnam et al 1982, Schulz et al 1987, Hira et al
1990) . Based on the same studies, it has been estimated that 10% to 40% o f all perinatal deaths 
arc caused by syphilis in countries with a  syphilis seroprevalence o f  around 10%.
P r e m a tu r e  d e l iv e ry  a n d  lo w  b i r th  w e i g h t :  The incidence of low birth weight is higher in 
developing than in industrialised countries, and is as high as 30% in many areas. RTIs are an 
important contnbuting factor for low b irth  weight (Wasserheit 1989). Low birth weight, which is 
a major nsk factor for infant mortality, occurs because of intrauterine growth retardation or 
premature delivery, and STDs are frequently associated with both Bacterial vaginosis, 
chlamydial and gonococcal infection m ay  all result in premature rupture o f membranes (French
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and McGregor 1997). Preterm delivery occurred in 12% of pregnancies of mothers with 
untreated syphilis in a study in Zambia (Hira et al 1990).
Congenital syphilis: About 30% to 40% of infants bom to mothers with active syphilis are 
infected with Treponema pallidum  as a result of intrauterine transmission (Wasserheit 1989, 
Temmerman et al 1993). About half of them have the signs of congenital syphilis which 
frequently leads to neonatal death or permanent disability and disfigurement (Schulz et al 1987, 
Temmerman et al 1993). Diagnosis at birth is difficult, and the problem is therefore often 
underestimated (Temmerman et al 1993).
Ophthalmia neonatorum (ON): During delivery, about 30 - 50% o f  mothers infected with 
Neisseria gonorrhoeae and about 30% of those infected with Chlamydia trachomatis pass the 
infection on to their babies (Wasserheit 1989). In many cases this results in purulent eye 
infection (ophthalmia neonatorum). Gonococcal ON in particular, if  untreated, often leads to 
blindness (Schulz et al 1987). This could be prevented by ocular prophylaxis, but in many 
African countries prophylaxis has been discontinued or is incompletely applied. It has been 
estimated that the incidence of ON ranges between 0.5% and 5% o f  all neonates in Africa, 
depending on the prevalence of cervicitis due to NG or CT among pregnant mothers (Meheus 
1988. Laga 1994). The incidence o f blindness from gonococcal ON in Africa is unknown, but 
the overall prevalence of blindness is low. It has been speculated that this is due to high mortality 
among blind children (Schulz et al 1987). The seriousness of gonococcal eye infection was 
demonstrated in a study from Mozambique, which documented that 26 o f  89 adults and 2 of 176 
babies lost sight in one or both eyes as a result of gonococcal eye infections (Bastos dos Santos 
et al 1992).
It follows from the facts described in sections 2.1.3 - 2.1.5 that the STD epidemic in the 
developing world in general, and in sub-Saharan Africa in particular represents one o f the most 
important public health problems (World Bank 1993) and is characterised by a high incidence 
and prevalence in many populations, a high rate o f serious complications, a high rate of 
asymptomatic infections, and an alarming problem of antimicrobial resistance (Laga 1994, Lind 
1997).
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2.1.6 STD case management
Appropriate STD case management comprises four steps: correct diagnosis, effective treatment, 
health education to achieve treatment compliance and sustainable risk reduction, and effective 
partner notification (Meheus et al 1990, Mayaud et al 1994, Adler et al 1996).
Approaches to STD case management
There are in principle three distinct approaches to STD case management: clinical, aetiological 
and syndromic case management. These approaches differ mainly in the way the diagnosis is 
made.
(i) Clinical case management attempts to arrive at a specific diagnosis based on clinical 
examination, and to treat the assumed aetiology. This traditional approach has been widely used 
by care providers without access to  laboratory services. However, the low sensitivity and 
specificity o f this approach has been emphasised by various authors (e g. Meheus et al 1983, 
Dangor et al 1990 et al, Ndinya-Achola et al 1996, Chilongozi et al 1996). The high rate of 
misclassification and the resulting inappropriate treatment has been demonstrated for example in 
a study from Kenya, where in 168 patients with clinical ulcers, the specific clinical diagnosis was 
compared with laboratory results. Sensitivity, specificity, and positive predictive value for the 
clinical diagnosis of chancroid were 93%, 16% and 41%, and for the diagnosis of syphilis 25%, 
88% and 25%. As can be expected, treatment was frequently inadequate, particularly for syphilis 
(Ndinya-Achola et al 1996).
(ii) Aetiological case management is based on laboratory diagnosis. A number of obstacles make 
this approach largely inappropriate for Africa and most developing countries elsewhere: 
Laboratories frequently do not exist, o r where they exist, quality control systems are insufficient 
(Mayaud et al 1994, Ndinya-Achola et al 1996, Adler 1996). For some STDs, such as 
Chlamydia trachomatis infection, available tests are expensive, sophisticated or not sufficiently 
sensitive (Noble 1997). Unfortunately, cheap, simple and sufficiently sensitive and specific 
diagnostic tests for Neisseria gonorrhoeae and Chlamydia trachomatis are not available (Piot 
and Islam 1994).
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(iii) Syndromic case management is based on the diagnosis of the syndrome (section 2.1.1). In 
principle, all likely aetiological causes o f that syndrome are treated simultaneously at the place 
and time o f first contact o f the STD patient with the health sector. The approach has been 
strongly promoted by the World Health Organization (WHO 1991).
Syndromic STD case management
Because the major possible causes of an STD syndrome are covered, the syndromic approach is 
by definition highly sensitive. Delays in the initiation of treatment are avoided, as patients do not 
need to wait for laboratory results (Mayaud et al 1994, Chilongozi et al 1996). The increased 
costs due to overtreatment are outweighed by the savings on laboratory costs. In a study o f 1500 
hypothetical STD patients with different syndromes using decision-theory analysis, it was 
demonstrated that both clinical and laboratory based case management cost two or three times as 
much as the syndromic based approach (WHO 1993). The treatment of STDs can be 
standardised with the help o f algorithms, thus enabling paramedical staff to  make use of it, and 
this approach facilitates procurement and logistics in control programmes. WHO has published a 
complete set o f syndromic treatment algorithms and recommendations for the selection of drugs 
(WHO 1994).
Syndromic case management allows STD treatment services to be integrated within the existing 
primary health care system of sub-Saharan Africa. This integration is essential because most 
STD patients in developing countries have no access to the few specialised services which may 
be available (Wasserheit 1989, Piot and Islam 1994, Laga 1994, Mabey 1996). The validity and 
the operational feasibility o f this approach in sub-Saharan Africa has been demonstrated in 
several studies (Vuylsteke et al 1993ii, Piot and Islam 1994, Mwijarubi et al 1993, Chilongozi et 
al 1996)
The validity o f specific algorithms depends on the correct choice of drugs to be included in the 
algorithms. Algorithms have to be adjusted therefore to the specific situation in a country' or 
region, in terms o f the underlying pattern of aetiologies and the antibiotic susceptibility of STD 
pathogens in that area (Mayaud et al 1994, Wilkinson 1997). At least one specialised clinic and 
reference laboratory is required to monitor these parameters (Adler et al 1996).
The syndromic approach has also a number of disadvantages and unsolved problems
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Patients are frequently treated for infections which they do not have, thus exposing them to 
possible side effects unnecessarily. Physicians who are familiar with an approach whereby 
treatment should only follow a  full microbiological diagnosis, have difficulties in accepting a 
method which they perceive as unscientific (Kumar et al 1995).
The main problem, however, lies in the management o f the vaginal discharge syndrome (Laga 
1994, Adler 1996). The most dangerous infective agents o f the female reproductive tract, 
Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT), are frequently asymptomatic. 
This has two consequences: I f  the treatment o f  these infections is included in the algorithm for 
VDS, the syndromic approach has a high sensitivity for these infections in women presenting 
with VDS, but a very low specificity, as many women will be treated unnecessarily; for example 
90% in a study from Zaire (Vuylsteke et al 1993i). On the other hand, as a result of 
asymptomatic infections, the syndromic approach has a low sensitivity to detect NG and CT 
among women in the community who have these infections, but the sensitivity would be zero if 
the treatment o f NG and CT were not included in the algorithm.
An attempt to overcome this problem has been made through the introduction o f a risk 
assessment step into the algorithm for the management o f  VDS, hoping that this would increase 
the algorithm’s specificity for N G  and CT infection without losing much sensitivity (Vuylsteke et 
al 1993i. WHO 1994, Mayaud et al 1995). The validity o f  this approach was recently evaluated 
in women presenting with vaginal discharge at the STD reference clinics in Mwanza. 
Unfortunately the sensitivity w as only about 46%  and 62% in pregnant and non-pregnant women 
respectively (Mayaud et al 1997ii). A final solution to this problem will only be possible once 
cheap, simple and accurate diagnostic tests are available for use at peripheral health facilities 
(Piot and Islam 1994).
Health education
The great importance of health education during the process o f case management is underpinned 
by the fact that STD patients are  at high risk for repeat infections and HIV, because o f their 
sexual behaviour or that o f their partners (Meheus et al 1990). HIV prevalences in STD patients 
sometimes reach very high levels, e g. 35% in Abidjan, 63% in Kampala or 55% in Lusaka in 
different studies (Somse, Hcllamann, Tembo as cited by Nkowane 1991). The contact o f a health
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Whilst the concept o f  health education is clear, implementation does not seem to be easy 
(Wilkinson 1997). The few studies which have been conducted so far in developing countries to 
investigate the performance of integrated STD services demonstrated that health education is 
actually given far too rarely, for example in only 30% of STD cases in some health facilities in 
Honduras, 20% in Ivory Cost, or 30% in India (Mertens et al 1993, Kantharaj et al 1995), and 
29% in Malawi (Chilongozi et al 1996).
worker with an STD patient should be regarded as a privileged moment for education about risk
reduction and condom use (Piot and Islam 1994).
Partner notification and  treatment
Partner notification is an essential part of good STD case management (Wellington 1994, 
Mayaud et al 1994, Adler et al 1996). It can be achieved through active efforts of health 
personnel to locate the sexual partner(s) of STD patients (provider referral), or through health 
education o f the STD patient (index case) to persuade his or her sexual partner(s) to seek 
treatment at the health facility- (partner referral).
Few studies have investigated the effectiveness o f these approaches in Africa It seems that the 
proportion of partners treated seldom exceeds 30% (Hayes et al 1997), and that provider referral 
in particular has a very low cost-effectiveness (Adler et al 1996). In a study in Nigeria, 156 STD 
patients were notified through partner referral, and 74 of these (47%) attended a clinic. Home 
visits by clinic staff to another 56 patients yielded only a further 4 successful provider referrals 
(Asuzu et al, 1984). On the other hand, in a programme in Harare, successful partner referral 
was achieved in only 23 % of 1513 sexual contacts, and subsequent provider referral yielded a 
further 17% (Winfield and Latif 1985).
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2.1.7 Options for STD control in developing countries
STD control has two major objectives: (i) to prevent infections through behaviour modification 
and the use o f barrier methods; and (ii) to keep the duration o f infection as short as possible 
through optimal case finding and management (Laga 1994, Adler 1996). To assist the design of 
control strategies, operational models have been developed to define the overall proportion of 
STD cases in the community that are successfully treated by the health services, and the stages 
at which failure occurs (Buve et al 1993, Fransen 1993, Laga 1994, Adler et al 1996).
An example is the Piot-Fransen model shown in figure 2.1 (Hayes et al 1997), based on real data 
on STDs in women obtained from a variety o f studies conducted in East and Central Africa 
(Vuylsteke et al 1993i, Newell et al 1993, Mulder 1994, Buve et al 1996).
In the absence o f improved STD treatment services, about half o f all sexually active women in 
the model community have a reproductive tract infection at any point o f time, but only about half 
of them are symptomatic. Only about two-thirds o f these symptomatic women seek treatment, 
and even fewer go to a health unit or other medically trained care provider. O f the 30% of 
infected women who present for treatment at a typical peripheral health facility, as few as one in 
five mat’ be treated appropriately. Not all o f these will complete their treatment, and not all will 
be cured O f those cured, at m ost 40% will persuade their partners to seek treatment.
Under these conditions, only 1 to  5% of the infected women will be cured, and many of these 
may be rapidly reinfected because their partners remain untreated. The situation in men is little 
better, especially considering that a high rate o f asymptomatic infections is also observed in men 
(Arya 1973, Grosskurth et al 1996, Buve et al 1996).
Classically, STD control programme planners have focused on the last steps o f the model, 
neglecting the initial ones, which may be crucial in determining the final outcome of the 
programme (Laga 1994).
It is clear from the model that the majority o f individuals with an STD in sub-Saharan Africa do 
not reach the health system, and that improved STD case management alone can reach at most 
about 30% o f those infected (figure 2.1, part b). The magnitude o f this problem was not yet 
known in the late 1980s when the Mwanza trial was designed to study the impact o f STD control 
through the improvement o f health services.
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A100%
50%
35%
30%
6%
4%
3%
1%
B
All women 
With STD/RTI 
Symptomatic 
Seek treatment 
Go to health unit 
Treated correctly 
Compliant 
Treatment effective 
Partner treated
C
All women 
With STD/RTI 
Symptomatic 
Seek treatment 
Go to health unit 
Treated correctly 
Compliant 
Treatment effective 
Partner treated
All women 
With STD/RTI 
Symptomatic 
Seek treatment 
Go to health unit 
Treated correctly 
Compliant 
Treatment effective 
Partner treated
Figure 2.1: Piot-Franscn model of obstacles to and possible strategies for effective STD control
The model shows overall STD/RTI prevalence and proportions of infected patients reaching different 
steps towards possible effective cure. The model uses a population of rural women in a hypothetical 
community in sub-Saharan Africa as an example. Data arc illustrative and based on observations from 
Uganda. Tanzania and Zaire (Hayes et al 1997)
A situation in the absence of improved STD services; B potential effect of improved STD case 
management services, C potential effect of mass STD treatment
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The model can be used to systematically consider the options available for improved STD 
control (Laga 1994, Adler et al 1996, Hayes et al 1997). These are:
• primary prevention o f STDs in those who are not (yet) infected
• screening for individuals with asymptomatic infections
• screening for patients w ith symptomatic but neglected STDs
• improvement o f treatment seeking behaviour
• improvement of STD treatment services
• improvement o f partner notification and treatment
Additional options are the  mass treatment o f STDs and targeted interventions through the 
provision of special intervention packages for sex workers and other members o f the ‘core group’ 
(Brunham 1991, Moses et al 1991, Over and Piot 1993).
Mass treatment o f STDs is a controversial option for STD control. It has the advantage o f 
reaching not only individuals with symptomatic STDs and their sexual partners, but also 
asymptomatic and neglected cases (figure 2.1, part c). Disadvantages are the unnecessary 
treatment of uninfected persons, the potential creation of antimicrobial resistance in STD and 
non-STD microbes, and the  enormous logistical requirements. A mass treatment intervention is 
costly, but may nevertheless be very cost-effective (Wawer et al 1996, Adler et al 1996, Hayes et 
al 1997).
The core group concept o f  STD control is based on the assumption that a relatively small 
proportion of the population is responsible for the maintenance of the STD epidemic, and that 
this group of transmitters is particularly important for disease control. The core is an 
epidemiological concept rather than a precisely defined group. Some sex workers are a relatively 
easy to reach part of the core, but the core comprises many other individuals (Hethcote and 
Yorke 1984, Over and Piot 1993).
Using a computer simulation model, Over and Piot showed that cunng a certain number of cases 
of gonorrhoea in the core prevents many more secondary and tertiary cases o f  gonorrhoea in the 
general population than curing the same number o f people in the noncore population. If this 
dynamic benefit is studied in a one-time intervention, the effect peaks several months afterwards, 
then decreases, but is still noticeable for a considerable time (Over and Piot 1993).
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Core group interventions are most successful if  they combine several intervention strategies as a 
package, e g. health promotion through peer education, unproved STD case management, and 
regular screening (Over and Piot 1993, Adler et al 1996). Unfortunately, core groups are often 
difficult to define or locate in rural populations, limiting the applicability o f this approach in 
many parts o f Africa.
2 .1 .8  S T D  c o n tr o l  p r o g r a m m e s  in  s u b - S a h a r a n  A fric a
Until recently, the health programmes of developing countries have not given a high priority to 
the control o f STDs. The same applies to international health agencies and to donor 
organisations (Rosenberg et al 1986, Over and Piot 1993). Although STDs on their own have 
such severe consequences for the health of the population in developing countries (sections 2.1.3 
- 2.1.5), it was only the emergence of HTV infection, and the suspicion that there is an 
epidemiological synergism between STDs and HIV infection, that has pushed STDs high up on 
the health policy agenda (Laga 1994).
As from the early 1990s, almost all countries in sub-Saharan Africa declared the control of 
STDs to be a major target o f their health policies. However, few have made a serious attempt to 
put this policy into general practice. Implementation is hampered by inadequate health services, 
expensive medications, and a variety of sociocultural factors. Another obstacle is posed by the 
multiplicity of the factors affecting acquisition and transmission o f STDs which means that the 
health sector alone would be overburdened with the control o f this problem, and that a high 
degree o f intersectoral cooperation is therefore required (Gelmon and Moses 1994).
Against this background it is not surprising that there is no country so far which has 
accomplished a comprehensive STD control programme which would cover the majority o f its 
population or which would include most of the options described in section 2.1.7.
However, some reports o f successful STD control efforts are available from different sub- 
Saharan African countries. These arc highlighted below, using the framework described in
section 2.1.7.
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Primary prevention
Adaptation o f sexual behaviour towards risk reduction is very difficult to obtain and, once 
achieved, to maintain. Programmes to increase awareness have largely failed to achieve a 
sustainable impact on sexual behaviour. Primary prevention is particularly difficult to achieve in 
many developing countries, because sexual behaviour is very much determined by social and 
economic factors. Not uncommonly, women have sex on a commercial basis against their will 
and are unable to effectively negotiate the use of condoms. Improving the status and the 
economic situation o f women could contribute substantially to the control o f STDs and HTV 
infection (Adler 1996). Against this background, primary prevention is a  difficult task.
Nevertheless, it has been demonstrated that behaviour changes and increased condom use in the 
general population are possible, provided the price of condoms is affordable (Piot and Islam 
1994) Social marketing has proven to be the most successful approach. For example in Zaire, it 
has been employed successfully in a large scale mass media based promotional programme 
which was able to increase annual condom sales from 20 000 to more than 18 million within one 
year (Kvungu 1992). Primary prevention in high risk behaviour groups through intensive 
condom promotion has also been shown to be successful (Laga et al 1994ii, Ettiegne-Traore et al 
1996).
More recently, the focus o f attention has shifted to primary prevention among adolescents. For 
example, as in several other areas, a school health education programme was established in 40 
schools of Kabalc District, Uganda An operational evaluation showed that the programme was 
well accepted in the community and by the students themselves. Self reported risk behaviour 
improved significantly over a period o f 2 years, as demonstrated by two consecutive cross- 
sectional surveys conducted among 400 primary school students (Bagarukayo et al 1995).
So far, no results on the impact of health promotion interventions based on well designed trials 
have been reported anywhere in Africa. The first trial to investigate the impact o f an educational 
intervention aiming at sexual behaviour changes in the general adult population is presently 
being conducted in 18 parishes of the Masaka district of Uganda (Kengeya-Kagondo et al 1996). 
A trial to determine the impact of an adolescent reproductive health intervention has started 
recently in 20 communities o f the Mwanza Region in Tanzania (LSHTM and AMREF 1996).
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Screening
It has been repeatedly recommended that both STD case management and regular STD screening 
should be integrated within family planning, antenatal and mother and child health services 
(Wasserheit 1989, Meheus et al 1990). Whilst cheap and simple screening tests for gonococcal 
and chlamydial infections are still awaited, it would for many years have been possible to screen 
all women for serological syphilis and for neglected or mildly symptomatic syndromes. Although 
the benefits are so obvious, however, large scale implementation of regular screening for syphilis 
has only been accomplished in a few places.
An exemplary evaluation study, which describes the status-quo of STD services in antenatal care 
in many countries, has been performed in East Africa. In Kenya, syphilis screening in pregnancy 
is part o f the national health policy. During the time o f the evaluation, an estimated 90% of all 
pregnant mothers attended ANC services in Nairobi. Blood taken at various ANC clinics w as 
sent for syphilis screening to a central laboratory. Women were informed about their results a  
few weeks later If they were positive, they were sent to a specialised STD clinic. Due to various 
logistical problems, a syphilis screening test was actually done for less than 10% of the women. 
Only a small proportion of seropositive women were able or willing to attend the STD clinic. 
Even after an intervention improving the logistical situation, only 62% of women were screened, 
and a result was available for only 87% of these 4% (eleven women) had active syphilis. O f  
these, only one woman was adequately treated (Temmerman et al 1993).
However, successful screening is possible and can be cost-effective, as demonstrated in a study 
in Zambia. An intervention trial was conducted at three centres in Lusaka involving 5007 
prenatal attenders to investigate the effectiveness o f health education given to pregnant mothers, 
and of prenatal syphilis screening which was performed on the spot using the RPR test. The 
prevalence of active syphilis in the study population was 8%. Compared to two control centres 
during the one year study period, the proportion o f mothers attending for prenatal visit at the 
intervention centre improved from 9%  to 43%, and adverse pregnancy outcomes were reduced by  
two-thirds (Hira et al 1990).
Improvement o f  treatment seeking behaviour
There are no reports o f interventions to improve treatment seeking among STD patients, 
although it has been acknowledged that the problem is a serious one (Buve et al 1993, Mulder 
1994, Hayes et al 1997).
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Improvement o f  STD treatment services
Most African countries have adopted a strategy’ of integrating improved STD case management 
into their primary health care (PHC) system, usually based on the syndromic approach for STD 
case management. Very few  have been successful in establishing such intervention programmes 
on a large scale Positive examples have been reported from Zimbabwe, Zambia, Mozambique, 
and Rwanda but even in these countries the improved services are still restricted to the capital 
and a few districts (Wellington 1994, Hira et al 1990, Bastos dos Santos et al 1992, Steen et al 
1996).
The example of Mozambique shows that the strategy is feasible even under the extremely 
difficult circumstances o f a  post-war situation. Available documentation describes that improved 
STD case management w as introduced at 20 health centres which served a population o f about 
1 2 million inhabitants. The intervention comprised the creation o f a management structure in the 
Ministry o f Health, the establishment o f  a training programme for PHC workers, o f a supply 
procurement system and o f  a reference centre, a monthly supervision system, the distribution o f 
an information leaflet to patients, and condom promotion. At some of the health centres, regular 
syphilis screening was introduced for pregnant mothers An operational evaluation covering a 
one-year period showed that about 34,000 STD patients and about 5,000 (15%) sexual partners 
had been treated, and that fewer than 5% o f the patients required referral to the reference clinic 
(Bastos dos Santos et al 1992). Impact data from this intervention are not available.
Improvement o f  partner notification and treatment
There are no reports on interventions which aim exclusively at improving partner treatment 
coverage Usually such efforts are part o f  improved case management (Winfield and Latif 1985, 
Asuzu et al 1984, Wellington 1984). The different approaches to improve partner notification 
and their effectiveness are outlined in section 2.1.6. It seems that for developing countries, 
partner referral and the use o f a simple coded contact referral card is the most effective solution 
(Mwijarubi et al 1993, M ayaud et al 1994, Adler et al 1996).
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Targeted interventions for sex workers and other core groups
This is probably the area where most STD control activities are being implemented at present in 
sub-Saharan Africa. However, with a few exceptions, there is still no large scale coverage. Most 
o f the interventions combine treatment of STDs with health promotion and condom distribution.
Sex worker intervention projects have been launched in many locations, including Nairobi, 
Kinshasa, Abidjan and Mwanza (Moses et al 1991, Laga et al 1994ii, Ettiegne-Traore et al 
1996, Matasha et al 1992). The interventions and evaluation results are described in section
2.3.5.
Truck drivers and their assistants are regarded as another important component of the core group 
(Over and Piot 1993). Truck driver intervention projects have been launched since the early 
1990s in various countries, notably Cameroon, Nigeria, Zimbabwe, Kenya, and Tanzania, but 
few reports have been published (Jackson et al 1997, Mwizarubi et al 1994). Some of these 
projects have achieved a high degree of coverage For example, in a nation-wide project in 
Tanzania, five different NGOs have covered different parts of the country and adopted a  
standard intervention approach which includes condom provision at truck stops, health education 
through leaflets, stickers on lorries and other promotional materials, health education to sex 
workers at truck stops, and improved STD case management in clinics at transport companies 
and at some of the truck stops (Mwizarubi et al 1994).
Mass treatment
For STD control, mass treatment of the general population is still a theoretical concept A trial to  
test this concept is underway in the Rakai district of Uganda (see section 2.3.5).
2.2 HIV infection and AIDS
2.2.1 Definition and synopsis
The acquired immunodeficiency syndrome (AIDS) was first described in the US in 1981, when 
an unexpectedly frequent occurrence of cases of atypical pneumonia caused by Pneumocystis
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carinii and of Kaposi’s sarcoma was noted in homosexual men (Friedmann-Kien 1981, Gottlieb 
et al 1981, Siegal et al 1981). AIDS is characterised by a marked reduction o f those T- 
lymphocytes which carry the CD4-receptor molecule, a progressive destruction o f lymphoid 
tissue, severe impairment of immune function, and a variety o f  opportunistic infections (Pantaleo 
et al 1997).
The retroviral aetiology of AIDS was revealed in 1983 (Barre-Sinoussi et al 1983). The newly 
discovered virus w as initially named human T-cell lymphotropic virus type III (Hahn et al 1984). 
In 1986, the term was replaced by human immunodeficiency virus type-1 (HTV-1). The 
laboratory detection o f serum antibodies against the viral antigen became possible as from 1984. 
These antibodies are  not protective, but their occurrence is diagnostic o f HTV-1 infection in 
adults, and can be used to study the prevalence o f the infection in epidemiological studies.
The typical course o f  HIV infection includes three phases: primary infection, clinical latency, and 
clinically' apparent disease which comprises different stages (Pantaleo et al 1997). The median 
incubation period from infection to AIDS is around 10 years in industrialised countries, and may 
be somewhat shorter in sub-Saharan Africa. Once a patient develops AIDS, death will usually 
occur within 2 to 3 years. The survival time from AIDS to death seems to be shorter in sub- 
Saharan Africa; for example in a rural cohort from Uganda it was 9 months on average (Morgan 
et al 1997).
Combination therapy with antiretroviral drugs can suppress viral replication, but is unlikely to be 
introduced on a large scale in developing countries for the foreseeable future because of the 
prohibitive costs. Efforts to develop a protective vaccine are underway, but no breakthrough has 
been achieved so far (Clements 1997).
In 1985 a second related human immunodeficiency retrovirus (HIV-2) was discovered in two 
AIDS patients from West Africa (Clavel et al 1986). Its core antigens resemble those o f HIV-1, 
but both agents differ substantially in their envelope glycoproteins. The West African virus is 
genetically- more closely related to the simian immunodeficiency virus (SIV) Antibodies against 
HIV-2 are specific and distinct from those against HIV-1, but still so similar that cross-reactions 
occur in many diagnostic assays.
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2.2.2 Global epidemiology of HI V-infection and AIDS
According to estimates by UNAIDS, 30.6 million people were living with HIV infection world­
wide by December 1997. O f these, 12.1 million were women and 1.1 million were children. In 
1997, 5.8 million new infections occurred, around 16 000 a day. Over 50% of those infected 
were 15-24 years old It has been estimated that more than 40 million people will be living with 
HIV in the year 2000 (UNAIDS 1997).
Since the beginning of the pandemic in the early 1980s, it has been estimated that 11.7 million 
people have died from AIDS, among them 4.0 million women and 2.7 million children. 8 million 
children became orphans because their mother or both parents died from AIDS.
More than 90% of HIV-infected people live in developing countries (UNAIDS 1997). The 
pandemic is composed o f distinct epidemics in different parts o f the world. HTV prevalence and 
incidence are still increasing in most parts of the world, but incidence appears to have declined in 
some populations, for example in gay men in North America, Australia and Western Europe, in 
young men in Thailand and in pregnant women in southern Zaire and Uganda (UNAIDS et al 
1996, Mertens and Burton 1996).
Estimates for average HIV prevalence among adults aged 1 5 - 4 9  years in developing regions 
ranges from 0.13% in North Africa and Middle East, and 0.5% in Latin America and South and 
South East Asia, to 7.4% in sub-Saharan Africa. Estimates o f adult HIV prevalences in 
industrialised countries are 0.07% for Eastern Europe, 0.1% for Australia, 0.3% for Western 
Europe, and 0.6% for North America (UNAIDS 1997).
2 .2 .3  E p id e m io lo g y  a n d  p u b lic  h e a l th  im p o r t a n c e  o f  H I V  in fe c tio n  a n d  A ID S  in  s u b -  
S a h a r a n  A f r ic a
Transmission
HIV can be transmitted sexually, vertically (from mother to child) and parentcrally In sub- 
Saharan Africa, the predominant mode of transmission is heterosexual intercourse, accounting 
for more than 90% of HIV infections in adults (Mann et al 1992, UNAIDS et al 1996). Less
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Vertical transmission has become a major problem in areas with high HIV prevalences among 
women of child bearing age. Vertical transmission rates vary between different studies and 
different geographical settings, most studies report that between 25% and 30% of babies bom to 
HIV-positive mothers will carry the infection (Working Group on MTCT HTV 1995). Other 
sources describe this proportion to be within a range from 25% to 40%, with a central estimate 
of one third (Mann et al 1992). Transmission by breast feeding has been documented, but it is 
difficult to estimate the proportion of vertical transmissions due to this mode (Mann et al 1992).
Transmission through transfusion o f blood or blood products accounts for only a small 
proportion of infections, and has been estimated at 4% in sub-Saharan Africa (Mann et al 1992). 
However it still represents a  public health problem because many health services have no 
facilities to screen donor blood for HIV infection (Bontick et al 1995). Nonsterile needles and 
syringes may occasionally contribute to the HIV problem (Piot et al 1988). The proportion o f 
adult HIV infection due to  intravenous drug has been estimated at 0.5% (Mann et al 1992).
By contrast, adult HIV infection in Western Europe and the US is due to heterosexual 
intercourse in 9 - 14%, homosexual contacts in 47 - 56%, blood and blood products 2 - 3%, 
injecting drug abuse 27 - 33%, and other or unknown courses in 4 - 5% (Mann et al 1992).
The proportion of people with multiple heterosexual partners, the network between heterosexual 
partners in the community and the presence o f some enhancing cofactors are the main 
determinants of the epidemic (Piot et al 1988, Larson 1989).
than 1% of adult HTV infections have been estimated to occur as a result of homosexual
intercourse (Mann et al 1992).
The course o f  the epidemic
Sub-Saharan Africa is the region with the most substantial HIV epidemic. It has been estimated 
that in 1997 about 3.4 million new HIV infections occurred here among adults, and about 530 
000 among infants (UNAIDS 1997).
Countries in East and Central Africa were the earliest to experience the full impact o f the 
epidemic, notably Uganda, Rwanda and parts o f Zaire (Piot et al 1984, Scrwadda et al 1985,
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Van de Perre et al 1984). Already in 1986, Quinn et al listed 17 countries in which the 
prevalence of HIV infection was substantial, ranging from 0.7% among blood donors in the 
Congo to 18% among pregnant women in urban centres in Rwanda (Quinn et al 1986). 
Prevalences in some high risk populations rose particularly fast. For example, the HIV 
seroprevalence among prostitutes o f  low socio-economic status in Nairobi, Kenya reached 66% 
by 1986 (Kreiss et al 1986).
At present, the epidemic is spreading particularly fast in the southern part o f the continent. The 
total number o f people living with HIV in the Republic of South Africa increased by one third 
from 1996 to 1997, and has now been estimated at 2.4 million. In Francistown, Botswana, 43% 
of pregnant women tested HIV positive in 1996, and 32% in Harare in 1995. In Beit Bridge, 
Zimbabwe, the prevalence in ANC attenders reached 59% in 1996 (UNAIDS 1997).
Recently, prevalence levels measured at four urban antenatal (ANC) surveillance sites in Uganda 
have started to decrease, reaching 14% to 16% respectively by 1996, equivalent to a reduction of 
about 40% compared to previous years (Asiimwe-Okiror et al 1997, Bagenda et al 1995). 
Similar observations were made in a rural cohort in the Masaka district of Uganda, where the 
prevalence in young men aged 13-24 years fell from 3.5% in 1990 to 1% in 1990 (Mulder et al 
1995). Uganda started to react to the epidemic rather early, and it has been speculated that the 
observ ed decrease may be a result o f a decade of health promotion. However, stabilising or even 
decreasing prevalences may also result from other factors, such as saturation of the population at 
risk, changes in virulence o f HTV, or changes in infectiousness of people infected with HTV 
(Mertens and Burton 1996).
The prevalence o f HIV infection is still increasing in most rural populations in sub-Saharan 
Africa Because most Africans still live in rural areas, the population at risk is very large 
(Barongo et al 1992).
Impact o f  the epidemic
HIV infection and AIDS has become the leading cause of adult death in many cities o f the 
continent (Van de Perre 1995). The increase in adult mortality has been dramatic, but many 
HIV-related deaths seem to occur unexpectedly and before patients have developed full blown 
AIDS (Todd et al 1997), and this may be a potential obstacle for health promotion and
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awareness raising programmes. The overall crude death rate is expected to more than double 
over the next 10 years in countries of East Africa, reaching 24 per 1,000 by the year 2010. For 
Botswana and Zimbabwe 5 to 6-fold increases of the crude death rate have been predicted, 
reaching 29 per 1,000 by 2010. Crude death rates are expected to double in various parts of 
West and Central Africa (Stanecki and W ay 1996). Life expectancy, which had increased 
substantially in many developing countries during the past 3 decades, is expected to drop to 
previous levels (Stanecki and W ay 1996, UNAIDS 1997).
It is expected that infant mortality' and the mortality o f children under 5 years o f age will increase 
substantially in sub-Saharan Africa, particularly in urban centres, thus reversing the successes of 
primary health care efforts of the two last decades, and placing additional burdens on families 
and health services (Nicoll et al 1994). A rise in infant mortality by 140% because o f AIDS has 
been predicted for Zimbabwe between now and the year 2010 (UNAIDS 1997), and is expected 
to reach 71 per 1,000 (Stanecki and Way 1996). For other countries in East and South Africa, 
increases of infant mortality by 40% to 120% have been predicted whilst increases by 10% to 
35% are expected for countries in West and Central Africa (Stanecki and W ay 1996).
In East and Southern Africa, child mortality rates have already risen by between 25% and 85% 
due to AIDS mortality, and are expected to have increased 18 to 4 times by the year 2010 
compared to estimates in the absence of AIDS, and will reach levels between 110 per 1,000 
(Kenya) and 240 per 1,000 (Malawi). The most extreme increase is expected to occur in 
Zimbabwe, where child mortality has been estimated at 38 per 1,000 without AIDS and is 
expected to reach 153 per 1,000 in the year 2010. Increases for West and Central Africa are 
expected to range between 15% and 70% (Stanecki and Way 1996). The amount o f suffering 
hidden behind these dry figures can hardly be imagined.
The likely overall demographic impact of the epidemic has been controversial. Some authors 
predicted that the epidemic will eventually lead to negative population growth in Africa. Other 
modellers predicted a  reduction o f  population growth from an average o f  3% to 1.1 to 2.2% 
(Anderson et al 1986, Bongaarts et al 1989, Stanley at al 1989, Way et al 1991, as cited by Over 
and Piot 1993) It is expected that the growth rate will become negative in countries with 
comparatively low infertility rates and high AIDS related mortality rates, for example in 
Botswana and Zimbabwe (Stanecki and Way 1996).
51
All authors agree that the increase in mortality is predominately due to increased deaths among 
young adults, and that this will have a severe effect on the health system, the economy and the 
social situation in many African countries (Over and Piot 1993). The substantial mortality 
increase among young adults has been demonstrated empirically in cohorts from Mas aka, 
Uganda and Mwanza, Tanzania. For example, in the Mas aka cohort with an HIV prevalence o f 
about 10%, over 80% of deaths among those aged 13-44 were attributable to HIV infection, and 
the mortality in HIV seropositive adults was 15-fold higher than in seronegative adults (Mulder 
et al 1994). Figures from the Mwanza cohort were consistent with this observation: the increase 
in mortality in seropositive adults aged 15 -54  years was 16 fold (Todd et al 1997).
HIV-2 infection
The modes of transmission o f HIV-1 and HIV-2 are very similar (Piot et al 1990, Miyazaki 
1995). In Africa the spread o f HIV-2 has been limited mainly to West African countries, 
although occasional reports of infections in Angola, Tanzania and Mozambique have been 
published (Santos-Ferreira et al 1990, Schmutzhard et al 1989, Barreto et al 1993). 
Simultaneous infection with HIV-1 and HIV-2 has frequently been observed (De Cock et al 
1988).
Although HIV-2 prevalences reached high levels in some risk groups during the 1980s, for 
example up to 64% o f prostitutes in some West African cities (Denis et al 1987), HTV-1 
prevalence has meanwhile exceeded that o f HIV-2 in some West African countries It is likely 
that transmissibility and pathogenicity of HIV-2 are lower than for HTV-1 (De Cock et al 1993). 
Intermittent screening o f sex workers in Mwanza, Tanzania from 1991 to 1995 did not reveal 
any HIV-2 infection (Klokke and Grosskurth, unpublished data).
Heterogeneity
The HIV epidemic in Africa is characterised by marked heterogeneity. Extremely high 
prevalences are observed in some parts o f the continent, whilst other areas continue to have 
relatively low prevalence rates. This phenomenon cannot be explained merely by the different 
stages o f the epidemic. Even in populations where HIV-1 has been present for a long time, the 
spread of the virus is very' heterogeneous (Piot et al 1990).
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For example, HIV-1 prevalences among 4486 pregnant women attending 2 urban antenatal 
(ANC) services in Rwanda in 1989 and 1990 increased annually by 3 - 5% and reached 26% and 
31% respectively in 1990 (Bucyendore et al 1993). In urban Malawi 18% of 461 urban pregnant 
women were infected in 1989, and the annual rise in prevalence during the previous years was 
estimated as 3 - 4% (Miotti et al 1990).
In contrast, the prevalence o f HIV-1 infection remained low and stable in some other African 
cities even many years after the introduction of the epidemic: for example, 3%  of 4205 ANC 
attenders from 4 urban sites in Shaba, Zaire were infected in 1991, and the prevalence did not 
increase over a 2 year period (Magazani et al 1993). Similarly the rate in pregnant women 
remained stable at 8% from 1985 to 1989 in Kinshasa, Zaire (N’galy et al 1989).
It could be argued that these figures may be distorted by selection bias. Population based HIV-1 
prevalence studies would be more conclusive for the comparison between different areas. 
However, the data available are consistent with the observation o f a markedly heterogeneous 
spread of the HIV epidemic.
The reasons for this heterogeneity are not well understood. Several factors seem to be at work 
and may include: demographic variables such as the male to female ratio in the population, 
behavioural variables such as the size o f  and rate of contact with, core groups, biological 
variables such as male circumcision, political and economic variables such as the official 
response to the epidemic o r civil unrest and war, and differences in the prevalence o f factors such 
as STDs which may enhance HIV transmission (Piot et al 1990).
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2.3 The association of STDs and HIV infection
2.3.1 The STD/HIV co-factor hypothesis
As described in section 2.2, the HTV epidemic in sub-Saharan Africa has spread very rapidly, 
and with marked heterogeneity This led to research questions as to the possible underlying cause 
of these observations.
By the mid 1980s, it was postulated that other sexually transmitted diseases (STDs) might 
enhance the transmission o f  HTV and contribute substantially to the rapid spread of HIV-1 in 
sub-Saharan Africa (Quinn et al 1986, Piot and Laga 1989, Cameron et al 1989) T h is “co­
factor effect” o f STDs on HIV transmission might have two components: Among persons not 
infected with HIV, STDs may potentially increase the susceptibility to HIV infection. Among 
persons infected with HIV, the presence of STDs may potentially increase their infectiousness 
for HIV (Mertens et al 1990).
This STD/HIV co-factor hypothesis seemed plausible from both epidemiological and biological 
points of view: STDs are very common in sub-Saharan Africa, and ulcerated or inflamed skin 
may render a patient either more infectious or more susceptible for viral transmission (Cameron 
et al 1989, Piot and Laga 1989).
The potentially great public health significance o f this hypothesis led to the formulation o f  the 
secondary hypothesis that an intervention which is effective in reducing the prevalence o f  STDs 
will lead to a reduction of HIV incidence.
There may be other potential associations between STDs and HIV infection: (i) STDs may 
influence the natural history o f  HIV infection, (ii) HIV infection may change the clinical course 
o f STDs, (iii) and HIV infection may increase the susceptibility to other STDs (Mertens et al 
1990). Such associations are beyond the scope of this thesis.
2.3.2 Methodological issues in research on the co-factor hypothesis
Support for the STD/HIV cofactor hypothesis came from a number of observational studies 
However, such studies encounter a variety of methodological problems The issues involved have
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been discussed extensively by Mertens and colleagues (1990), by Laga and colleagues (1991 and 
1994i) and by Wasserheit (1992).
Issues o f  validity: confounding and bias
An association, if proven, may not be causal. An alternative explanation could be that persons 
with multiple sexual partners are at risk of acquiring both HIV infection and STDs. Both groups 
of infections share the same mode o f  transmission. Therefore the association may be completely 
confounded by sexual behaviour, and the presence o f other STDs could merely be a marker for 
high risk behaviour rather than a causal factor.
It is therefore necessary that study design and analysis should control for the confounding effect 
of sexual behaviour (Mertens et al 1990, Laga et al 1994i, Wasserheit 1992).
However, in observational studies, complete control for this type o f confounding cannot be 
achieved. This would require data for each subject on their number of HIV infected sexual 
partners, the degree of exposure to these partners and their level o f infectiousness. It is not 
possible to  measure sexual behaviour in such detail. Recall bias and deliberate incorrect response 
add to this dilemma This means that residual confounding by sexual exposure will remain even 
if great care is taken to control for it (Mertens et al 1990).
Residual confounding means that persons are misclassified in terms o f their sexual exposure. 
This misclassification may be differential or non differential with respect to their HIV or STD 
infection status. It can be shown that misclassification o f the confounding variable results in 
overestimation of the degree o f association between STDs and HIV infection if the 
misclassification is non-differential. If  it is differential, the degree o f association may be either 
over- or under-estimated (Mertens et al 1990).
Another type of bias is caused by the nature o f the laboratory tests used to diagnose HIV 
infection and STDs None of the tests used in epidemiological studies have a sensitivity and 
specificity o f 100%. This fact will lead to misclassification o f the infection status o f  some of the 
study participants. If it is non-differential, as would usually be expected, the resulting effect of 
this type o f  misclassification would be a dilution of the measurable effect, thus biasing the study 
results towards finding no association (Mertens et al 1990).
55
Issues o f  the direction o f  causality
Studies which investigate the co-factor hypothesis would not only need to demonstrate that there 
is an epidemiological association between the two types o f infection, but a lso  that STDs 
preceded the HIV infection. However, in observational studies, it may be impossible to establish 
whether the STD or the HIV infection occurred first. This is particularly the case in cross- 
sectional and case-control studies. In such studies, both infections occurred in the past, and 
therefore the sequence of events is not clear. It could be that the HTV infection preceded the STD, 
and that a proven association between the two types of infection indicates that STD  symptoms, 
for example genital ulcers, are manifestations of HTV infection (Mertens et al 1990). HIV 
infected subjects may be more susceptible to STDs as a consequence of impaired immune 
function (Piot et al 1989, Pepin et al 1989).
Intervention studies
For all these reasons, observational studies may not provide conclusive evidence for the existence 
of an enhancing effect o f STDs on HIV transmission.
The only way to control reliably for confounding variables would be through a randomised trial 
which seeks to determine whether an intervention against STDs reduces the transmission of HIV. 
Randomisation into an intervention and a control arm would help to ensure th a t confounding 
factors are distributed equally and could not bias the result of the study (M ertens et al 1990, 
Laga et al 1994i).
Biological plausibility
If the co-factor hypothesis were correct it could be expected that the enhancing impact of STDs 
on HIV transmission would manifest itself through biological mechanisms.
There seem two be two separate biologically plausible explanations for how ST D s may facilitate 
HIV transmission: (i) Inflammatory processes and exudates from STD related lesions may 
increase the shedding o f HIV in genital fluids; (ii) STD-related lesions may facilitate the access
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of HIV to CD4 receptor cells, thus leading to an increased susceptibility to HIV infection (Laga 
et al 1994i).
It would give much support to the co-factor hypothesis if it could be shown that the viral load is 
increased in the genital tract in the presence of an STD, and that it decreases after treatment. 
Such an observation could not be regarded as a definite proof o f the hypothesis, as the actual 
mechanism of HTV transmission is not yet fully understood. Recently data have become available 
from studies comparing viral shedding in HTV infected subjects with and without STDs (see 
section 2.3.6). Such data were not available at the time the Mwanza trial was formulated.
2 .3 .3  C r o s s - s e c t io n a l  a n d  c a s e - c o n t ro l  s tu d ie s
Probably the first work demonstrating an association between other STDs and AIDS was a case- 
control study conducted in homosexual American men in 1982, at a time when the aetiology of 
AIDS was not yet known. The study involved 50 AIDS patients and 120 controls. Controls were 
recruited from patients of STD clinics and general practices Among other risk factors, AIDS 
was associated with a history o f syphilis (Jaffe et al 1983).
This observation stimulated intensive research. Many cross-sectional and case-control studies 
have been conducted since, most o f which showed that either a history o f STDs or a clinical 
diagnosis of STDs were more prevalent among HIV-infected persons than in the various control 
groups. Unfortunately, in many published studies no effort was made to control for confounding 
factors. In some other studies, control for confounders did not include sexual behaviour A 
selection of studies from sub-Saharan Africa is listed in table 2.4.
The strength of the association between present or past STDs and HIV infection, as measured 
through the odds ratio (OR) in these studies, varies widely. The strongest OR has been reported 
in a study from Rwanda and relates to a history of STDs (OR= 11.2), but no adjustment for other 
variables was made in that study (Van de Perre et al 1987). Some o f the observational studies 
were conducted in sex workers. Results from such studies may not be generalisable to other 
populations (Mertens et al 1990).
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Table 2.4: Selected cross-sectional and case-control studies of the association between STDs 
and HIV infection
Locality / 
Country
Study
population
N HIV-1
preva­
lence
Risk factor for 
HTV infection 
investigated
OR
(95%  Cl)
Reference
Cross-sectional studies
Kigali / 
Rwanda
rural
population
207 3.4% history of any 
STD past 2 yrs
11.2 1
(3.5 -35.9)
Van de Perre et al 
1987
Harare / 
Zimbabwe
wives of
HTV+ve
men
75 60.0% husband had 
history of GUS 
past 2 years
1.9 1
(1.0 - 4  8)
L atifetal 1989
Mwanza / 
Tanzania
men 2000 2.4 - 
8.7%
GUS ever 
GDS ever
1.1*
(0.7 - 1.9) 
2.2 2
(1.4 -3 .5)
Barongo et al 1992
women
(general
population)
2161 2.8-
15.2%
GUS ever 
GDS ever
1.1 2
(0.5 - 2.5) 
1.7 2
(0.9 -2.5)
Rakai / 
Uganda
rural
women
4718 14.2 - 
26 7%
Any bacterial 
vaginosis
1.5 4
(1.2-1.9)
Sewankambo et al 
1997
Severe bacterial 
vaginosis
2.1 3 
(1.5-2.9)
T richomoniasis 1.0 3
(0.9-1.2)
Active s\philis 1.65 3 
(1.3 - 2  1)
Case-control studies
Nairobi / 
Kenya
men
attending 
STD clinic
340 11.2% history of GUS
current genital 
ulcer
7.2 4
(3.8 - 13.8) 
2.0 4
(1.0 - 4  1)
Simonscn ct al 
1988
Nairobi female sex 
workers
124 67% history of GUS 3.3 5
(1.2-10.1)
Plummer et al 1991
history of 
CT infection
2.7 5
(0 92-7 8)
GUS genital ulcer syndrome, GDS genital discharge syndrome, CT Chlamydia trachomatis 
' no adjustment for confounding factors; 2 adjusted for all other significant risk factors;
3 adjusted for age, number of sexual partners past year, other STDs
4 adjusted for socio-demographic factors and frequency of contact with sex workers; 
adjusted for socio-economic status
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The association of present STDs with HIV infection could have several possible explanations. It 
may be the result of the sexual behaviour which led to both types o f infection. Or it could be due 
to the co-factor effect of past STDs, because present STDs are more likely to occur in subjects 
who had STDs previously, because of their higher risk behaviour.
Of interest was the rather unexpected finding in a cross-sectional study from Uganda that 
bacterial vaginosis (BV) is associated with HTV-infection (Sewankambo et al 1997): In principle, 
BV is not marked by inflammatory changes of the vaginal walls (French and McGregor 1997). 
However, this study from Uganda showed that the adjusted odds ratio o f HTV infection 
associated with any vaginal flora abnormality was 1.52, for moderate BV it was 1.5 and for 
severe bacterial vaginosis it was 2.08. All these observations were significant.
Because of the methodological problems described in section 2.3.2, none o f these studies gives 
conclusive evidence that STDs enhance HTV transmission (Laga et al 1991, Sewankambo et al
1997).
2.3.4 Prospective observational studies
The methodological problems described above can be overcome, at least in part, if initially HIV 
negative individuals are recruited into a cohort study and followed prospectively in order to 
determine the association between STDs and HTV infection. The major advantage of this strategy 
is that the time sequence o f events can be established (Mertens et al 1990). It is also easier to 
control for the confounding effect o f sexual behaviour, because recall bias can be minimised, or 
because more information can be collected about risk behaviour.
The first prospective study giving some evidence in support o f the STD cofactor hypothesis was 
performed in Nairobi in a cohort o f 422 heterosexual men with STDs who were clients of 
prostitutes known to have 85% prevalence of HIV-1 infection (Cameron et al 1989). 88% of the 
men were HIV negative. 293 of these HIV-negative men were followed-up for at least 2 weeks 
from the time of the reported sexual exposure 8% of these seroconverted a few weeks after they 
had experienced an STD and had been treated for it Newly acquired HIV infection was 
independently and significantly associated with frequent sex worker contact (relative risk: RR = 
3.2), w ith genital ulcer syndrome (RR = 4.7) and with lack of circumcision (RR = 8.2).
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Furthermore, there was a subgroup of 73 initially seronegative men who reported only one single 
contact with a sex worker before they acquired the STD Again, 8% of them seroconverted 
within some weeks. In this subgroup the link between a particular exposure at a particular time 
(genital ulcer in the sex worker, indicated by the consecutive ulcer in the client) and the outcome 
(HTV infection in the client) seemed to be quite clear. No seroconversion was observed in the 
absence of genital ulcers. Unfortunately, all seroconverters also lacked circumcision, so that 
reciprocal confounding of these factors cannot be excluded.
Again in Nairobi, in 1991 Plummer et al showed that the association between genital ulcer 
syndrome and HIV-1 seroconversion existed also in women. This was demonstrated in a cohort 
o f 595 sex workers, of whom 196 were initially seronegative. The authors were able to follow 
up 124 women for at least 12 months. Women were regularly screened and treated for STDs. 
Seroconversion occurred in 67%, corresponding to an extremely high annual incidence o f 47%.
After adjustment for number o f sex partners and condom use, multivariate analysis confirmed 
independent and significant associations between HIV-1 infection and oral contraceptive use (RR 
= 4 5) and genital ulcer syndrome (RR = 3.3). There was also an almost significant association 
with cervical infection due to Chlamydia trachomatis.
In 1993, Telzak et al reported results from a cohort study of 758 heterosexual men attending an 
inner-city STD clinic in New York City. None of them reported a history o f injected drug abuse. 
HIV-1 seroconversion occurred in 1.8% of all men, and after adjustment for sexual exposure 
was significantly associated with genital ulcers (RR = 3.0).
In a survey o f 1607 initially HIV negative male factory workers followed for 1738 person-years 
o f observation, 51 men seroconverted (2.9%). After adjustment for various confounding factors 
including number of partners and reported visits to sex workers in a Cox regression analysis, 
seroconversion was significantly associated with recently having genital ulcers (hazard ratio 
HR=3.6), but not with other STDs (Mbizvo et al 1997).
Using the results from the two Nairobi cohorts, it was possible to make estimates for the size of 
the cofactor effect of genital ulcers for single exposures. Under the assumption that the observed 
associations in the Nairobi cohorts were due to a genuine cofactor effect (and not the result of 
residual confounding), Hayes and colleagues calculated that the observed data were consistent 
with a 1 0 -5 0  fold increase in the probability for male to female HIV transmission, and a 50 -
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300 fold increase for female to male transmission The authors concluded that, although subject 
to w ide margins o f error, these estimates support the potential role o f STD control as an effective 
intervention strategy against HIV (Hayes et al 1995i).
There are some longitudinal studies addressing the possible link between non-ulcerative STDs 
and HIV-1 seroconversion. Based on earlier cross-sectional and case-control studies, it was 
expected that an association would be much weaker than that for genital ulcers. However, it 
could also be expected that, if a causal link did exist, their population attributable fraction (PAF) 
for HIV infection could be larger than that o f genital ulcers, as the non-ulcerative STDs are 
much more prevalent (Wasserheit 1992, Laga et al 1993).
The first cohort study providing some evidence for an enhancing effect o f non-ulcerative STDs 
on HIV infection was conducted among sex workers in Kinshasa (Laga ct al 1993). 431 initially 
HIV-1 negative women working as sex workers in Kinshasa were followed for a mean duration 
of 2 years with monthly STD check-ups and 3-monthly HIV-1 serology tests. During this period 
9.8% of the women seroconverted for HIV.
A nested case-control study was performed within this cohort During the period of HIV-1 
acquisition, cases had a much higher incidence of gonorrhoea, chlamydial infection and 
trichomoniasis than controls who did not seroconvert. After adjustment for the level o f sexual 
exposure, these infections remained significantly associated with HIV seroconversion (giving 
ORs of 4 8, 3.6 and 1.9 respectively) Genital ulcers were much less common than other STDs, 
but also appeared more often among cases (Laga ct al 1993).
2 .3 .5  I n te r v e n t io n  s tu d ie s
Randomised controlled trials
Whilst longitudinal observational studies to test the STD/HIV co-factor hypothesis arc 
methodologically stronger than cross-sectional and case-control studies, residual confounding 
cannot be excluded, as explained in section 2.3.2. However, intervention studies, in which 
participants or groups are randomised to different levels of STD control, while other preventive 
activities arc kept equal in the different treatment arms, offer an opportunity to control for any
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confounding effects (Mertens et al 1991, Laga et al 1994i), and are therefore better able to 
produce valid results than other study designs.
Such randomised controlled trials (RCTs) have a double rationale: they represent a valid test for 
the co-factor hypothesis, and they are also able to measure the effectiveness of a specific 
intervention programme. RCTs are recognised as the gold standard for the evaluation of public 
health interventions (Hayes et al 1997).
To date, only three randomised controlled trials of improved treatment of STDs have been 
conducted or are in progress, all of them in East Africa. The first trial was completed in Mwanza 
Region, Tanzania in 1995, and is the subject of this thesis (Grosskurth et al 1995). Two further 
randomised trials are in progress. A trial in Rakai District, Uganda is investigating the impact of 
intensive STD control via periodic mass treatment for STDs among adults in the general 
population (Wawer et al 1996). Nearby, in Masaka District, Uganda, a further trial is comparing 
groups receiving health promotion, health promotion together with improved syndromic 
treatment services for STDs, and a comparison group receiving a community development 
intervention (Kengeya-Kavondo et al 1996). Investigators from the three trials conducted a joint 
technical workshop in 1996, and produced a technical document on randomised trials of STD 
treatment for HIV prevention (Hayes et al 1997). Further details o f the Rakai and Masaka trials 
arc given in the discussion (chapter 7).
Uncontrolled intervention studies in core groups
Intervention studies in sex workers and other high risk behaviour groups are important to test the 
operational concept o f  core group interventions, to identify’ the best strategy o f intervening in the 
core, and to evaluate the performance of specific intervention programmes
Some intervention studies in sex workers have been conducted or are under way. These studies 
either do not have a controlled design, and compare infection rates before and after the 
intervention, or they compare different types o f intervention, rather than comparing an 
intervention with a do-nothing alternative. This is done mainly for ethical reasons: because sex 
workers arc often highly mobile, and as close follow-up is required, it would be difficult to 
justify- withholding intervention activities from the control group.
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That a well-designed targeted intervention for sex workers may lead to a major decline in HIV 
and STD incidence has been demonstrated impressively in a cohort study conducted by Laga and 
colleagues in Kinshasa. From a study population of female sex workers, with high STD 
prevalences and an HIV prevalence o f 35%, 531 initially HTV-seronegative women were 
enrolled The intervention was provided through a special health care centre in an area where the 
women lived and worked It consisted of free monthly screening and treatment for STDs and 
provision of condoms. Health promotion was provided through group sessions conducted at 3- 
monthly intervals. This intervention was started in 1988 and interrupted in 1991 because of 
political turmoil. The impact evaluation was conducted through monthly screening for STDs and 
3-monthlv screening for HTV seroconversion.
Over the 36 months of the study period, there was a statistically significant decline in the 
incidences of gonococcal infection, trichomoniasis and genital ulcer syndrome, but not of 
chlamydial infection The incidence of HIV infection declined from 11.7/100 women-years (wy) 
during the first 6 months to 4.4/100 wy during the last 6 months (p=0.003). Regular condom 
use with clients increased simultaneously from 11% to 68%. Risk factors for HTV 
seroconversion after multivariate analysis were irregular condom use, trichomoniasis and genital 
ulcer syndrome during the probable period of HIV acquisition. In women who attended more 
than 90% of their monthly appointments, the incidence was much lower when compared to those 
who attended less regularly (Laga et a) 1994ii). Because of the study design, it was not possible 
to distinguish whether the observed effect was due to the health promotion or the STD treatment 
component, or both. The study was conducted primarily to evaluate an intervention package, 
rather than to provide information on the co-factor hypothesis
A comparison o f two different interventions is presently being studied in Abidjan (Ettiegne- 
Traore ct al 1996). Sex workers report once a month to a confidential clinic where they receive 
free STD treatment, health education, and free condoms. They are randomised into those who are 
examined only when symptomatic and treated according to a basic case management strategy, 
and those who are examined systematically every month and treated according to an intensive 
diagnosis and case management strategy.
The outcome is being assessed at six-monthly intervals through testing for HIV, gonorrhoea, 
chlamydial infection and trichomoniasis Preliminary results of this study, comparing a pilot 
period without intervention and the first 6 months intervention interval, show a high HIV 
incidence (20%) before the intervention, and a marked decrease o f HIV incidence to 7% after 6
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months of intervention. The authors do not report whether there was also a reduction in STD 
prevalence or incidence No significant difference in STD prevalence or incidence was observed 
between the two intervention groups, but the study was still in its initial phase (Ettiegne-Traore 
etal  1996).
Another successful core group intervention has been documented in Nairobi where a population 
of more than 1000 predominantly HIV-1 positive female sex workers have been exposed to an 
intervention which started in 1985 and is still ongoing. The intervention comprises STD 
diagnosis and treatment through a special health clinic, and health promotion both individually 
and through public meetings. A major aspect of the health education component is to counsel the 
women on how to promote condom use among their clients.
For a study o f the cost-effectiveness o f the intervention, data were collected on the operational 
performance o f the programme and the number of clients per sex worker, and epidemiological 
data on the infection status of both women and their clients A number o f assumptions about 
transmission probabilities, the possible co-factor effect and condom efficacy were made. It was 
estimated that the programme prevented between 6000 and 10 000 new cases of HIV infection 
per year among clients and contacts o f clients. The operating costs were estimated at US $ 8 to 
US $ 12 for each case o f HIV infection prevented, a figure which compares extremely favourable 
with other public health interventions (Moses et al 1991, World Bank 1993).
A trial to study the impact of monthly presumptive STD treatment of sex workers from a mining 
community has recently been completed in South Africa (AIDSCAP/FHI et al 1997), and 
another is underway in Kenya (Richard Hayes, personal communication 1998). Preliminary 
results of the South African trial showed a 70 - 85% reduction in prevalence o f gonorrhoea, 
chlamydial infection and genital ulcers, despite continued exposure and a high incidence of 
subsequent infection Reported condom use increased considerably. Interestingly, the study also 
demonstrated that the prevalences of symptomatic and asymptomatic gonococcal and chlamydial 
infections and o f genital ulcers in men from the mining community were significantly reduced at 
follow-up, less than a year after the baseline survey. This was the first intervention study 
investigating the impact of a core group intervention on STD prevalence and HIV incidence in 
the surrounding general population (AIDSCAP/FHI ct al 1997).
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2.3.6 Studies of viral shedding
Several research teams have investigated whether the secretion of HTV in genital fluids is 
increased in the presence o f STDs.
The group of Ndinya-Achola, Plummer, Kreiss and colleagues reported a study o f  92 HTV- 
infected sex workers from Nairobi, in which they found a significant correlation between cervical 
inflammation and cervical shedding o f HTV (odds ratio OR=8.7) (Kreiss et al 1994). In an  earlier 
study o f 97 HIV-infected women attending an STD clinic, they observed that cervical shedding 
was significantly associated with cervical mucopus (OR=6.2) and cervical ectopy (Clemetson et 
al 1993). In both studies, no statistically significant association was seen between cervical or 
vaginal HIV shedding and the diagnosis of particular RTI agents.
More recently, the same group conducted a cross-sectional study in Mombasa, Kenya in 318 
HIV-infected women attending an STD clinic. HIV shedding was measured in vaginal and 
cervical secretions, using PCR amplification. A variety of possible risk factors for HTV shedding 
were also investigated. HIV-1 infected secretions w'ere found in 51% of endocervical and 14% of 
vaginal specimens. After adjustment for CD4 count, cervical HIV shedding was significantly 
associated with the use of oral contraceptives, and vaginal shedding with vitamin A deficiency. 
After including these two factors in a logistic regression model, gonococcal cervicitis was 
significantly associated with cervical HIV shedding (OR 3.1), and candidiasis with vaginal HIV 
shedding (OR 2.6). Vaginal HIV shedding was also significantly associated with moderate or 
high vaginal polymorpho-nuclear cell counts (ORs 2.2 and 3.8 respectively). Trichomonas 
vaginalis and Chlamydia trachomatis were not associated with HIV shedding (M ostad et al 
1997).
Cohen and colleagues conducted a study in Malawi of the effect of gonococcal and chlamydial 
urethritis on the concentration of HIV-1 in semen. HTV-1 was found in the seminal plasma of 
135 HIV-1 positive men. 86 of these men had urethritis, whilst the others were controls without 
urethritis. Samples were analysed at baseline and 1 and 2 weeks after treatment. The viral load 
of HIV-1 was eight times higher in the urethritis group, a statistically significant difference, 
despite similar CD4 cell counts and viral load in blood plasma in both groups. The increase was 
particularly large in cases of gonococcal infection. After successful treatment, seminal HIV 
shedding decreased significantly over the next 2 weeks. No change was observed in blood plasma 
viral RNA concentrations. The authors conclude that urethritis increased the infectiousness of
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men with HIV-1 infection, and that targeted interventions against urethritis may be an effective
public health strategy (Cohen et al 1997).
2 .3 .7  C o m p u t e r  s im u la tio n  s tu d ie s
The possible co-factor effect of STDs on HIV transmission has also been the subject of 
computer simulation studies.
Over and Piot were probably the first to use computer simulations to look at the interaction 
between STDs and HIV infection. However, their work concentrated on the effect of the 
hypothetical association on public health issues such as the cost-effectiveness o f interventions 
against HIV infection and STDs. For this purpose, they assumed certain co-factor effects, for 
example a five-fold increase of HIV transmission probability in the presence of genital ulcers, a 
3-fold increase for gonorrhoea and a 2-fold increase for chlamydia infection, and then studied 
case numbers and disability-adjusted-life-years (DALYs) saved because o f new STD and HIV 
cases which were averted as a result o f an STD intervention
For example, they showed that, i f  the co-factor hypothesis and the assumptions on the size of the 
enhancing effects were true, the one-time cure o f  100 core cases of gonorrhoea would avert 
thousands o f  new cases o f gonorrhoea within the next 2 years, a substantial number o f new HIV 
cases, and would save thousands of DALYs mainly because o f the preventive effect on HIV 
transmission (Over and Piot 1993).
To study the transmission dynamics o f HIV infection and STDs, and to determine whether HIV 
infection rates observed empirically in sub-Saharan Afnca would be possible without the 
existence o f  an STD co-factor effect, Robinson and colleagues applied an age-structured 
stochastic simulation model (SIMULAIDS). For this purpose, they used detailed data on HIV 
and STD prevalences, sexual behaviour and other demographic characteristics available from a 
cohort study o f a rural population o f 10 000 in the Masaka district of Uganda Assumed HIV 
transmission probabilities per sexual contact in the absence o f STDs were in the order of 0 001, 
based on observations from elsewhere.
The authors showed that without any co-factor effect, it was not possible to reproduce the HIV 
prevalence and incidence rates actually observed in the cohort The scenario most consistent with
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the observed data assumed that the transmission o f HIV per sexual contact was enhanced 100- 
fold during all episodes of ulcerative STDs, and 5-fold during episodes o f non-ulcerative STDs 
in females. For the first 10 years of the epidemic, over 95% of HIV infections were attributable 
to STDs under this scenario. The role o f STDs decreased considerably with the progression of 
the HIV epidemic (Robinson et al 1997).
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Chapter 3: Background
3.1 T h e  s tu d y  a r e a
3 .1 .1  G e o g r a p h y  o f  M w a n z a  R eg io n
Mwanza Region stretches along the southern shores of Lake Victoria, the largest of the African 
lakes, and includes the Ukerewe Islands (map 3.1). The area is situated 190 - 360 kilometres 
south o f  the equator, on a plateau about 1100 m above sea level. The region extends about 260 
km from East to West and up to 170 km from North to South (Leverenz and Gover 1997).
The region has about 2 million inhabitants (Bureau of Statistics 1992'), o f whom about two 
hundred thousand live in the regional centre, Mwanza town, which is the second largest town of 
Tanzania. There are also five semi-urban centres with a population o f about 15, 000 each, 
serving as district administrative headquarters The great majority o f the population lives in 
rural villages or in communities with widely scattered compounds. A compound is a group of 
houses which is occupied by one or more families, and surrounded by their farm land
3 .1 .2  V e g e ta t io n  a n d  c lim a te
The landscape is semiand and comprises mostly cultivated bushland, small spots of marshland 
and little patches of forest Huge boulders o f  smooth rock can be seen in many places
The mean annual rainfall is about 900 mm with 70% of the rain falling during the mam rainy 
season from March to May, and 30% during a  second but weaker rainy season from October to 
December. During the rains, many villages become inaccessible, and even the main long distance 
truck routes may occasionally be blocked for some days.
Average temperature oscillates between 20 degrees Celsius during the rains and 30 degrees 
during the dry season, and usually does not drop below 18 or exceed 35 degrees. 1
1 Data from 1988 population census, extrapolated to 1991 assuming a 3% per annum population
increase
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MAP 3.1 MAP OF NORTH-WESTERN TANZANIA
SHOWING MWANZA REGION AND NEIGHBOURING AREAS
6<;
3.1.3 Ethnicity, language and religion
The region is almost entirely occupied by ethnic groups of Bantu origin, with the Sukuma being 
by far the most numerous Wakerewe and Wakara inhabit the islands of the Ukerewe 
archipelago, the most densely populated rural area of Tanzania Other ethnic groups from 
neighbouring regions and other parts o f  Tanzania can be found in Mwanza town and in centres 
along the main roads These include W ahaya, Chagga and others, but also Indians and Arabs.
Each of these ethnic groups has its own language, but Kiswahili is the official national language 
and is commonly used as lingua franca. People with secondary school education can usually also 
communicate to some extent in English.
About 60% of the population in Tanzania are Christians, 30% are Moslems and 10% belong to 
other religious groups (Bureau of Statistics 1997). The proportion of Moslems in rural Mwanza 
is only about 5% (Munguti et al 1997).
3 .1 .4  E c o n o m y  a n d  tra f f ic
The population lives mostly on subsistence farming The main products are rice, maize, cassava 
and beans Cattle breeding is common, and other livestock include goats, sheep and poultry. 
Cotton and maize are the main cash crops Inhabitants of lake shore communities and o f  the 
islands of Ukcrewc engage in fishing, fanning, or both
Some small scale industnal development can be seen in Mwanza town, comprising a fish 
processing factory, boat yards, a cotton ginnery, a textile factory, and a brewery Some gold 
mining is done in the western part o f  the region, partly under government auspices, partly by 
private petty miners, and in recent times partly by foreign companies
Mwanza town is an important traffic junction, situated on one o f  the main truck and bus routes 
from Kenya to Central Africa There a rc  a railway connection to the capital, Dar es Salaam, and 
shipping lines to neighbouring Kagcra Region and to Uganda and Kenya
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3.1.5 Administration
Together with the neighbouring regions o f Mara, Kagera and Shinyanga, Mwanza Region forms 
the Lake Zone o f the United Republic of Tanzania.
The region comprises six districts, with Mwanza Municipality and its rural outskirts forming 
one of them Districts are divided into divisions, wards and communities.
The administrative system in Tanzania has recently been revised, as part o f a whole range of 
political changes which also included the introduction of a multi-party system. However, from 
independence until 1996, and thus throughout the time of the trial, the lowest administrative unit 
was the ‘balozi', or 10-household unit. The leader of this unit was the representative o f the state 
and of the ruling party at the lowest level. This balozi leader was usually a male inhabitant of 
the community, appointed by the administration
During the time o f  the trial, the one-party system still prevailed, with representatives being in 
key positions at all levels of the administration. This hierarchical system was broadly accepted 
by the population. It assisted the flow o f instructions and information from the centre to the 
periphery and vice versa. For the trial, this system was extremely helpful as it facilitated 
community mobilisation, enumeration of the cohort and follow-up o f study participants.
At regional and district level, the administration is run by civil servants, headed by a regional 
commissioner and in Mwanza by the six district commissioners, who work under the Central 
Government The health sector is administered by the Regional Medical Officer Mwanza 
(RMO) and the six District Medical Officers (DMOs).
3 .1 .6  H e a l th  s e rv ic e s
The teaching hospital for the Lake Zone, Bugando Medical Centre (BMC), is situated in 
Mwanza town It is one of Tanzania’s four teaching and referral hospitals, and comprises a 
variety of clinical services and several training institutions, notably schools for assistant medical 
officers, for x-ray technicians and for nurses. The hospital had a well organised HIV laboratory 
which played a major role in the trial implementation.
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At the time, Mwanza town also had one municipal and two private hospitals. There are also two 
government health centres with busy antenatal clinics, and eight dispensaries. STD clinic 
services were integrated into the outpatient department o f the Sekou Toure Municipal Hospital 
and one of the antenatal clinics (Makongoro Centre), and served as reference and training units 
for the trial (see section 5.2.9).
Regional health services are supervised by the Regional Medical Officer (RMO). The RMO is 
assisted by a team of senior officers, o f whom the Regional AIDS Control Coordinator (RACC) 
is responsible for AIDS and STD control activities. The RMO and the RACC are physicians. 
Almost throughout the trial period, the RACC had to deputise for other functions, and had 
limited capacity to play a role in the intervention. However, a Regional STD Intervention officer 
was appointed and seconded to the programme.
At each of the five rural district headquarters, there is a district hospital, and the region also has 
three mission hospitals However, the majority o f the rural population depends on the services of 
health centres and dispensaries Some dispensaries are run by mission health services, but most 
are government facilities In total, the region had 23 functioning rural health centres and 150 
dispensaries at the time of the trial.
A health centre is staffed by about 8 - 1 2  trained personnel and is managed by a medical 
assistant (MA) A dispensary has 2 - 3  trained staff and is led by a rural medical aide (RMA). 
Both cadres have a formal training of three years, but the MA is usually a secondary school 
leaver Except for delivery care, there arc usually no beds for inpatients Drugs are supplied 
through standardised kits as part o f  the national Essential Drug Programme (EDP)
Dispensaries do not have laboratory facilities. Some, but not all health centres arc staffed by a 
laboratory technician, and arc equipped with a microscope However, there is no system for 
quality control, the equipment is often damaged, and the supply of reagents irregular
Public health services in each district arc supervised by a health management team This is 
headed by the District Medical Officer. Issues o f AIDS control arc addressed by the District 
AIDS Control Coordinator (DACC), who is mainly expected to organise educational activities 
Unfortunately, due to very limited funds and the lack o f transport, the DACC’s capacity is very
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limited In the context o f the trial, a new cadre was created, the so-called District STD Control 
Coordinator.
In Mwanza town, several registered private medical practitioners exist, but at the time of the 
trial, there were no such practitioners in any o f the participating rural communities The same 
applied to pharmacies Traditional healers still play a substantial role in health care in both 
urban and rural areas.
3 .1 .7  H I V  in fe c tio n  a n d  S T D s  in M w a n z a  R e g io n
Precise epidemiological data on HIV infection and STDs were not available until early 1991, 
but were urgently needed to  assist with the sample size calculations for the intervention trial
In 1990 and 1991, a regional cross-sectional survey was conducted by a collaborative team 
involving LSHTM, AMREF and TANERA (see section 3.2.3 and table 3.2). The survey 
involved a random selection of 20 communities or urban wards from each of 3 strata: rural 
villages, roadside settlements and urban areas. Random cluster sampling was used to enrol 2000 
participants aged 1 5 -5 4  years from the rural communities, and 1000 each from the other two 
strata (Barongo et al 1992, Mosha et al 1993).
Results of the study showed that about a year before the trial started, the prevalences of HIV-1 
infection in rural villages and roadside settlements were 2.5% and 7.3% respectively. In 
Mwanza town the prevalence had reached 11.8% (Tab 3.1). Women had a higher HIV-1 
seroprcvalcncc than men, and they acquired HIV-1 infection at a younger age than men. The 
prevalence peaked at 20% in urban women aged 25-34 years.
Sentinel surveillance m antenatal clinic attenders from Mwanza town had shown an HIV 
prevalence oscillating around 12% for some time (Kigadyc ct al 1993). It was concluded that the 
HIV-1 epidemic had entered the region some years before and had possibly reached a mature 
stage in Mwanza town, but was still spreading in rural areas and in settlements along the main 
traffic routes
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No information was available about the incidence of HIV infection in the region, but a rough 
estimate was possible based on preliminary data from a cohort study in neighbouring Kagera 
Region, where an incidence o f  1% had been found in rural communities (Killewo et al 1993).
Table 3.1 Scro-prevalences o f  HIV infection and syphilis (%) and self-reported prevalence and 
incidence (%) of genital ulcers and/or genital discharge in 3 strata of Mwanza Region 1990/91, 
about one year before the intervention trial started 1 __________________ __________________
Rural villages Road-side
settlements
Urban wards
N=
Men
974
Women
1045
Men
431
Women
527
Men
595
Women
589
HIV-1
prevalence 2.4% 2.8% 5.4% 8.7% 8.7% 15.2%
N= 978 1046 434 528 597 590
Syphilis prevalence 
(TPHA+/RPR+) 7.0% 7.9% 12.3% 13.2% 9.3% 12.4%
Svphilis prevalence 
(TPHA+) 13 1% 13.5% 22.4% 21.7% 15.9% 20.5%
Genital ulcers: reported 
prevalence 1.7% 0.4% 0.3% 0.9% 0.2% 1.0%
Genital discharge: 
reported prevalence 2.6% 2.1% 2.1% 1 4% 1.0% 1.0%
Genital ulcers and/or 
discharge: ann incidence 10.5% 5.7% 8.6%% 5.0% 9.6% 4 8%
' (Barongo et al 1992, Mosha et al 1993)
The regional cross-sectional survey showed that STDs presented a major health problem in the 
region Active syphilis, as assessed through the prevalence o f positive TPHA and RPR tests, 
was very common with prevalences of 8 - 13%, in both men and women (Tab 3.1). TPHA 
prevalence, giving evidence o f  past or present infection, reached 18 - 35% in the oldest age 
group (45 - 54 years), indicating well established endcmicity.
About 10% of the men reported at least one STD episode during the past year. In women the 
self-reported incidence was m uch lower, but this was thought to be affected by underreporting
(Mosha et al 1993).
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3 .2 .1  R a tio n a le  f o r  an  S T D /H I V  in te rv e n t io n  t r ia l  in  M w a n z a  R e g io n
The rationale for a trial of the impact of improved STD case management on HIV transmission 
is discussed in detail in chapter 2.3. Why was rural Mwanza Region chosen as the location for 
this project?
Preliminary data suggested that the region would provide the necessary epidemiological 
conditions: a high prevalence o f  STDs, a well established but not yet matured HIV-epidemic 
and a rather stable population
In Mwanza town, there was a branch of the Tanzanian National Institute for Medical Research 
(N1MR). The institute had laboratories for microbiology and serology and a statistical unit, 
though all o f these needed major inputs in terms of training and equipment An HIV laboratory, 
headed by an experienced biochemist, was available at the Bugando Medical Centre (BMC) in 
Mwanza The regional and municipal health services o f Mwanza were well staffed so that it 
should be possible to identify suitable personnel for recruitment as field workers Mwanza town 
provided sufficient logistic conditions to establish the programme.
3.2 The STD/HIV Intervention and Research Programme Mwanza Region
3.2.2 AMREF and LSHTM
For the implementation of a large scale intervention trial, it was necessary to identify an 
organisation which had the necessary capacity and was well accepted both by the government 
and the population It was felt that a non-govemmental organisation (NGO) with its greater 
flexibility was preferable to a government institution.
The African Medical and Research Foundation (AMREF) fulfilled these conditions and 
developed a keen interest to take the task on.
This indigenous NGO was founded in the early 1960s as the Flying Doctor Service of East 
Africa w ith headquarters in Nairobi Over time it had acquired expertise in the fields of primary 
health care, the control of infectious diseases, training o f health workers and production of
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health learning materials. B y  1990, AM REF had country offices and programmes in Kenya, 
Tanzania and Uganda, and ran various projects in Sudan, Rwanda and Somalia. Within 
Tanzania, activities of the foundation were so far limited to Dar es Salaam, Arusha and Rukwa.
AMREF became the main contract holder and implementing agency for the trial, and the 
collaboration with LSHTM was formalised through a sub-contract. It was agreed that the 
director of the trial would be recruited by LSHTM and seconded to AMREF as its programme 
manager in Mwanza
The programme manager would establish an AMREF office for north-west Tanzania and would 
be responsible for the implementation of the trial, but also facilitate other AIDS related projects 
in the Lake Zone which were to be launched in parallel with the trial. For all these components, 
close collaboration would b e  established with various partner organisations in Mwanza and
elsewhere in the Lake Zone.
These arrangements had been negotiated very effectively by Dr Angus Nicoll both with 
AMREF and with government authorities. When the author took over from Dr Nicoll as 
programme manager in January 1991, most of these arrangements were in place, ready for the 
detailed planning and implementation of the intervention trial The overall programme was 
named the ‘STD/HIV Intervention and Research Programme Mwanza’
3 .2 .3  O th e r  c o l la b o r a t in g  in s t i tu t io n s
The STD/HIV intervention trial was a collaborative effort involving many more institutions 
besides AMREF and LSHTM . Their input covered various aspects of the intervention and the 
impact evaluation Details a rc  listed in tab 3.2. The coordination of all these institutions 
represented an interesting management task.
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Tabic 3.2 Institutions collaborating on the STD/HIV Intervention Trial Mwanza
Institution Function Input provided
LSHTM Scientific guidance 1. Trial design and planning,
2. secondment of scientific personnel to Mw anza,
3. assistance during implementation and data 
analysis,
4 logistic support in London
AMREF Implementing agency 1. Programme management and scientific 
direction in Mwanza
2. coordination of intervention,
3. training of health workers,
4. training of district STD coordinators
5. supervision of health units,
6. drug supply,
7. coordination of impact evaluation,
8. training of field workers,survey implementation
9. transport and logistics
10. logistic and administrative support through 
offices in Dar es Salaam and Nairobi
National Institute for 
Medical Research (N1MR)
Collaboration on impact 
evaluation
1. Laboratory tests (microbiology and serology),
2. data entry', processing and data analysis,
3. co-management of field work during surveys,
4. provision of staff for surveys
Bugando Medical Centre
(BMC)
Collaboration on impact 
evaluation
1. development of HIV test strategy,
2. HIV serology,
3. quality control for syphilis serology, 
4 provision of staff for surveys
Sckou Tourc Municipal 
Hospital
STD reference clinic 1. Monitoring of STD aetiologies and resistance. 
2 practical training of health workers
Makongoro Antenatal 
Clinic
STD reference clinic 1. as for Sckou Toure Hospital
Regional Medical Office Supervision and 
coordination at regional 
level
1. Policy support for implementation in districts.
2. secondment of a regional STD intervention 
officer to the programme,
3. provision of staff for survevs
Municipal Health Office 
Mvvanza
Supervision and 
coordination in Mwanza
1. Policy support for STD reference clinics,
2. provision of staff for survevs
District Health Services Integration of improved 
STD case management 
services
1. STD case management at health facilities,
2. provision of District STD Control Coordinators,
3. health education campaigns
Tanzanian Netherlands 
Support Project on AIDS 
Mwanza (TANESA, 
formerly TANERA)
Collaboration on impact 
evaluation and 
intervention
1. Joint implementation of initial cross-sectional 
survey
2. support of intervention in comparison 
communities in one district after the trial
3. shared provision and maintenance of NIMR 
equipment
National AIDS Control 
Programme / MoH
Overall supervision 1 Formulation of policy, supervision,
2 support within MoH
Muhimbili University 
College of Health 
Sciences (MUCHS)
Scientific collaboration 1. Consultancies on aspects of STD treatment, 
epidemiological and behavioural research
Institute for Tropical 
Medicine Antwerp
Facilitation of 
supplementary studies
1 personnel support to NIMR (1 senior lab 
technologist for microbiology 1992-95) 
2. scientific input for supplementary studies
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3.2.4 Management s truc tu re  for the trial
The trial was implemented by a management team which comprised the senior staff responsible 
for the various scientific and  operational components. Details are presented in fig. 3.1.
Some of these components were managed by expatriate personnel: the intervention, the main 
cohort survey, the clinical studies, the laboratories and the statistical unit. The expatriate staff 
shared responsibility with counterpart Tanzanian colleagues, who received intensive in-service 
training and most of whom were sent for formal training courses (PhD, MSc) at LSHTM during 
or soon after the completion of the trial.
The author had organisational responsibility for the overall programme and direct responsibility 
for the implementation o f  the intervention and of the main cohort study. These latter tasks were 
shared with two counterparts, the regional STD intervention officer (Mr. Ezra Mwijarubi) and 
the cohort study field manager (Dr. Frank Mosha) whom he trained and supervised.
As described in section 3.2.3 and table 3.2, several institutions contributed to the trial 
implementation To coordinate their inputs, a Steering Committee was formed which comprised 
the Director of BMC (Dr. Zacharias Berege), the Director of NIMR Mwanza (Dr. Reverianus 
Gabone), the Regional Medical Officer (Dr Awene Gavyole), the Municipal Medical Officer 
(Dr Zebedayo Sckirasa) and the author However, the coordination was achieved mainly 
through frequent informal contacts between the author and senior staff o f the collaborating 
institutions.
3 .2 .5  P ro g r a m m e  o f f ic e ,  c lin ic s  a n d  l a b o r a to r ie s
As a base for the trial and for AMREF’s various other activities, a compound with 2 buildings 
was rented It was located near the centre of Mwanza town, and provided 18 rooms for office 
space About half of these were used for staff actually working part-time or full-time on the 
trial
A seminar room for training courses and meetings was built next to the office, which could 
accommodate up to 24 participants Two stores for the supply unit were also erected All project
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cars could be parked in the compound, and cars were maintained and repaired here as well with 
the help o f a contracted car mechanic.
Consultation rooms to be used for STD treatment services at Sekou Toure Hospital and 
Makongoro Clinic, and laboratories at the two clinics and also at NIMR and at BMC, were 
refurbished and upgraded with equipment and furniture.
One of the greatest problems for the programme was the irregular electric power supply. Power 
cuts could occur at any time without warning, and lasted anything between a few minutes and a 
week. Even worse were sudden or gradual power surges, with voltages anywhere between 60 
and 400 Volts. As a result, the electrical and electronic equipment in offices and laboratories 
were subject to serious damage. In 1993 the situation became so difficult that robust generators 
had to be purchased and installed both at AMREF’s programme office and at NIMR At NIMR, 
costs were shared with the TANESA project.
3 .2 .6  S t a f f  r e c r u i tm e n t
Staff recruitment started late in 1990. The personnel involved in the implementation of the trial 
were either directly employed by AMREF (22), LSHTM (3) or ITM Antwerp (1); fully 
seconded to AMREF from government institutions (3); or temporarily attached to the 
programme for particular tasks (39). Other staff collaborated on specific aspects without any 
change in their institutional affiliation or line of management (23). In total, 79 staff worked on 
the trial during peak survey times
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Figure 3.1: Management structure for thè STD/HIV Intervention Trial Mvvanza (Aprii 1993)
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Accountant 
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3.2.7 Logistics
Many o f the consumables and almost all of the technical equipment had to be purchased from 
outside Tanzania. The bulk of these purchases and their airfreight was very ably organised by 
the AIDS Programme Overseas Coordinator at LSHTM, Ms Sarah Henson.
Most shipments went to Dar es Salaam and were cleared and forwarded by the Mwanza Liaison 
Officer, Mr. Alfred Kiswaga at AM REF's Country Office.
In Mwanza, AMREF’s Administrator and Supply Officer, Mr. Stephen Simbila and his team 
arranged for clearance and storage. They also handled all local purchases.
Two field research teams usually left for their work on Monday mornings, and returned after 
one or two weeks on Friday afternoons. For the following trips, two other teams went to the 
field, to alternate with the first two teams, and so on. The same applied for the intervention 
officers who usually spent one week in the field supervising all the health units belonging to the 
same intervention community. Equipment and consumables of all the teams were prepared using 
standard supply lists during the week before departure The preparations were done jointly by 
the supplies clerk and the outgoing field team leaders or intervention officers Maintenance and 
repairs o f vehicles and field equipment were done between two successive trips for each team
3.2.8 Funding
The initial preparation of the programme from 1989 to 1990 was supported by the Wellcome 
Trust.
The mam donor for the intervention trial was the Commission o f the European Communities 
(EC) through its Directorate General VIII (DG VIII), with ECU 624,000 for phase 1 (1990-93), 
and ECU 830,000 for phase 2 (1993-96). The last year included a continuation of the 
intervention after the end of the research work.
The Life Sciences and Technology in Developing Countries Programme of the EC (DG XII) 
funded a set of supplementary studies, including the sexual behaviour surveys and the cross- 
sectional STD studies in pregnant women which are briefly described in this thesis.
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The UK Overseas Development Administration (ODA) funded the AIDS Research Programme 
of LSHTM The employment o f the Manager of Clinical Studies (Dr Philippe Mayaud) was 
supported through this programme, but it also facilitated regular visits to Mwanza o f Prof David 
Mabey and of the Microbiologist Mrs Beryl West in order to provide scientific guidance and 
support.
The UK Medical Research Council (MRC) funded regular visits of Prof Richard Hayes to 
Mwanza and supported the Tropical Epidemiology Group of LSHTM through which additional 
epidemiological and statistical input was provided.
The author as the programme manager o f the trial and AMREF’s director in Mwanza was 
recruited by the School, but employed by AMREF and funded by both AMREF and the German 
Government through its Centre for International Migration and Development (CIM).
The World Health Organization funded the development and printing costs o f  an STD self 
learning training manual, which has since been used in the intervention in Mwanza and 
elsewhere The operational evaluation o f the intervention was supported by AMREF Austria
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Chapter 4 A im s a n d  o b je c t iv e s  o f  th e  t r ia l
The overall aim of the trial was to test the hypothesis that STDs enhance the transmission of 
HIV and that improved treatment o f STDs reduces the incidence of HIV infection.
The primary objectives of the trial were:
1 to establish a programme for the improved case management of STDs, integrated into the 
rural primary health care system o f  Mwanza Region
2 to evaluate the impact of this intervention on the incidence o f HIV infection in the general 
population
Secondary objectives were:
1 to evaluate the impact of the intervention on the prevalence and incidence o f  STDs
2 to evaluate the feasibility and the cost-effectiveness of the intervention
The integration of the treatment services into the primary health care system aimed at creating a 
sustainable and replicable intervention It was not an objective o f the trial to evaluate the impact 
of STD control on HIV transmission under optimised conditions.
Likewise, although the trial would contribute substantial evidence for the STD  cofactor 
hy pothesis, if an impact on HIV transmission were observed, it was not an objective of the trial 
to estimate the size of STD cofactor effects.
This thesis deals principally with the epidemiological objectives of the trial However, feasibility 
aspects are addressed in the sections on the operational performance of the intervention (chapters
5.3 and 6 1). and issues of cost-effectiveness in the discussion section (chapter 7.3).
Chapter 5 Methods
5.1 D es ig n  o f  t h e  t r ia l
5.1 .1  O v e r a l l  s t u d y  d e s ig n
The study was a community randomised controlled trial o f the impact o f improved STD case 
management on the incidence o f HIV infection and the prevalence and incidence o f STDs in the 
general population o f Mwanza Region, Tanzania
The intervention was provided through existing health facilities, but included health education of 
the general population in order to improve treatment seeking behaviour.
The impact was studied in six matched pairs of communities. Within each pair, one community 
was randomised to the intervention group and one to the comparison group. In each community a 
cohort o f about 1000 adults aged 15 to 54 years was selected from the population by random 
cluster sampling regardless o f their HIV status at baseline, and followed for 2 years.
To facilitate the interpretation of the results o f this cohort study, additional data were collected 
through two sexual behaviour surveys in subsamplcs of the cohort and two consecutive cross- 
sectional studies in pregnant women in the same communities.
The operational performance o f the intervention was also evaluated, partly through an analysis 
of health centre records, and partly through a cross-sectional study of patients who did not return 
for clinical follow-up
The rationale and details of the study design are described in the following parts o f  chapter 5.
5 .1 .2  R a tio n a le  f o r  c o m m u n ity  r a n d o m is a t io n
Randomised controlled trials arc the accepted “gold standard" for the evaluation of health 
interventions Random allocation o f study subjects to either an intervention arm or a comparison
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Why was a community-randomised design chosen for th is trial rather than randomisation by 
individuals? There were several reasons:
1. The nature of the intervention: The improved STD treatment services were to be provided 
through health facilities. The intervention was therefore available to the entire community 
served by these facilities. It would not have been ethical or feasible to withhold the services 
from particular individuals when they sought treatment a t the facilities.
2. The preventive effect o f the intervention on the rest o f  the community: even the individuals 
who are not directly benefiting from the intervention are protected because o f the overall 
reduction in STD prevalence in the population. Thus randomisation by community captured 
the ‘mass effect' o f the intervention, analogous to the  ‘herd immunity’ achieved through 
vaccination.
3. The expected bilateral direction of the HIV/STD cofactor effect: it can be assumed that 
STDs increase both infectiousness of an HIV-infected individual and the susceptibility o f an 
HIV-negative individual. Randomisation by individuals would only allow assessment o f the 
effect of the intervention on susceptibility in the study cohort. Randomisation by community 
captured the effects of the intervention on both susceptibility and infectiousness, as both HIV- 
mfccted and HIV-negative individuals who sought care for an STD were treated
5 .1 .3  D e f in itio n  o f  s tu d y  c o m m u n itie s
For the purpose of this trial, the ‘community’ was defined as a group o f  villages with a health 
centre located in a central village, and several satellite dispensaries in some or all o f the more 
peripheral villages. In communities within the intervention arm, improved STD services were to 
be provided in all of these health facilities.
arm helps to ensure that both measured and unmeasured confounding factors are equally
distributed in the two groups (Mertens et al 1990).
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5.1.4 Selection, matching and randomisation of communities
Selection
Mwanza Region had 23 rural health centres and 150 dispensaries at the time of the trial. In 
1991, the newly recruited regional STD intervention officer, the field manager of the planned 
cohort study and the author visited all health centres in the region and about 40 dispensaries, and 
gathered information on the state o f these facilities and the characteristics of the surrounding 
communities.
Based on this assessment, eight communities with health centres were excluded from 
participation in the trial for of a variety o f reasons: periurban locality, high mobility of the 
population in a gold mining area, health centre operational but barely utilised by the population, 
health centre utilised but not by STD patients From the remaining 15 communities, twelve were 
selected randomly. The rationale for selecting twelve communities is described in section 5.1.5.
Matching rationale and criteria
The twelve participating communities differed in terms of their accessibility, their distance from 
Mwanza town, their distance from main truck routes or from the lakeshore, and in terms of the 
occupational activities of their populations It was therefore likely that the communities differed 
substantially in HIV prevalence and incidence at baseline With a comparatively small number of 
communities, a simple randomisation procedure could possibly lead to an imbalanced allocation 
of communities into the intervention and comparison groups, with for example the average HIV 
baseline prevalence in the intervention arm being much lower or higher than in the comparison 
arm. thus making the interpretation o f impact data very difficult.
Ideally, for an intervention trial on HIV incidence, communities should be stratified or matched 
on baseline HIV incidence before randomisation Pair matching o f communities is the extreme 
form of stratification Such a matched pair design was chosen for the Mwanza trial.
Pre-trial incidence could only be obtained through an initial cohort study. However, the required 
time and cost o f this would have been prohibitive. HIV prevalence at baseline might have been 
used as a proxy. Unfortunately, neither prevalence nor incidence data were available for the
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study communities before the trial started. Some data on HIV prevalence in the region had been 
obtained from the cross-sectional survey mentioned in section 3.1.7. Tins was helpful for the 
sample size estimate, but could not assist the randomisation process, as that survey had been 
performed in different communities
Other variables which may be associated with HIV incidence are the geographical and 
occupational factors mentioned above For the Mwanza trial, it was decided to use type of 
settlement (roadside, lake shore or rural), geographical area (location within low or high 
prevalence districts) and pre-existing levels of STD attendance a t health centres, as matching 
criteria
Randomisation o f  communities
Within each pair, one community was allocated to the intervention group by tossing a coin The 
results are listed in table 5.1 The locations o f the study communities within the region arc shown 
in Map 5.1.
Table 5.1 Result of the matching and randomisation process
Pair
number
Matching criteria Intervention
communities
Comparison
communities
1 rural communities,
rclativclv difficult access from Mwan/a Nyangwhalc Mbarika
2 island communities.
located in low HIV prevalence district Ukara Muriti
3 roadside communities (on a main high way), 
located in high HIV prevalence district Nassa Nvangugc
4 lakcshorc communities, easy access from 
Mwanza, high STD attendance rate at HC Katunguru Sangabuvc
5 lakcshorc communities, difficult access from 
Mwanza, lower STD attendance rate Chikobc Mwangika
6 rural communities,
relatively easy access from Mwanza Mwamashimba Malva
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MAP 5.1 MAP OF MWANZA REGION
SHOWING THE LOCATION OF STUDY COMMUNITIES
KK
5.1.5 Sample size considerations for community randomised trials
Two questions followed from the decision to use a community-randomised design:
(i) How mans' communities were needed in each trial arm? (ii) How many person-years of 
follow-up were required in each community?
Clearly, these two choices are mutually interdependent. Within certain limits, an increase in the 
number o f person years o f follow-up per community (y) would allow a reduction in the number 
of communities needed (n) in each arm, and vice versa.
The required sample size depends on the incidence of infection in the absence of intervention (Io), 
such that a smaller sample size is needed if incidence is higher, since a larger number of events is 
then expected for a given number of person years o f follow-up. It also depends on the degree o f 
the reduction of incidence resulting ffom the intervention, such that a smaller sample size is 
needed if the difference between the incidence with and without the intervention is high (10 -I ,) ,  
since a larger difference can be detected more easily.
Furthermore, as in all intervention trials, the sample size depends on the required power of 
detecting a reduction, and the required level of statistical significance The higher the required 
power and level of significance, the larger the sample size.
Lastly, the required number o f communities in each arm depends strongly on the variability o f 
incidence between the communities, which can be expressed by the coefficient o f  variation (k), 
calculated as the quotient o f the standard deviation and the mean o f  all incidences in one arm of 
the trial The greater the variability between communities, the greater is k, and the greater is the 
number of communities required.
An approximate estimate o f  the required number of communities in each trial arm can be 
obtained through the following calculation (Hayes et al 1997):
f  [ d o  + I , ) / y  + k: ( I 0J + I,2) ]
n = 1 + -------------------------------------------
( I o - I i ) 2
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where f  is a  function o f the required power and the required significance'. E.g. for 80% power 
and significance at p < 0 05 (in the two-sided test), f  = 7 84 (Hayes et al 1997).
5 .1 .6  S a m p le  size  e s t im a te  f o r  th e  M w a n z a  t r ia l
To calculate the required number o f communities in each arm (n) and the required number of 
person-years o f  observation per community (y), pre-trial information on I0, Ii and k are needed 
For the Mwanza trial, none of these were readily available, so that plausible estimates had to be 
used instead.
A value o f 1 %  was assumed for 10 , the annual incidence in the absence o f the intervention, based 
on observations in the neighbouring region of Kagera (Killewo et al 1993).
Ii , the incidence with the intervention, should be lower than I0 if the cofactor hypothesis was 
correct However, it was unclear how much impact could be expected. From a public health 
perspective, it seemed worth launching an intervention if a reduction of about 50% of the original 
HIV incidence could be achieved It was therefore decided to make the sample size sufficiently 
large to detect a reduction of this order. It followed that the estimate for I* should be 0.5%.
To arrive at an estimate for k, the coefficient of variation, it was assumed that the true incidence 
rates in the communities without the intervention 10 would follow a normal distribution. Thus for 
a small number of communities, the lower and upper limits o f Iu would differ from the mean by 
approximately 2 standard deviations o f Io . It was also assumed that the true incidence rates 
would vary between approximately 0.5% and 1.5%. Under these assumptions, the standard 
deviation was S D  = 0.25 and k = S D / mean of I0 = 0.25/1.00 = 0.25.
It was further assumed, that the degree o f variation would be similar in the communities with 
intervention, giving a range from 0.25% to 0.75%, and k = 0.125/0.50 = 0.25 as before. 1
1 for significance at p < a  (z-test) and power = (1 - P ) , f  can be calculated as f  = (a, + zp ) J, 
using a table of the percentage points of the standard normal distribution (Kirkwood 1995).
For example for a  m 0.05, z . “  1.96; and for power of 0.8, p -  0.2, Zp “  0.84; which gives f  -  7 84
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It was anticipated that the matched design would result in a smaller degree o f variation within 
matched pairs, and so the sample size calculation (based on an unmatched design) was assumed 
to be conservative.
Using the above formulae, different possible values (n) for the number of communities in each 
group were obtained for different numbers of person-years o f observation (y) per community. 
The interdependence between these two sample size parameters is displayed in fig 5.1.
Fig 5.1 shows that at least 5 communities were required in each trial arm, and that nothing much 
would be gamed by increasing the person-years of observation in each community beyond 2,000. 
For a smaller number o f person-years, the required number of communities would be larger, the 
increase being non-linear. The trade-off between the two parameters is clear.
Fig 5.1 Number of communities required in each arm per person-year of 
observation, to give 80% power of detecting a reduction of HIV incidence from 1% to 
0.5%. assuming that the coefficient of variation k=0.25
From a logistical point o f view, it was easier to choose a comparatively high number of person- 
years per community than to increase the total number of communities which participated in the 
trial Therefore, a decision was made to aim for 2000 person-years o f observation per
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community It followed from the sample size equation in 5.1.5, that the required number o f 
communities would be n = 5.8. Therefore it was decided to select 6 communities for each arm o f 
the trial.
The required person-years o f observation were to be obtained by following a certain number o f 
study participants for a certain time period Again, there was a trade-off between these two 
parameters: a long follow-up period would have permitted a reduction in the number of study 
participants, but the benefits o f this were limited because of the higher rate o f losses to follow-up 
which was then to be expected. Conversely, an increase in the number o f participants would 
theoretically permit a shorter trial duration. However, this option was subject to logistic 
limitations Besides, an impact could reasonably be expected only if the intervention had been in 
place for some time.
For these various practical reasons, it was decided to recruit about 1,000 cohort participants in 
each community', and to follow them for a period o f 2 years, thus obtaining the required 2,000 
person-years o f observation
Incidence calculations can only be based on participants who were HIV-negative at baseline. 
However, for the sample size estimate this was ignored as baseline HIV prevalence was expected
not to exceed 4%.
Losses to follow-up were expected to be in the range of 20 - 30%. This would decrease the 
number of person-years. However, as follows from the sample size equation in section 5.1.5 
when keeping all other parameters equal, the power to detect a halving o f HIV incidence would 
only be reduced to 74 - 77%, a rather modest reduction
Sample size considerations for the cross-sectional studies on STDs in ANC attenders and the 
sexual behaviour surveys arc discussed briefly in the respective sections (5.4 6 and 5.4.7).
5 .1 .7  O u tc o m e  m e a s u re s
The primary outcome measure was the incidence o f HIV infection in the cohort in the 
intervention and comparison communities, established through a baseline survey and a follow-up 
survey after a period of 2 years
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(i) STDs: Data on the prevalences and incidences of different STDs in the two groups o f 
communities were obtained using a variety of approaches, mostly using the same basic format o f 
a cohort study with the baseline and follow-up surveys described above:
1. The cohort was tested for seroincidence and seroprevalence of syphilis.
2 Prevalences o f self-reported symptoms o f genital discharge and of genital ulcers were 
determined through interviews of all study participants in the cohort. Symptomatic study 
participants were examined for signs of genital infections.
3 Urine specimens of all men in the cohort were screened with the leukocyte esterase dipstick 
test Men who reported genital discharge, those with signs o f discharge detected on 
examination and all men with a positive dipstick test were examined and urethral smears were 
taken for the detection o f gonorrhoea, chlamydia infection and non-specific urethritis Thus 
minimum prevalences o f symptomatic and asjmptomatic infections were established in the 
cohort.
4 It was not possible to perform detailed investigations on STDs in women within the main 
cohort, for ethical and logistical reasons. To determine the impact o f the intervention in 
women, a sample o f 100 consecutive antenatal clinic attenders was selected at each o f the 12 
health centres, at baseline and again after 1 year All women in these two cross-sectional 
surveys were examined clinically, and vaginal and cervical specimens were tested for 
pathogens of reproductive tract infections.
Laboratory methods used in these surveys are described in detail in sections 5.4 4 and 5.4 6.
(ii) Sexual behaviour: The intervention did not aim at inducing changes in sexual behaviour. 
Nevertheless, it was possible that sexual behaviour differed between intervention and comparison 
communities already at baseline and that the intervention led to differential changes over time, 
thus confounding any impact results It was therefore important to collect data on sexual 
behaviour at baseline and at follow-up This was achieved through in-depth interviews o f a sub- 
sample o f cohort participants Details arc given in section 5 .4,7.
Secondary outcomes referred to the prevalence and incidence o f STDs and to the sexual
behaviour of the study population
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5.2 Design and implementation of the intervention
5.2 .1  G e n e r a l  p r in c ip le s  o f  th e  in te r v e n t io n
To make the intervention more sustainable and cost-effective, it was integrated within the 
existing primary health care (PHC) system: improved STD case management was provided 
through rural health centres and dispensaries, health educational activities for the general 
population were performed by the district health management team, and a reference clinic and 
laboratory were established at government health facilities in Mwanza town.
AMREF/LSHTM played a supportive and facilitating role, providing central services such as 
training, drug supply and supervision, but even these components were integrated as much as 
possible into the regional and district health system.
5 .2 .2  I n te r v e n t io n  c o m m u n i t ie s  a n d  h e a l th  fa c ilitie s
During the trial, the intervention was introduced stepwise into the 6 intervention communities In 
each of the communities, this involved one health centre and at least 3 dispensaries Two 
communities had 4 dispensaries. At one o f these, STD services were discontinued after the first 
intervention year, because o f  disciplinary' reasons In total, 25 health facilities participated 
without interruption At the end of the trial, the intervention continued in all the intervention 
communities, and was extended to the six comparison communities, and to other communities of 
the region thereafter
5 .2 .3  I n t e r v e n t io n  c o m p o n e n ts
The intervention had six components:
1. Training of health workers
2 Improved STD case management at health facilities
3 Supply o f effective drugs, essential equipment and consumables
4 Supervision of STD services at health units
5. Health education campaigns in the general population
6. Reference clinic and laboratory
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The intervention aimed to provide STD treatment services for the entire population. There was 
no targeted intervention for high risk behaviour groups, as such groups were difficult to identify. 
There were no brothels, and except for the two roadside communities, no bars or hotels. 
However, the operational capacity of the programme was also used to  intervene in Mwanza town 
and in other communities outside the trial area. In such places, identifiable high risk populations 
often existed and received special attention.
5 .2 .4  T r a in in g  o f  h e a l th  w o r k e r s
Selection o f  trainees
Health workers were selected for training by the respective District Medical Officer (DMO) in 
collaboration with the Regional STD Intervention Officer (see management structure fig. 3.1). 
From each o f the health facilities, the officer in charge was invited to a STD training course, 
usually a Medical Assistant (from health centres) or a Rural Medical aide (from dispensaries).
Within two to four months, two additional health workers (HW) followed from each health 
centre, and one additional HW from each dispensary. For the 25 health units in intervention 
communities, 65 staff were trained during the trial period, including replacements for transfer or 
retirement (about 15% in 2 years).
At some of the remote dispensaries, clinical services are provided by auxiliary staff who have a 
few months training only. Although these HWs are officially not permitted to prescribe, they are 
in fact the ones who often maintain the clinical routine at such units. The programme obtained 
permission to include such personnel in the STD training, following the principle of training 
those who actually do the job.
District personnel (MAs) who were to be become District STD Control Coordinators, and HWs 
from facilities outside of the trial area, also participated in the training
None of these HWs had prior exposure to training on STD case management. In Tanzania as in 
most sub-Saharan countries, STDs are usually covered only superficially during the basic
95
training of paramedical staff Even most physicians have only limited skills in the management of
this group of infections
STD training courses
The basic training in STD case management consisted o f a one week training course, performed 
at the seminar room at AMREF’s programme office. This was followed within two months by 
two weeks o f practical training at one of the STD reference clinics in Mwanza town
Training courses were conducted at two monthly intervals, with an average o f 6 to 7 courses per 
year with usually about 15 to 18 participants Practical training was performed continuously 
throughout the year
The training syllabus included the following topics:
1 public health importance of STDs
2 STD syndromes and syndromic case management
3 non-judgmcntal and caring attitude towards STD patients
4 health education, risk reduction and condom promotion for STD cases 
5. partner notification
6 AIDS
C ourse contents were standardised for all cadres of HWs Care was taken that teaching was not 
overloaded with biomedical details Formal lectures alternated with exercises, group discussions 
and role plays The standard training plan is attached as annex 1
Training manual
Early in 1991, David Mabey (LSMTM) and John Nduba (AMREF Nairobi) developed a self- 
learning training manual for health workers (Nduba and Mabey 1991)
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The manual was provided to all HWs about a month before started their training course, and 
they were encouraged to study it prior to the course. During the course it was used as the main 
resource material.
Refresher training
Onc-and-a-half years after their initial training, health workers were invited to Mwanza to 
participate in a 3-day refresher course. They used this time to exchange experiences with their 
peers, and to discuss common problems. Important messages were reinforced, and feedback from 
supervision and monitoring was given Because o f the limited capacity a t the training clinics, no 
practical refresher training was conducted.
STD training team
Training courses were conducted by the Regional STD Intervention Officer and two senior 
nurses all o f whom had substantial practical experience in STD case management The 
Intervention Officer was an MA, who was also regularly involved in the supervision of STD 
services in the intervention health facilities, so that field experience was constantly fed into the 
training
Physicians were usually not involved as trainers. However, the author gave a major input into the 
design of the courses, and both the author and the Manager of Clinical Studies monitored the 
quality and the output o f the training
Practical training
The practical training lasted two weeks. It was conducted at the STD reference clinics which 
were integrated into the outpatient services of Sekou Toure Hospital and the Makongoro 
Antenatal Clinic (see table 3.2).
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Trainees were attached on a one-to-one basis to skilled clinicians who acted as their tutors. They 
were expected to watch the correct management o f at least two cases o f each major syndrome by 
their tutor, and then to manage another two cases o f each syndrome on their own, but under 
supervision. This was roughly equivalent to seeing 30 new STD cases, this number o f patients 
usually presenting within 2 weeks.
5 .2 .5  I m p r o v e d  S T D  c a s e  m a n a g e m e n t  a t  h e a l th  fac ilitie s
Pre-intervention management o f  STD patients
Prior to the intervention, STDs were already treated at health facilities. However, health workers 
were not adequately trained, and lacked effective drugs They usually tried to establish an 
actiologic diagnosis, for example ‘gonorrhoea’ without having the necessary laboratory support, 
and treated using drugs from the kits provided to them through the Essential Drug Programme of 
Tanzania Treatment was not standardised and ineffective drugs or inadequate doses were often 
prescribed
Many HWs showed a reproachful attitude to STD patients, privacy was not maintained, and 
patients had doubts about confidentiality (Lwihula and Grosskurth 1993). Patients were usually 
not examined, health education was not given, and little efTort was made to extend the treatment 
to sexual partners
Improved case management
In the intervention health facilities, through training and regular supervision, HWs were 
encouraged to manage all STD patients according to the following standard procedure: 1
1 take a short history
2 perform a clinical examination
3 establish a syndromic diagnosis
4 provide immediate treatment based on a syndromic algorithm
5 give health education and promote risk reduction
6 offer condoms, and promote their use
7. encourage partner notification
8 keep simple records
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Clinical examination
This was done through a simple inspection o f the genitalia, anus, palms and soles and the oral 
cavity.
During the first year of the intervention, all health workers were trained in the use of the 
speculum, and were expected to perform a speculum examination for the diagnosis o f vaginal 
discharge, cervical infections and intravaginal ulcers However, the available time for practical 
training was too short for HW s to become confident with the method As a result, few health 
workers made use of the speculum It also became apparent that the speculum examination 
contributed little to the treatment decision in most cases Its use w as discontinued as from the 
second year of the intervention
Syndromic treatment
Health workers used a syndrome-based approach to the management o f most STDs A syndrome 
is a consistent combination o f  symptoms and easily recognised signs Syndromic treatment aims 
to cover the majority of the microbiological agents responsible for that syndrome in the 
population in question, usually by presenption of a combination o f drugs (WHO 1994).
The rationale, advantages and disadvantages of syndromic STD treatment are discussed in detail 
in the literature review (section 2.1)
In the Mwanza trial, the following syndromes were diagnosed and treated using standardised 
algorithms:
1 urethral discharge syndrome (UDS)
2 vaginal discharge syndrome (VDS)
3 genital ulcer syndrome (GUS)
4 balanitis syndrome
A syndromic algorithm was also used for the management of the pelvic inflammatory disease 
(P1D) syndrome, although it is not easy do diagnose this condition by clinical means only. As an
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approximation, lower abdominal pain (LAP) was used as a marker syndrome, recognising that 
this complaint is non-specific and often unrelated to a genuine acute reproductive tract infection.
For some STDs or complications of STDs an unambiguous aetiologic diagnosis is possible, so 
that monotherapy could be applied, again using standard treatment algorithms:
1. condylomata accuminata (genital warts)
2. condylomata lata (a form o f secondary syphilis)
Treatment algorithms were produced in the form o f user friendly flow-charts which were 
supplied to health workers in transparent folders to be kept readily available on their desks.
An example o f such a flow-chart is shown in fig. 5.2, and a summary of syndromes, aetiologic 
agents and treatment regimens is given in Table 5.2.
The algorithms were similar to those recommended by WHO (WHO 1994), except that second 
and third line treatment options were included for treatment failures. The regimen used for the 
management o f  vaginal discharge differed from the one suggested by WHO: a risk assessment 
step for the diagnosis of cervical infections was not included in the algorithms of the Mwanza 
trial
Health education, promotion o f  risk reduction
Health workers were trained to use a simple check list to guide the health education of their STD 
patients. Topics to be discussed were:
• the infectious nature of the disease: transmission through sexual intercourse
• some frequent complications: infertility, illness o f  children, AIDS
• the importance of completing the treatment course
• the reasons and the necessity for treating partners
• risk reduction: how to avoid future infection
• condom demonstration
Condoms were available in sufficient numbers at all health facilities, provided free of charge by 
the National AIDS Control Programme.
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Fig 5.2 Flow-chart for the management of 
genital ulcer syndrome
Genital ulcer syndrome ?
!
Benzathine penicillin 2.4 MU 
(ìm. half in each bunock) plus 
T rimethoprim-sulfamethoxazole 
1920 mg (=2 tbs) bd, for 2 days
|  7 days
Ulcer not improved ?
i
T ri methoprim-sulfamethoxazole 
1920 mg (=2 tbs) bd , for 3 alternate days
|  7 days
Ulcer not improved ?
1
Ciprofloxacin 250 mg (=1 tb) bd for 3 days
Partner notification an d  treatment
Health workers were encouraged to explain carefully to their patients the reasons why partner 
treatment was important. Each patient (index case) received small contact cards, one for each 
sexual partner reported The card was to be handed to the partner(s), and the patient was asked 
to encourage them to come to the clinic for treatment The card carried only the reference number
of the index case.
Partners who came forward were offered treatment, even if free o f symptoms. Health education 
was given A genital examination was offered, but was not a precondition for the treatment.
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Table 5.2: Syndromes and their causative agents occurring in Mwanza, with treatment regimens 
used for each syndrome in the STD intervention
Syndrome Aetiologies occurring in 
Mwanza
Treatment regimen used in the STD intervention
Genital ulcer 
syndrome
• chancroid 
(Haemophilus ducreyi)
• syphilis
(Treponema pallidum)
•  herpes
(Herpes simplex virus-2)
1 TMP-SMX 320mg/l 600 mg bd for 2 days + 
benzathine penicillin 2.4 mill.units un stat
2. TMP-SMX 320mg/1600 mg bd alternate 
days x 3
3. ciprofloxacin 250mg bd for 3 days 
(no treatment for herpes)
Urethral 
discharge 
syndrome in men
•  gonorrhoea
(Neisseria gonorrhoeae)
• Chlamydia infection 
(Chlamydia trachomatis)
• trichomoniasis
(Trichomonas vaginalis)
1. TMP-SMX 400mg/2000mg bd for 2 days + 
doxycycline 100 mg bd for 7 days
2. metronidazole 2g stat + doxycycline lOOmg 
bd for 7 days
3. ciprofloxacin 500mg stat
Vaginal discharge 
syndrome
• trichomoniasis
• bacterial vaginosis 
(anaerobic bacteria)
• cervical infections 
(gonococcal and 
chlamydial)
• candidiasis 
(Candida albicans)
A if discharge does not appear like thrush:
1. TMP-SMX 400mg/2000mg bd for 2 days 
+ doxycycline 100 mg bd for 7 days
+ metronidazole 2g stat
2. doxycycline 100 mg bd for 7 days
3. ciprofloxacin 500mg stat
B if discharge appears like thrush:
nystatin pessaries 1 at night, for 7 days 
or: application of 1% gentian violet sol
Lower abdominal 
pain s>Tidrome
if caused by pelvic 
inflammatory disease:
• gonorrhoea
• Chlamydia infection
• anaerobic bacteria
1. TMP-SMX 400mg/2000mg bd for 2 days + 
doxycycline 100 mg bd for 14 days + 
metronidazole 400 mg bd for 7 days
2. ciprofloxacin 500mg stat
Balanitis
syndrome
• non-infcctious
• various skin bacteria
• ulcer o f glans or fore­
skin
A if foreskin retractable and no ulcer seen: 
application of 1% gentian violet solution 
B if foreskin not retractable: 
treat as genital ulcer syndrome
Genital warts • Human papilloma virus application o f 1% podophyllotoxin-ethanol, 
washing after 3 hours, application lx per day
Condylomata lata •  Secondary syphilis benzathine penicillin 2 4 million units im stat
NB: in pregnancy, doxycycline and ciprofloxacin are replaced by erythromycin 
(500mg td for 7 days)
Legend:
1 : treatment given at first visit
2: treatment given if no improvement after 7 days
3: treatment given if no improvement after further 7 days
bd: twice per day, td: three times per day, stat: single dose
im intramuscular,
TMP-SMX trimethoprim-sulfamethoxazole
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Recording and reporting
At health facilities, simple records of each patient seen were kept using a special STD register 
book Standard information w as collected and included: a register number, the date, the name, 
the community o f residence, the syndromic diagnosis and the treatment given. Provision was also 
made to record condom acceptance by the patient, partners treated subsequently, and any follow­
up observations (e g : improved, cured, not better, worse, 2nd or 3rd line treatment given). It was 
noted if patients were referred, and which destination health facility they were referred to.
On request of the NACP, a standard monthly report form was completed by the health worker in 
charge of the facility. Copies were sent to the DMO and the NACP.
5 .2 .6  S u p p ly  o f  e ffec tiv e  d r u g s ,  e s se n tia l  e q u ip m e n t a n d  c o n s u m a b le s
Drug supply
Drugs were purchased from cheap bulk suppliers in the UK or the Netherlands They were 
airfreighted half-yearly to Dar-es-Salaam, cleared by AMREF’s country office, forwarded to 
Mwanza, and administered by the programme’s supply officer.
Health facilities kept a standard drug stock which was regularly replenished by the programme. 
During the initial phase o f the trial, drugs were supplied to health facilities by AMREF’s 
intervention supervisors on the occasion of their supervision trips to the intervention 
communities After district STD  control coordinators (DSCCs) had been trained, the programme 
supplied drugs to the district level, and DSCCs ensured the supply to health facilities.
The consumption was carefully monitored. Drug stocks were regularly taken at health facilities 
by supervisors, and observed drug consumption was compared with the expected consumption as 
calculated from the STD case register books which were kept by health workers. Discrepancies 
were checked and discussed. Consumed drugs were replaced, initially every six weeks, and later 
at quarterly intervals.
The effectiveness of the drugs was monitored at the reference clinic and laboratory in Mwanza 
town (sec below).
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Other supplies and equipment
Besides the drugs, disposable plastic gloves for examination and batteries for examination torch 
lights were regularly supplied.
The following items of equipment were regarded as essential for the improved STD services at 
health facilities:
• a simple desk and two chairs
• an examination bed
• a torch
• a screen to ensure privacy during examination
• a functioning door to close the consultation room
• a mug for drinking water, to ensure directly observed treatment
• a wooden box with padlock to keep the STD drugs
• a register book
• transparent folders with syndromic flow-charts
The intervention programme had to provide chairs, tables and examination beds to about a 
quarter o f  the health facilities. A screen had to be provided for about half of them. All these 
items were produced at low cost by local craftsmen. Several doors had to  be repaired. All health 
facilities received the smaller items listed above.
5.2.7 Support supervision
Objectives
Regular supervision visits to peripheral health facilities were regarded as one of the key elements 
of the STD intervention The guiding principle was support rather than mere checking. The visits 
had four objectives: 1
1. to provide in-service training 
2 to give feedback and motivation
3. to audit the consumption o f drugs
4. to replenish the drug stock
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Rationale
Experience from another STD intervention programme outside Mwanza Region without a 
regular supervisory component, had demonstrated that the training of health workers alone, 
although essential, was not in itself sufficient to ensure successful implementation o f the 
programme at peripheral health facilities (Felix Ndyetabura, NACP Tanzania, personal 
communication). Health workers found it difficult to put their new skills into practice, 
particularly to apply the new treatment algorithms, to provide health education to patients 
reliably and regularly, and to utilise the drugs for the purpose they were intended for. 
Furthermore, the lack o f feedback and in-service training within this programme had a negative 
effect on the motivation o f health workers
Supervisors
Two Medical Assistants (MAs) acted as regional supervisors in addition to the Intervention 
Officer (Fig 3.1), one o f them on a half-time basis They were based at AMREF's programme 
office, and toured all participating health facilities and the respective district health offices 
regularly, initially every 6 weeks and later at quarterly intervals
As the intervention programme aimed at complete integration into the district health structure, a 
new- cadre was created: the District STD Control Coordinator (DSCC). The DSCC, usually an 
experienced MA by background, was a member of the distnet health management team The six 
DSCCs received formal STD training in Mwanza, and in-service training by the regional 
supervisors Initially they performed their work together with a regional supervisor, but after 2 
years most supervision visits were conducted by DSCCs.
During leave or illness, the District AIDS Control Coordinator (DACC) acted as a replacement 
for the DSCC However, these two jobs were in principle quite distinct the DSCC needed to be 
an experienced clinician, whilst the DACC had mainly an educational task directed at the general 
population Since 1989, all districts in Tanzania have been staffed by a DACC.
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Supervision checklist
During supervision visits, the regional and/or district supervisors worked with the trained health 
facility' staff To standardise this process, a checklist was introduced which covered the following 
points:
• staff availability: any problems anticipated due to illness or leave?
• equipment: is it complete ? are repairs needed ?
• patient register book: is the information complete and consistent ?
• treatments given: have algorithms been followed ?
• clinical discussion: did the health workers see any interesting or difficult cases ?
• in-service training revise a topic with the HW, sec a patient jointly if  possible
•  statistics: how many patients ? which syndromes ? cure rates ?
• feedback discuss performance and statistics, compare with rest of the district
• drug consumption: how much has been consumed according to cases treated?
• stock taking: does the physical stock tally with the calculated consumption ?
• reporting have forms for the district and higher authorities been forwarded ?
• drug replacement new drugs arc provided so that a standard stock is maintained
Supervision forms
A supervision form, which included the checklist given above, was used to record the 
performance of STD services at the health facilities, check drug consumption and identify 
training needs (annex 2).
5 .2 .8  H e a l th  e d u c a t io n  c a m p a ig n s
About twice per year, a health education campaign was performed in each village served by an 
intervention health facility The campaigns focused on the availability of free and effective 
treatment at the facility and on the public health importance of STDs People were encouraged 
to attend promptly for treatment if they had symptoms
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The campaigns were conducted during market days when a large part o f the population was 
likely come to the village centre. A variety o f  strategies were used: (i) group discussions were 
held with local opinion leaders, (ii) health educators and opinion leaders jointly made public 
speeches, (iii) the population was attracted by means of large picture boards which dealt with 
STD related topics, (iv) health educators discussed these topics in public, and (v) leaflets were 
distributed which addressed the importance o f  early STD treatment and means o f risk reduction.
The campaigns were conducted by district health personnel, notably the District AIDS Control 
Coordinator (DACC), and were facilitated by AMREF through one of the intervention 
supervisors.
5 .2 .9  R e fe re n c e  c lin ic  a n d  la b o r a to ry
At Sekou Toure Hospital (the Municipal Hospital of Mwanza) and at Makongoro Clinic (the 
largest antenatal clinic in Mwanza town), improved STD case management was integrated into 
the outpatient services Both facilities were used as STD reference clinics. Adjacent laboratories 
were equipped and refurbished, so that some on-site tests could be done For all other STD 
diagnostic tests, specimens were sent to the laboratories o f the National Institute of Medical 
Research (NIMR).
The reference clinics served the following functions within the intervention programme:
• to monitor the aetiology of STD syndromes
• to monitor the antibiotic susceptibility of Neisseria gonorrhoeae
• to train health workers in STD case management
This important component was planned and supervised by the Manager o f Clinical Studies, Dr 
Philippe Mayaud, and his counterpart, Dr Gina ka-Gina The microbiological work was 
conducted at NIMR by Mr John Changalucha and later by Mrs Beryl West and Mr Jan
Comclisscn
The reference clinics did not routinely function as referral clinics. The great majority of the 
patients came from Mwanza town.
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Monitoring the aetiology o f STD syndromes
Monitoring the pattern of STD aetiologies was essential to ensure that the syndromic treatment 
algorithms covered most of the causative agents occurring in the region. To achieve this 
objective, vaginal, cervical or urethral specimens were collected from all patients presenting 
with vaginal or urethral discharge syndromes at the reference clinics. The specimens were used 
to diagnose infection with Neisseria gonorrhoeae by Gram stain and culture, Chlamydia 
trachomatis infection by antigen detection Elisa test, infection with Trichomonas vaginalis by 
wet preparation microscopy, Candida albicans by wet preparation and Gram stain, and bacterial 
vaginosis by Gram stain, pH test and KOH test.
To diagnose genital ulcer aetiologies, swabs were obtained from the ulcer base. Treponema 
pallidum, the bacterium causing syphilis, was diagnosed by dark field microscopy and later by 
PCR (at LSHTM) ; Haemophilus ducreyi, the causative agent of chancroid, was diagnosed by 
culture; lymphogranuloma venereum (caused by Chlamydia species) and infection with Herpes- 
simplex virus type-2 were diagnosed by their specific antigen detection Elisa tests. In addition, 
blood specimens were obtained from all STD patients for syphilis serology (RPR and TPHA 
tests). Granuloma inguinale (donovanosis) did not occur in the region.
Treatment decisions at the reference clinic did not depend on the laboratory test results but were 
guided by the same syndromic algorithms used in the intervention health facilities2. This was 
necessary because some patients did not return to collect their results. *•
: Three exceptions were made to this rule, mainly for ethical reasons:
• In patients with vaginal discharge, the wet preparation microscopy result, usually available within a 
few minutes, was used to decide whether treatment for Trichomonas vaginalis had to be given This 
procedure saved many women from taking metronidazole unnecessarily.
• When a patient with urethral discharge returned after 7 days without improvement, third-line 
(rather than second-line) treatment was given if gonorrhoea had been found at the first visit. This 
situation indicated the possibility of gonococcal resistance to the first-line drug and a short-cut to 
third-line treatment seemed justified Reinfection was excluded, if possible, before this decision was 
taken.
• RPR test positive patients were treated for syphilis, even if presenting with a non-ulcerative STD.
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Monitoring the antibiotic susceptibility o f  Neisseria gonorrhoeae
It was essential to monitor the effectiveness of the drugs used for treating gonococcal infections. 
Resistance of Neisseria gonorrhoeae to  many antibiotic drugs is widespread, and can develop 
comparatively fast (Holmes 1990, West e t al 1995).
Strains of Neisseria gonorrhoeae were cultured from patients presenting with genital discharge 
SNudromes. After initial isolation and identification, strains were stored at minus 70°C in 
Mwanza, and once per year sent to LSHTM  for further characterisation and determination of 
minimum inhibition concentrations (M ICs) using an agar dilution technique.
The training o f  health workers is described in detail in section 5.2.4.
5 .3  O p e r a t io n a l  e v a lu a tio n  o f  th e  in te r v e n t io n
5 .3 .1  M o n ito r in g  o f  o p e ra t io n a l  p e r f o r m a n c e
During their regular visits to health facilities, regional and district supervisors monitored the 
performance of health workers using the supervision checklist described in section 5.2.7, and 
tried to assist the health workers concerned to solve any problems. They also assessed the 
reported cure rates o f patients with STDs, based on entries from the STD patient register book.
Supervisors completed a supervision form  (annex 2), which was discussed during a weekly 
debriefing session on return from the field with either the Intervention Officer or the Programme 
Manager If necessary, decisions were taken at this time to address more substantial problems 
regarding training, supplies or, occasionally, discipline. The supervision forms were not used for 
further evaluation.
5 .3 .2  E v a lu a t io n  o f  o p e ra t io n a l  p e r f o r m a n c e  b a s e d  o n  h e a l th  fa c il i ty  d a ta
At the end of the trial, that is after the intervention had been in place for two years in each of the 
intervention communities, all register books were collected from the health facilities and replaced
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by new ones. This process lasted one year, because o f the phased implementation of the trial (see 
section 5 .4.1)
An experienced STD clinician from Sekou Toure Hospital, who was not involved in the 
intervention in rural health facilities, was trained by the author to extract all relevant operational 
data from the register books.
The following parameters were compiled:
1 number o f STDs presenting to health facilities by sex and type o f syndrome
2. proportion of dual or multiple syndromes
3. proportion of patients with complete follow-up visits
4 proportional cure rates after 1st, 2nd and 3rd line treatment for GUS, UDS and VDS 
5. proportion of patients referred 
6 proportion of patients who accepted condoms 
7. proportion of patients for whom at least one partner was treated
The analysis was performed manually at AMREF’s office.
5 .3 .3  E v a lu a t io n  o f  o p e r a t io n a l  p e r fo r m a n c e  th r o u g h  h o m e  v i s i t s  o f  p a t i e n t s  w ith  
in c o m p le te  fo llo w -u p : a  c ro s s -s e c t io n a l  s tu d y
Objectives
Primary objective: to assess the cure rates o f STD patients in intervention communities who 
had been treated syndromically, but who had not returned for a final test o f  cure,
Secondary objectives: to asses health workers' performance and patients' satisfaction with the 
improved STD services.
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Rationale
As described in 5.3.1, the routine supervisory visits of health facilities helped to monitor whether 
cure rates were sufficiently high to  confirm the adequacy o f the drugs and the treatment regimens 
in use.
However, complete follow-up da ta  were only available from about one third o f the patients (see 
section 6.1) The majority of the patients did not return for a test of cure. It was assumed that 
most patients were not willing to  sacrifice time for further visits if they were already cured. 
However, it was not clear whether this assumption was correct. It was therefore necessary to 
perform a survey of patients who did not return for follow-up and to compare the cure rates of 
these 'non-returners' with those o f  the ‘returners’.
At the same tunc, this survey offered a possibility to collect information about the patients’ 
perceptions of the STD services.
Study design, selection o f participants and sample size
A cross-sectional survey was performed in 1995 through home visits of STD patients from 
intervention communities who had not returned for follow-up visit to their health facilities
The necessary sample size was calculated at 250. This was sufficient to detect whether the cure 
rate in non-returners was unacceptably low (the mam research question of this supplementary 
study) We expected the cure ra te  to be about 80%, and wished to estimate this with 95% 
confidence limits of +/- 10%. It was expected that the participation rate in this kind of survey 
might be low, so that it was decided to define the time span for eligibility in such a way that at 
least 500 persons would be enlisted.
Eligible study participants were all patients who had been treated for STDs at the six 
intervention health centres, or at 12 randomly selected intervention dispensaries, within a period 
of more than 2 weeks but less than 3 months prior to the survey, and who had not completed
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women
367 patients, more than expected, were successfully recruited, 164 men (66% of those eligible) 
and 203 women (64%).
In order to avoid embarrassment for the patients and to ensure good compliance, the home visits 
also included 375 patients with diarrhoea, respiratory tract infections and suspected malaria. The 
study therefore did not have the character o f an STD survey. However, except for information on 
treatment satisfaction, the data from these additional patients were not processed further, as no 
clear information could be obtained about the original clinical condition.
follow -up v isits for a  clinical tes t o f  cure 567 patients fulfilled these crite ria , 249 men and 318
Survey methods
The survey was conducted by two teams each comprising a team leader, three male and three 
female interviewers, and a driver. Supervision was provided by the author and the Field 
Manager. All field research assistants were clinically experienced MAs or RMAs, and had been 
involved in the main cohort study.
A structured questionnaire was designed in English, translated into Kiswahili, backtranslated into 
English and pre-tested in a community with STD intervention outside the trial area
Patients were interviewed in their homes Great care was taken to ensure confidential interview- 
conditions Questions concerned the treatment patients had received, their compliance, the 
treatment results, and present symptoms Patients were shown a collection of drugs as used in the 
intervention, and they were asked if they recognised the drugs and remembered how many tablets 
they had been given, and with what instructions. Other questions addressed the patients' 
cxpenence with regard to examination, health education, condom promotion and partner 
notification, and general service satisfaction Patients who reported symptoms were offered a 
clinical examination, and treatment if necessary.
5.3.4 E valuation  of the r e f e r r a l  system
During the compilation of data from the treatment register books as described in section 5.3.2, a 
complete list was generated o f the 99 patients who had been referred by their local health worker 
to a higher level health facility during the two years of the trial. Hie list included the patient's 
name, the date of referral, the  diagnosis, the reason for referral, and the destination health
facility.
Permission to access the patient register books of these destination facilities was given by the 
Regional Medical Officer M wanza and the various officers in charge of the facilities. Possible 
alternative health units which a  patient might have chosen for referral attendance were also 
included, for example other health centres or hospitals in the wider area
A medical assistant who had no t been involved in the intervention in rural communities toured all 
these health facilities, and made a careful attempt to trace the names o f the referred patients in 
the register books For this purpose, he searched the entries of the month in which the referral 
decision had been made plus the  3 month period which followed.
If the patient's name could be traced, the MA tried to verify their identity if possible, for example 
through entries regarding the patient's place of residence The diagnosis, the treatment, and any 
available follow-up observations were extracted and recorded
The data were analysed manually at AMREF's office.
5 .3 .5  A sse ssm e n t o f  th e  c o n ta m in a t io n  b e tw e e n  c o m p a r is o n  a n d  in te r v e n t io n  c o m m u n itie s
It was the primary objective o f  the intervention tnal to investigate the impact of improved STD 
case management on HIV transmission (chapter 4). It was possible that STD patients from 
comparison communities might seek and receive treatment from intervention communities. In this 
case, any impact of the intervention would be diluted.
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It was therefore desirable to obtain a good estimate o f  the proportion of patients who were 
residents in comparison communities among those seeking treatment at intervention facilities.
This was achieved through a survey of all treatment register books at the end of the two year trial 
period at each of the 25 intervention facilities, and by extracting the available information 
regarding the community of residence.
The investigation was performed simultaneously with the analysis o f the recorded clinical data 
described in section 5.3.2.
5 .4  Im p le m e n ta t io n  a n d  a n a ly s is  o f  th e  im p a c t  e v a lu a t io n
5 .4 .1  P h a s e d  im p le m e n ta t io n
After completion of preliminary work, the trial commenced in December 1991. The time plan is
shown in fig. 5.3
A period o f 2 months was needed to introduce each matched pair of communities into the trial 
Dunng this period, the baseline survey was carried out simultaneously in the intervention and the 
comparison communities, and staff training was conducted. The intervention was launched in the 
intervention communities as soon as the baseline survey was completed
After 2 months, the cohort survey field teams moved to  the next pair of communities, and the 
next batch of health workers from intervention communities came to Mwanza for their STD 
training course. Twelve months were therefore required to  enter all six pairs
The follow-up survey was conducted in each pair o f communities 2 years after the corresponding 
baseline survey For each community, the follow-up lasted therefore exactly 2 years. Because o f 
the phased implementation the overall time required ffom the beginning of the baseline survey to 
the end o f the follow-up survey was 3 years (fig. 5.3).
Immediately after completion of the follow-up survey in each pair, the intervention was 
introduced into the comparison communities On completion of the trial, the intervention was
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therefore in place in all communities involved in the study. The one year interval between the end 
of the baseline and the beginning o f the follow-up surveys in the main cohort was used to launch 
the intervention in health facilities within Mwanza town and elsewhere in the Lake Zone, far 
distant from the trial communities. This approach ensured that the capacity of the programme to 
implement the intervention was fully utilised throughout the 3-year period of the trial
Figure 5.3 Phased implementation o f the trial. Timetable of main cohort surveys, start of intervention, 
and supplementary studies
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The first sexual behaviour survey was conducted between February and April 1993, four to 
fourteen months after the baseline survey in the main cohort. The second sexual behaviour
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survey lasted from August 1994 to February 1995, two to seven months after the follow-up 
survey in the main cohort.
The first cross-sectional study among pregnant women was performed from May 1992 to 
November 1992. The second study followed one year later. A third study of the same type was 
planned for year 3, but was not implemented due to lack o f  funds
5 .4 .2  M a in  c o h o r t  s tu d y :  c o m m u n ity  m o b il is a t io n
About 3 weeks prior to the start of the cohort survey in each pair o f communities (for both the 
baseline and the follow-up surveys), the Field Manager and one of the research field team leaders 
visited the study communities to discuss the plans for the survey. They were accompanied by 
either the DMO or another high ranking officer from the district administration. The health 
worker in charge of the local health facility was also involved. The delegation introduced itself 
with an official document signed by the Director of the National Institute for Medical Research 
giving information about the study and its approval by the government.
A meeting was held with community and opinion leaders, including officials from the local party 
office After obtaining the approval of the community leaders, the random cluster selection was 
performed jointly with these authorities (see below 5 .4.3). A larger meeting followed the next day 
involving all balozi leaders whose 10-household unit had been selected (see section 3.1.5 on the 
administrative system in the region). At both meetings, the objectives of the study and the 
expected benefits for the community were carefully explained, and concerns discussed
The concern raised most frequently regarded the amount o f blood to be taken and fears that the 
blood samples might be sold abroad. To overcome these anxieties, the survey team demonstrated 
the size of the blood vials used for taking the specimens. In several communities, it was even 
agreed that the vials would be burnt in the community after the serum samples had been
separated.
The population was informed that blood specimens would be tested anonymously for HIV 
infection, and that the programme statistician would be the only person who could theoretically
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link names with results. Voluntary linked HTV testing was offered for those requesting it, for 
which a second small blood sample would have to be taken
5 .4 .3  M a in  c o h o r t  s tu d y : e n u m e ra t io n  o f  th e  s tu d y  p o p u la t io n
The target was to  recruit 1000 participants aged 15-54 years through random cluster sampling 
Within each community, the cohort was sampled from a study population o f approximately 2000 
to 3000 adults, defined as those living within 90 minutes walking distance around the health
centre.
The twelve study communities were rather large entities, between 20 and 30 km in diameter, with 
an average population of 25,000 inhabitants, living in several distinct villages. It was assumed 
that in a scattered rural population, patients from the periphery of the communities might not 
necessarily use their own local health facility, because o f possibly more convenient access to 
neighbouring villages outside the intervention area. The above definition ensured that, in 
intervention communities, the population within the more central parts was unlikely to seek care 
from health facilities without improved STD services, thus reducing 'contamination'. This 
allowed us to define a sizeable population to be eligible for recruitment into the cohort study (Fig 
5.4).
Figure 5.4: Cohort recruitment zone of a 
study community.
H health centre, D dispensary .
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As described in section 3.1.5, the smallest administrative unit was the balozi, which consisted in 
principle o f  10 households. In each study population, 1 6 - 2 0  clusters were formed each 
consisting o f three to four neighbouring balozis. Each cluster had a population o f 120 - 150 
eligible adults. A random sample of seven to nine clusters was selected in each community.
A house to house visit was performed, and with the help of balozi and household leaders a list 
was made o f  all adults resident in the selected cluster. Eligibility was defined b y  age (15 - 54 
years) and residence (living in the selected cluster and having lived in the community' for the last 
2 months or longer, or planning to live in the community for the foreseeable future).
All enumerated persons who were present and willing to participate were enrolled in the study, 
even if this exceeded 1000 participants.
According to the study protocol, if by the end of the baseline survey in a particular community' 
the target o f 1000 participants had not been achieved, an additional cluster was to  be chosen at 
random. However, this situation did not arise.
5 .4 .4  M a in  c o h o r t  s tu d y :  d a t a  c o lle c tio n  a n d  l a b o r a to r y  m e th o d s
Interview
Nurses and Rural Medical Aides were selected and carefully trained as interviewers. All 
interviewers were of Sukuma origin and spoke the local language Each field team had one male 
and one female interviewer.
Separate structured questionnaires were designed for the baseline survey and later fo r the follow­
up surveys They were drafted in English, translated into Kiswahili, and backtranslated into 
English The Kiswahili versions were pre-tested in pilot studies first among hospital workers and 
afterwards in two rural communities outside the trial area (see annexes 3 and 4).
Questions concerned personal characteristics, circumcision status in men, history of STDs, 
treatment seeking behaviour and present STD symptoms. Questionnaires for baseline and follow­
up surveys were similar
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«The interview was the point o f first contact between field research team and cohort participants. 
At the start of each interview, a standard explanation was given about the objectives o f the study 
and the data and specimens to be collected. It was emphasised that participation in the survey 
was voluntary and that any information obtained would be kept strictly confidential. The 
participant was given the opportunity to ask questions about the study. After completion of this 
procedure, informed oral consent was obtained, and recorded in writing by the interviewer.
If a  participant requested to know his/her HTV status, an offer was made to collect an additional 
small blood sample for a linked HIV test after pre-test counselling. Such a participant was told 
that the HIV test result would be channelled confidentially to the District AIDS Control 
Coordinator who would visit the village to feed the result back to the participant after post-test 
counselling5.
Serological tests
A sample of venous blood was taken from consenting subjects, serum was separated and a Rapid 
Plasma Reagin (RPR) test (VD-25, Murex, Dartford, Kent, UK) was performed immediately, so 
that individuals with positive results could be treated on the spot.
Sera were later tested in Mwanza for HIV-1 antibodies using an enzyme-linked immunosorbent 
assay (ELISA, HTLV-III-ELISA, Organon Teknika, Boxtel, Netherlands). All positive samples 
underwent confirmatory testing with a methodologically independent ELISA (Wellcozvme 
HIV 1+2 G AC ELISA, Murex Diagnostics, Dartford, UK) In case of discrepant or indeterminate 
results, a western blot test was performed (HIV-1 Westemblot, Epitope, Beaverton, Oregon, 
USA). For the follow-up survey, HTLV-III-ELISA was no longer available, and the successor 
product Vironostika HIV MIXT Microelisa (Organon Teknika, Boxtel, Netherlands) from the 
same company was used instead The HTV-1 specific component of this ELISA was identical 
with the previous test (Amoud Klokke, personal communication)* 4.
5 Only six cohort participants requested to know their HIV test results.
4 The test used for the follow-up survey differed from the one used for the baseline survey mainly 
because of its additional HIV-2 specific component However, surveillance among HIV positive sex 
workers in Mwanza town in 1992 and 1994 with an HIV-2 specific test failed to show any evidence that 
HIV-2 had reached Mwanza Region.
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Sera were also tested in Mwanza for syphilis serology by the Treponema Pallidum 
Hacmagglutination Assay (TPHA) test (Fujirebio, Tokyo, Japan). An R PR  test was performed 
(as above) on all sera positive for TPHA. Titres (1:2 - 1:32) were determined for RPR positive 
sera Only results of syphilis tests conducted in the laboratory were used in the analysis. TPHA 
seropositivity was considered to indicate past or current syphilis infection, while positivity on 
both TPHA and RPR tests was considered as indicative o f active syphilis, particularly if the 
RPR titre was >=1:8.
Urine specimens
Male subjects were asked to provide a first void urine sample, which was tested for the presence 
of leukocytes using a leukocyte esterase dipstick (LED) test (Nephur-Test + Leuco, Boehnnger- 
Mannheim, Lewes, Sussex, England, UK).
Clinical examination
All study participants were seen by the clinician who offered an examination to all those 
reporting current STD symptoms on interview, to all participants yvith a  positive RPR and to all 
men with a positive LED test Symptoms and signs were recorded using a clinical examination
form.
Urethral swabs and tests
Men reporting a urethral discharge, men with other complaints who were found to have a 
urethral discharge on examination and all men with a positive LED test were asked to permit the 
collection o f two urethral swabs.
One of the swabs was smeared on a glass slide which was heat fixed in the field for subsequent 
Gram staining at the laboratory ofNIM R The presence o f intracellular gram-negative diplococci 
was taken as evidence o f infection with Neisseria gonorrhoeae (NG). For logistical reasons, it 
was not possible to attempt isolation of NG during this study
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The second swab was inserted more deeply ( 2 - 3  cm) and rotated within the urethra. This swab 
was placed in transport medium at about +4°C, and later frozen at -20°C. These specimens were 
tested at the NIMR laboratories for Chlamydia trachomatis (CT), using an antigen capture 
enzyme immunoassay (IDEIA Chlamydia, Novo Nordisk Diagnostika, Cambridge, 
Cambridgeshire, England, UK). A blocking assay was used to confirm a positive test result.
Urethritis was identified as the presence o f NG and/or CT infection and/or five or more 
poKmorpho-nuclear (PMN) cells per high power field on Gram stain
Numbering o f study participants and o f  specimen and data sheets
Each individual who was enrolled in the study was given a unique identity (ID) number which 
consisted of
1 two digits indicating the community
2 two digits indicating the cluster within the community 
3. one digit indicating the balozi within the cluster
4 three digits indicating the individual within the balozi
In addition, all specimens and data sheets for the same individual were marked with an identical 
sequence number Adhesive labels printed with these sequence numbers were prepared in the 
week before the field trip Questionnaires and clinical examination forms earned both the ID 
number and the sequence number
5 .4 .5  M a in  c o h o r t  s tu d y :  o rg a n is a t io n  o f  s u rv e y s
Field teams
Two field research teams worked in parallel, one in each paired community. Teams usually 
remained in the field for two weeks They alternated with another pair of two teams, so that the 
survey could be conducted without interruption for two months in each community.
Each team comprised seven staff: a team leader, two interviewers (one male and one female), two 
laboratory technologists, a clinician and a driver.
Implementation o f  field work
It was not possible for the field research teams to transport their equipment including a generator 
and centrifuge from household to household. A convenient central site was therefore established 
for members o f each cluster to be interviewed and examined, usually at a school house, a party 
building or somebody’s residence. The site was within 15 min walk from each household After 
one week, the team moved to the next cluster.
Participants were first seen by an interviewer of the same sex, where their identity was checked, 
the objectives o f the survey explained, consent obtained and the interview' conducted The 
interview lasted about 10 minutes Care was taken that conditions o f confidentiality were strictly 
maintained dunng the interview.
Thereafter the blood sample was drawn by one of the laboratory technicians, and the serum was 
separated immediately and stored in thick-walled cool boxes at about +4°C Men were requested 
to provide a sample o f first void urine. Laboratory technicians performed the RPR and the LED 
tests as described above, and reported the results on standardised data sheets to the clinician 
w ithin one hour after obtaining the specimens
Study participants were then seen by the clinician for examination and specimen taking as 
described above.
As a service to the population, treatment for STD syndromes w as provided using the syndromic 
algorithms discussed in section 5.2 5, and for syphilis if the R PR  test was positive Treatment 
was also given for any other reported ailment. Such treatment was also provided for any other 
villagers who presented Occasionally, the team provided assistance if a villager needed referral
for a serious or urgent condition
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When eligible individuals failed to attend, repeated home visits were made by the team leader in 
collaboration with the local balozi leader to encourage attendance. Transport was provided for 
those too sick to walk. At the end of the field work in a community, one week was used to revisit 
those clusters where many people had been absent, so that coverage could be increased further. If 
an individual was definitely not present or unwilling to attend, the reason was recorded.
A rendezvous shuttle service was arranged to transport sera and other specimens to Mwanza 
twice per week and to bring new ice packs to the field.
5 .4 .6  S u rv e y s  o f  th e  p r e v a le n c e  o f  S T D s in  p r e g n a n t  w o m en
Objectives (according to the original protocol)
To determine the prevalence of STD pathogens in pregnant women in intervention and 
comparison communities at baseline, after one year and after two years.
Rationale
Self-reporting of STD symptoms in women is a problematic criterion for assessing the presence 
of STDs, because of the frequency of mild and asymptomatic infections and the lack o f 
specificity o f genital symptoms in females (Wasserheit 1989) Reliable information on STD 
prevalence among women therefore requires internal examination and the taking of specimens for 
laboratory analysis. This is usually not feasible and logistically difficult during a general 
population survey, but is possible during attendance at antenatal clinics.
Study design, selection o f  study participants, and sample size
Three consecutive cross-sectional surveys were to be conducted of 100 pregnant women, 
presenting consecutively to antenatal clinic services at each o f the 12 health centres in the 
intervention and comparison communities, giving a total sample size of 1200 in each survey.
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The sample size and power of the survey to detect a significant difference in the prevalence of 
key STDs between intervention and comparison communities was calculated using a similar 
equation' as the one given in section 5.1.5. For 6 communities in each group, 100 women per 
community, and with the assumption that k = 0.1, the study had 75% power to detect a reduction 
o f the prevalence of active syphilis from 8% to 4% at the 5% significance level. For ‘any STD’, 
the study had 75% power to detect a reduction from 40% to 30%.
Timing
The first cross-sectional study among pregnant women was performed from May 1992 to 
November 1992. The second study followed one year later A third study was planned for year 3, 
but was not implemented due to lack o f funds.
Survey methods
The field work was performed by a team comprising an experienced MA and a nurse, under the 
supervision of the expatriate Manager o f Clinical Studies or his Tanzanian counterpart (see the 
organogram in fig 3.1).
The study participants were enrolled over a 2-week period at each health centre. After obtaining 
informed consent, subjects were interviewed using a standard questionnaire in Kiswahili which 
had been piloted in an antenatal clinic in Mwanza town Questions concerned sociodcmographic 
factors, a full obstetric and gynaecological history, and details o f current symptoms. 
Questionnaires for the tw o surveys were identical.
A gynaecological examination was performed by the clinician including speculum examination 
On this occasion, endocervical and vaginal swabs were taken for various laboratory tests A 
blood sample was obtained for the diagnosis of syphilis
5 If the objective is to compare the proportions (pu and pi ) of individuals with the outcome of interest in 
the intervention and control groups in a cluster-randomised trial, the following equation can be used in 
order to calculate n (the number of clusters required per arm), in terms of r (the number of individuals 
sampled per cluster), k (the between-community variation in p) and f  -  (z^  + z,,)2 (Hayes. personal 
communication 1997): n “  1 + f  ( Po(l - Po) / r + Pi(l - pi) / r + k2 ( po2 + Pi2) J / (Po- Pi) 2
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Women found to be infected were treated in collaboration with the health centre staff. If 
laboratory' results were positive, these were fed back to the health centre within two weeks after 
completion o f the field work, and the drugs for treatment were provided
laboratory methods
In the field, vaginal swabs were used to prepare saline wet mounts for the diagnosis of infection 
with Trichomonas vaginalis and Candida albicans.
Two cervical swabs were obtained for the diagnosis o f Neisseria gonorrhoeae infection: one was 
smeared on a glass slide and heat-fixed for Gram staining, the other inoculated onto 
commercially available culture kits (Gonoline, Merieux SA, France) A portable field incubator 
was used, and the specimens shipped to Mwanza twice per week The diagnosis was confirmed 
using the Phadcbact agglutination test (KaroBio Diagnostics, Huddingc, Sweden)
A third cndoccrvical swab was placed into cooled transport medium, and later tested for 
Chlamydia trachomatis infection using an antigen-detection enzyme immunoassay (IDEIA, 
NovoNordisk Diagnostics, Cambridge, Cambridgeshire, UK) A blocking assay was used to 
confirm a positive test result
Venous blood samples were centrifuged in the field and stored at about +4°C, and later tested for 
syphilis using the TPHA (Fujircbio, Tokyo, Japan) and RPR tests (VD-25; Murex, Dartford, 
Kent, UK) No tests were performed for HIV infection
5 .4 .7  S e x u a l  b e h a v io u r  s tu d ie s
Objectives
To determine the prevalence of behavioural and other risk factors for HIV infection in the trial 
population at baseline and after 2 years, and to compare these prevalences both between the two 
arms of the trial and over time.
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Rationale
The purpose o f  the trial as a whole was to determine the impact o f  the intervention on HTV 
incidence, and on the prevalence and incidence of other STDs. However, it was possible that a 
reduction in incidence might be caused by other factors related both to the intervention and to the 
transmission o f HTV or STDs, thus acting as confounding variables.
One of the most important potential confounding variables in the context o f this trial w as the 
sexual behaviour o f the study population. Two situations could occur: (i) sexual behaviour may 
have differed between the two trial arms for reasons unconnected with the intervention, and this 
may have caused a difference in HIV incidence even in the absence o f  the intervention; (ii) the 
intervention may have led to a differential change in sexual behaviour between the intervention 
and comparison communities, which may have caused a  difference in HIV incidence between the 
two arms unrelated to the improvement of STD case management The latter situation is not 
strictly one of confounding, but could be one of the mechanisms whereby the intervention has its 
effect.
In any case, to be able to interpret the results of the trial, it was necessary to measure (and if 
necessary adjust for) this confounding variable. D ata were therefore required on the sexual 
behaviour o f the population in both arms of the trial, both at baseline and at follow-up
In the main cohort study, it was not possible to collect detailed data on sexual behaviour. This 
needed to be done in a smaller sample o f the study population.
Study design, selection o f  study participants, and sam ple size
Two consecutive nested cross-sectional studies were carried out, at baseline and follow-up, in 
sub-samples o f the main cohort, taking a 1 in 8 random sample from each of the communities. 
For the first o f these studies, the sample was chosen from  the individuals enrolled at baseline; for 
the second it was selected from individuals who were seen during the follow-up survey o f the 
cohort6.
6 The tw o sexual behaviour surveys formed part of two larger nested case-control studies of risk factors 
for HIV infection (baseline) and HIV incidence (follow-up). The results of the first of these case-control
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The follow-up study had a power in excess of 90% at the 5% significance level to detect a 
reduction of the proportion o f men with 3 or more partners during the past year from 30% to 
15%, under the assumption that k=0.1.
Timing
The first sexual behaviour survey was conducted between February and April 1993, four to 
fourteen months after the baseline survey of the main cohort. The second sexual behaviour 
survey was conducted between August 1994 and February 1995, two to seven months after the 
follow-up survey o f  the main cohort (fig. 5.1).
Survey methods
Non-medical personnel (mainly teachers and social workers) were selected and carefully trained 
as interviewers. They were closely supervised by an anthropologist (Mr. Katua Munguti) and by 
the field manager (Dr. Frank Mosha, see organogram in fig. 3.1).
Structured questionnaires were designed in English, translated into Kiswahili, backtranslated into 
English and pre-tested in pilot studies Questions concerned sociodemographic factors, marital 
partners, non-marital and casual partners, sexual behaviour and sexual practices, and perception 
of risk. Questionnaires for the two surveys were almost identical.
Approval for the study was obtained from various authorities (see section 5.5.2). Study 
participants were asked to give informed consent, and were interviewed in or near their houses. 
Every effort was made to ensure conditions of privacy for the interview, and the confidentiality 
of the information was stressed. Interviews took about 30 minutes on average.
Interviewers were kept blind to the HIV and STD infection status o f the subjects, as determined 
during the main cohort surveys.
studies have been published Data from the second study are currently being analysed These case- 
control studies are beyond the scope of this thesis
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5 .4 .8  D a ta  a n d  l a b o r a t o r y  q u a l i ty  c o n tro l
Data quality
Several methods were used to both promote and monitor data quality. All questionnaires and 
forms were checked by the field team leader before the  end of the week, and mostly before the 
end o f the day. In the main cohort study and the sexual behaviour surveys, team leaders 
conducted full reinterviews o f 5 - 10% of the interviewees, without the interviewer knowing 
beforehand which o f  the participants were to be seen again.
The central management team at headquarters arranged for frequent but unscheduled supervisory 
field visits which were conducted in turn by the author, the expatriate statistician and the field 
manager. During these visits, they observed the data collection procedures, checked 
questionnaires and forms and discussed any problems with the field team Similar supervisory 
visits were made by the anthropologist and the manager o f  clinical studies and his counterpart for 
the sexual behaviour and the antenatal clinic surveys, respectively.
During the baseline survey o f the main cohort, field team s were blind as to which trial arm a 
community was to be allocated to. This was not possible during the follow-up round, but field 
teams were exchanged between the trial arms in an attempt to prevent bias due to differences 
between field teams.
To maintain high motivation, feedback was provided by headquarters staff to the field teams 
during regular meetings when teams returned to base.
Data were double-entered by two different data entry’ clerks, and the data files compared to 
identify discrepancies. A check digit assisted with the detection o f  transcription errors in the 
identity numbers. Logical checks were performed after data entry, and inconsistencies corrected, 
if necessary in collaboration with the field team which generated the data
Quality control fo r  laboratory tests
An external and internal quality control system was established for the various laboratory tests. 
The programme laboratory technologists o f the National Institute for Medical Research
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participated in the UK NEQUAS7 scheme for diagnosis o f  syphilis and chlamydia infection in 
which specimens were received ‘blind’ from a central laboratory in the UK at regular intervals. 
The laboratory tested these specimens and reported the results back to the central laboratory 
which sent a critical assessment soon afterwards.
A 10% sample of serological tests performed at NIMR were retested at BMC. For the HTV 
ELISA tests, a 10% sample of negative sera were retested in the same laboratory, without the 
technologist being aware that these specimens had been tested already. HTV positive sera were 
checked using the procedure described in section 5.4.4. A 20% sample o f Gram stain specimens 
were re-read for the diagnosis of Neisseria gonorrhoeae. NG cultures were read by a 
technologist, but regularly checked by the microbiologist and the senior laboratory technician.
5 .4 .9  D a ta  p r o c e s s in g  a n d  a n a ly s is
Equipment and software used
All data entry and processing were performed at NIMR in Mwanza using IBM compatible 
computers Epilnfo (Division of Surveillance and Epidemiology, Centers for Disease Control and 
Prevention, Atlanta, Georgia, USA) and dBaselll (Ashton-Tate Corporation, Torrance, 
California, USA) software packages were used for data management. Analyses were earned out 
in Mwanza and London, using the Egret (Statistics and Epidemiology Research Corporation, 
Seattle. Washington, USA) and Stata (Stata Corporation, College Station, Texas, USA) 
statistical computer packages.
Analysis o f  H IV impact data
Statistical analysis had to take account o f the fact that the unit o f randomisation was the 
community rather than the individual study participant. In principle, the outcome o f interest was 
studied in twelve entities only, and this required the use o f  statistical methods designed for small 
numbers of observations. Statistical inference also needed to take account o f the variation in HIV
7 NEQUAS = National Ensurance of Quality Scheme
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The following procedure was chosen:
1. For each community, the HIV incidence for the 2-year follow-up period was calculated 
by relating the number o f new infections to the number o f persons who were HIV-negative at 
baseline and who were seen at both surveys.
2. The relative risk (RR) of HTV incidence in the intervention community relative to the 
comparison community was computed separately for each matched pair. A point estimate for the 
overall RR was calculated as the geometric mean o f  the six pair-specific RRs. Significance was 
assessed using the paired t-test on the logarithms o f  the pair-specific RRs, and the corresponding 
95% confidence interval was computed.
3. To obtain an alternative assessment o f statistical significance, the non-parametric 
Wilcoxon sign test was applied.
4. These calculations were done both on crude RRs and after adjustment for possible 
confounding factors. The adjustment was achieved through logistic regression using data on the 
individual study participants and by fitting a model which included terms for the matched pair, 
age group, sex, circumcision in men, travel out o f  village during the 2 -year follow-up period, 
reported history o f STD (ever) at baseline and the community-specific baseline prevalence of 
HIV infection.
incidence between communities. Lastly, the matched design needed to be accounted for in the
choice of analytical method.
Analysis o f  STD impact data
Similar anal>tical methods were used to assess im pact on STDs. Relative risks were computed 
based on prevalences or incidences of STD markers as appropriate. For the adjusted analysis, 
terms for the community baseline prevalences of the STD under investigation were included in 
the logistic regression model .
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5.5 E th ic s
5 .5 .1  E th ic a l  c o n s id e ra t io n s
Intervention methodology
The s\ndromic management o f  STDs implies by definition that most patients are overtreated 
with the antibiotic drugs prescribed according to the treatment algorithm In some cases, drugs 
may cause side effects. The syndromic algorithms used in Mwanza followed WHO guidelines. 
Drugs were chosen which rarely lead to serious side effects.
Trial design
The intervention was provided to the comparison communities only at the end o f the trial, two 
years after the baseline survey. However, the intervention was launched in additional 
communities, other than those participating in the trial, and the capacity of the programme to 
implement the intervention was fully utilised throughout the study and after the trial was 
completed
Effective implementation of this type of intervention over a wide geographical area necessitates a 
phased introduction The trial exploited this fact by randomising the implementation scheme in 
such a way that valid comparisons would be made between communities in which the 
intervention was introduced at an early stage, and matched communities in which it started later.
The ongoing AIDS control efforts of the NACP of Tanzania, launched through the District AIDS 
Control Coordinator and through public mass media, continued unchanged in both intervention 
and comparison communities. STD treatment was not withheld in the comparison communities, 
but continued as before The services available in the comparison communities were similar to 
those in many other parts of Tanzania, and in other African countries.
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HIV testing
The trial followed the Tanzanian government guidelines on anonymous HTV testing. Health 
workers and investigators were not aware of the results of individual participants. Linkage of 
survey results was done using code numbers, and only the senior statistician had access to an 
electronic file linking these numbers with names. This file was kept in conditions of strict
secrecy.
Individuals who wished to know their HTV status received pre-test counselling and a separate 
blood specimen was taken. The results were fed back  to these individuals through a  member of 
the district health management team, after post-test counselling.
All individuals who agreed to provide a blood sam ple had the immediate benefit o f a serological 
test for syphilis and treatment if necessary.
Other examinations and laboratory tests
In the main cohort survey, for logistical reasons, it was not possible to feed back results of 
microbiological investigations to the individual patient. However, all symptomatic patients and 
men with a strongly positive LED test (grades 2+ and 3+) were treated automatically using the 
syndromic algorithms. Through this procedure, most patients in whom a gonococcal or 
chlamy dial infection was discovered later, would already have been adequately treated
Cross-sectional study o f  STD patients with incomplete follow-up
Patients with a recently treated STD had to be confident that home visits performed by field 
workers did not disclose this fact This was achieved by including patients with other illnesses in 
the survey. Furthermore, the public was informed that the survey aimed at an evaluation of 
health services in general and of AMREF’s programme in particular, rather than at the health 
status o f individuals.
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Health workers had to be confident that the survey would not undermine their authority. The 
objectives of the survey and the questionnaire were carefully explained to them. They did not 
participate in the field work, but were involved in the negotiations with the community prior to 
the survey. Again, emphasis was laid on the fact that the survey was aimed at an evaluation of 
the programme rather than at an assessment of health workers’ personal performance.
Sexual behaviour surveys
The most important aspect was to ensure strict confidentiality. This was achieved by careful 
selection and training of interviewers who had the skills and natural authority to facilitate a 
confidential interview situation and to make the study participants feel comfortable with the 
questions.
Antenatal clinic studies
All clinical or laboratory investigations were of direct benefit to the women participating, as 
current infections were treated either on the spot, or within two weeks if  an asymptomatic 
infection was discovered through laboratory tests.
5 .5 .2  E th ic a l  a p p r o v a l
Ethical approval for the trial including the supplementary studies was obtained from the Ministry 
of Health of Tanzania, and from the ethics committee of the London School of Hygiene and 
Tropical Medicine. Approval was also obtained from the Tanzanian Institute for Health and 
Technology, and from the Director General of the National Institute for Medical Research
The trial was explained in detail to all the regional and district authorities concerned and to local 
community leaders who gave their approval. Informed verbal consent was obtained from each 
participant after careful explanation of the study. On advice from the Tanzanian authorities, 
study participants were not asked to sign a consent form, but a written declaration was signed 
instead by the field workers who performed the interviews.
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Chapter 6 Results
6.1 O p e r a t io n a l  p e r f o r m a n c e  o f  th e  in te r v e n t io n
6 .1 .1  T r a in in g  o f  h e a l th  w o r k e r s
During the three years of the programme, 16 basic training courses and 5 refresher courses were 
conducted. The capacity was used for the training o f health workers from the intervention 
communities, from health facilities outside the trial area and, mainly during the third year, from 
comparison communities (Table 6.1).
Table 6 .1 Summary' of training courses during the trial period
Year No. full 
courses
No. of HWs 
trained
Total no. of
HWs
trained
No.
refresher
courses
Total no. of 
HWs trained
Intervention
communities
O ther health 
facilities
Comparison
communities
1 6 52 38' 90
2 4 6 502 83 64 3 66
3 6 8 512 48 107 2 44
Total 16 66 139 56 261 5 110
' mainly staff from reference clinics and survey clinicians
2 mainly staff from health facilities in Mwanza town and outside of the region
3 by end of year 2. in preparation o f  intervention in comparison communities
6 .1 .2  S y n d r o m e s  t r e a t e d
In the 6  intervention communities, 6  health centres and 20 dispensaries participated in the 
programme During the first year, services at one o f the dispensaries were discontinued for 
disciplinary reasons. Data w ere compiled from the 25 health facilities which participated 
throughout the 2 -year trial period.
Overall, 11,632 STD syndromes were recorded (table 6.2), with almost equal numbers in men 
and women A few patients had more than one syndrome In men, urethral discharge was the
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commonest syndrome accounting for two thirds o f  all cases, followed by genital ulcers in about a 
quarter of the total. Half o f  the women sought treatment for vaginal discharge, a third presented 
with lower abdominal pain and tenderness, and about 10% with genital ulcers. 8899 persons 
reported with genital discharge and/or genital ulcers.
Table 6.2: Attendance rates and distribution of STD syndromes over 2 years 
recorded at 25 intervention health facilities in Mwanza Region
STD syndrome Men Women
N = 11,632 N =5,466 47% N=6,166 53%
Genital discharge syndrome 3662 67 % 3046 49%
Lower abdominal pain0 2226 36%
Genital ulcer syndrome 1489 27% 745 1 2  %
Buboes without ulcer 164 3 % 31 0.5 %
Other syndromes:> 151 3 % 118 2  %
Patients with discharge and/or ulcers 5138 94% 3761 61%
Patients with more than one syndrome 55 1 % 123 2  %
11 Treated as pelvic inflammatory syndrome
21 Men: Balanitis, suspected secondary syphilis, genital warts, epididymitis, pubic lice
Women: Suspected secondary syphilis, genital warts, pubic lice; detailed breakdown 
for other syndromes not available
6 .1 .3  T r e a tm e n t  e f fe c t iv e n e s s  a t  h e a l th  u n i ts
During the 2 years of follow-up, data on treatment effectiveness were collected for genital ulcer, 
urethral discharge and vaginal discharge syndromes from health facilities in the intervention 
communities. Outcomes were recorded for syndromes rather than patients.
A complete follow-up assessment was available for only 33% o f the 8942 ulcer or discharge 
syndromes treated (table 6.3).
The great majority of these syndromes were clinically cured after 1st line treatment. Some 
required 2nd or occasionally even 3rd line treatment Patients with genital ulcer syndromes were 
more likely to be given 2nd or 3rd line treatment than patients with discharge syndromes 
Definite treatment failure was observed in one case o f urethral discharge and 2 cases o f genital 
ulcers, all in men. Outcomes for patients who were referred are reported in section 6 .1.6 .
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Table 6.3: Clinical treatment effectiveness for genital ulcer and genital discharge syndromes 
(GUS and GDS) summarised over two years
Men Women
Syndrome GUS
N=1489
UDS
N=3662
GUS 
N = 745
VDS
N=3046
Assessment
completed’’
N
389 26 %
N
1177 32%
N
235 32 %
N
1136 3 7 %
of these:
cured after 
1 st line trmt. 324 83 % 1153 98 % 191 81 % 1087 9 6 %
cured after 
lst-3rd line 381 98 % 1161 99% 233 99 % 1104 9 7 %
definite 
trmt failure 2 0.5% 1 0 .1 % 0 0
referred 6  1.5% 15 1.3% 2  0 . 8  % 32 3 %
1 total number of syndromes for which a definite outcome is known.
Possible outcomes were: cured, definite treatment failure, referred.
GUS = genital ulcer syndrome, UDS = urethral discharge syndrome, VDS = vaginal discharge 
syndrome
6 .1 .4  P a r t n e r  n o t i f i c a t i o n
Patients were routinely requested to notify their partners, using a contact information card. 
However, the treatment o f  a sexual partner was recorded for only 35%  of genital ulcer or 
discharge syndromes in men and for only 33% of these syndromes in women, (table 6.1.4). The 
treatment o f 2 partners w as recorded for only 0.5% o f the patients. Treatment of more than two 
partners was never observed.
Table 6.4: Success o f partner notification
Men Women
Syndrome GUS
N=1489
UDS
N=3662
GUS 
N = 745
VDS
N=3046
Partners
treated
432
(29%)
1353
(37%)
255
(34%)
997
(33%)
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6.1.5 Condom promotion
Health unit staff were trained to routinely promote and offer condoms to STD patients However, 
only 83 (0.9%) o f the 8899 patients with genital ulcers or discharge were recorded as accepting 
condoms.
6 .1 .6  F o llo w -u p  o f  r e f e r r e d  cases
During the 2 years o f follow-up, 97 STD patients (55 patients with GDS/GUS) were referred, 
most of them from dispensaries to health centres, and some from dispensaries or health centres to 
hospitals including the STD reference clinic.
Only 25 patients (26%) reported to the unit to which they had been referred The others could 
not be traced, even at alternative health units. Among these 25 patients, complete outcome 
assessment was possible in only 5 patients (who were cured). The rest were lost to follow-up 
after one visit.
6 .1 .7  T r e a tm e n t  e f fe c tiv e n e s s  a n d  r e - in fe c tio n s  in  n o n - r e tu r n e r s
567 STD patients were eligible for the study of non-returners, 249 men and 318 women. 367 
(65%) of these patients could be traced at their homes, 164 men (6 6 % of the eligible men) and 
203 women (64%).
The following reasons for non-participation were recorded: wrong address or name (45%), 
travelling (28%), moved to another village (16%), village inaccessible because of heavy rains 
(1 1%), died (0.5%), and refused to participate (0.5%). These reasons were similar in men and 
women. Non-participants did not differ significantly from participants with respect to type o f 
syndrome or type o f treatment received.
The 367 STD patients had presented with 389 syndromes, and had been treated at the 
intervention health facilities with 1st line treatment (90%), 1st and 2nd line treatment (8 %), or 
1st, 2nd and 3rd line treatment (2%). After treatment, 240 (62%) of the syndromes were
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clinically cured, a further 107 (28%) had been free o f symptoms for some time, but were 
symptomatic again at the time of the survey, and 42 (11%) had not observed any improvement. 
Among the 28% with recurrence o f symptoms, it was not possible to  distinguish between those 
who had genuinely been cured (reinfection) and those who had not been cured but been 
temporarily asymptomatic (recurrence o f symptoms).
To facilitate comparison with the clinical outcomes for the main syndromes reported above for 
patients with complete follow-up (table 6.3), a breakdown o f these findings by sex and main 
syndrome is given in table 6.5. The overall treatment failure rate for GUS and G DS was 11%. 
The reported rate of reinfection or recurrence of symptoms was very high, particularly in 
women, and in most o f these cases signs were confirmed on clinical examination.
Table 6.5 Treatment effectiveness for genital ulcer syndrome and genital discharge 
syndrome based on a survey of STD patients who did not return for follow-up
Men Women
Syndrome
Treatment result reported 
bv patients:
GUS
N=64
GDS
N=89
GUS 
N = 42
GDS
N=97
Cured and no recurrence 52 81% 62 69% 2 2 52% 51 53%
Reinfection or recurrence 
of s\mptoms
9 14% 2 0 23% 1 1 26% 34 35%
Not cured 3 5% 7 8 % 9 2 1 % 1 2 1 2 %
Present signs confirmed 
bv clinician
1 2 19% 2 2 25% 2 1 50% 52 54%
6.1.8 Performance o f  health workers
The study o f non-retumers was conducted primarily to establish likely cure-rates in this group, 
but was also used to collect some data on the performance o f health workers
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Study participants were interviewed regarding various steps in the provider-patient interaction 
The results are listed in table 6 . There were no significant differences between the results for 
different syndromes (data not shown).
Table 6 . 6  Performance o f  health workers
Men
N=164
Women
N=203
Total
N=367
Patient was 
examined 114 70% 158 78% 272 74%
Patient received 
health education 98 60% 1 1 0 54% 208 57%
Condoms were 
offered 73 45% 38 19% 1 1 1 30%
Patient received 
correct treatment 114 70% 117 58% 231 63%
Patient reported full 
compliance 157 96% 183 90% 340 93%
Patient was satisfied 
with service 141 8 6 % 164 81% 305 83%
The category ‘patient received correct treatment' was assumed if on demonstration 
of the various drugs available in the programme, the patient pointed at the correct 
t>pe of drug(s) and recalled the correct dose, or if he/she pointed at the correct type 
of drug(s) but was not sure about how many tablets he/she should have taken.
As described in the Methods section, examination, health education, condom promotion and the 
correct svudromic treatment had been intensively emphasised during training courses and 
supervision visits. All o f the above parameters showed results below expectations. The low rate 
of reported condom promotion among women is particularly worrying. Information on the type 
and number of drugs received is probably not reliable, but gives rise to concern.
Thirty-three patients (9%) reported that they were asked to pay for the services, although 
services at primary care level in Tanzania are officially ffee o f charge. All of them paid. The 
sums involved ranged from the equivalents o f US $ 0.40 to $ 6.80 per patient. Fees reported by 
patients with other diseases ranged from $ 0 . 0 2  to $ 2 .0 0 .
The proportion of patients in the different communities reporting that they were satisfied with the 
services at the health unit ranged from 81 to 8 6  % in STD patients and 59 to 77% in patients 
with other diseases. Data for men and women were similar.
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6 .1 .9  M o n ito r in g  o f  S T D  ae tio lo g ies a t  th e  S T D  re fe ren ce  clin ics
The pattern of STD  aetiologies was intermittently monitored at the STD clinic o f Sekou Toure 
Hospital and at the Makongoro ANC Clinic in Mwanza town.
During 1993 and 1994, 3143 patients were seen at the STD reference clinic o f Sekou Toure 
hospital (Philippe Mayaud, personal communication). 25% of these were men presenting with 
urethral discharge, 39% women complaining o f  vaginal discharge and 13% women presenting 
with suspected pelvic inflammatory disease. 14% of the patients presented with genital ulcers, 
two-thirds of whom were men. 8 % of the patients presented with various other complaints.
During different periods, between 55 and 870 consecutive patients with GDS and between 100 
and 200 consecutive patients with GUS were sampled, to determine STD aetiologies. The 
aetiologic pattern for men complaining o f urethral discharge was: Neisseria gonorrhoeae 40 - 
60%, Chlamydia trachomatis 5 - 15%, Trichomonas vaginalis about 2%, Candida albicans 
about 2%  and non-specific urethritis 5 - 15%. Multiple infections occurred in about 20%. In 20 
- 35% of the men no aetiology could be demonstrated.
The aetiologies found in women presenting with vaginal discharge included Trichomonas 
vaginalis 20 - 30% , Candida albicans 35 - 40%, Bacterial vaginosis 35 - 40%, Neisseria 
gonorrhoeae 5 - 10%, and Chlamydia trachomatis about 5%. Multiple infections occurred in 
30 - 40%. In 20 - 25 % of the women, no aetiology could be found.
In genital ulcer patients, Herpes simplex virus tvpe-2 was clinically suspected in up to  42 %, but 
could be demonstrated in only 5 - 10%. Haemophilus ducreyi was suspected in 20 - 55%, but 
the infection w as proven in 20 - 25% Syphilis was suspected in 20 - 30%, but a positive dark 
field result was obtained in only 4%, whereas TPHA+/RPR+ serology was observed in 40 - 
50%, but partly in combination with other aetiologies. Mixed infections seemed to occur in 10 - 
20 % In 40%, no aetiology could be demonstrated. There was one man with lymphogranuloma 
venereum (LGV)- None of the patients had donovanosis.
These data supported the effectiveness o f the syndromic algorithms chosen for the intervention 
trial.
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6.1.10 Monitoring of antibiotic sensitivity of Neisseria gonorrhoeae
The sensitivity of Neisseria gonorrhoeae was monitored at yearly intervals to ensure that the 
drugs chosen for the treatment o f gonorrhoea (trimethoprim-sulfamethoxazole, ciprofloxacin) 
were effective. Monitoring was performed at the reference clinics, as it was not possible to 
obtain antibiograms from rural health units. The sensitivity was also determined for some drugs 
prescribed for the treatment o f urethral discharge by private providers in M wanza town 
(tetracycline, spectinomycine) or by health workers in comparison communities (tetracycline, 
penicillin) o f for those recommended by WHO as alternative options for the treatment of 
Neisseria gonorrhoeae (ciprofloxacin, céphalosporines, spectinomycin) (WHO 1994). Results 
of this surveillance for 1992 are shown in table 6.7. To give an impression o f the changes 
occurring over time, data for 1996 are shown for comparison.
Intermediate susceptibility to trimethoprim-sulfamethoxazole, the drug in use fo r 1st line 
treatment, was found in around 60% of the gonococcal strains. However, at the dose levels used 
in the treatment algorithms for genital discharge, 96% of the strains were sensitive in 1992. 
Sensitivity deteriorated slowly, but 90% were still sensitive in 1996. Ciprofloxacin, the drug 
available for 3rd line treatment, remained fully effective throughout, and the algorithms were not 
changed therefore.
Table 6.7: Antimicrobial sensitivity o f  Neisseria gonorrhoeae in 1992 and 1996 
(West 1995 et al, and West: personal communication)
Sensitivity'*
Antimicrobial sensitive intermediate resistant
Penicillin 24% (7%) 26% (33%) 50% (60%)
Tetracycline 5% (0%) 60% (4%) 35% (96%)
TMP-SMX 35% (28% ) 61% (62%) 4% (11%)
Spectinomycin 100% (97% ) 0% (3%) 0 %
Azithromvcin 1 0 0 % ( 1 0 0 %) 0 % 0 %
Cefotaxime 1 0 0 % ( 1 0 0 %) 0 % 0 %
Cefuroxime 1 0 0 % ( 1 0 0 %) 0 % 0 %
Ciprofloxacin 1 0 0 % ( 1 0 0 %) 0 % 0 %
* N=130 strains in 1992; N= 138 strains in 1996; data from 1996 in brackets 
TMP-SMX = trimethopnm-sulfamethoxazolc
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Resistance to  penicillin and tetracycline was observed in the majority of gonococcal strains, and 
increased steeply over time. Their continued use for urethral discharge by other providers in 
Mwanza tow n is clearly inappropriate .
6 .11  C o n ta m in a t io n  b e tw e e n  in te r v e n t io n  a n d  c o m p a r i s o n  c o m m u n i t ie s
O f the 11,632 syndromes treated at intervention health units, records showed that the patients 
were residents o f comparison communities in only 59 (0.5%) cases O f these, 45 came from the 
island comparison community, and had visited the corresponding intervention community within 
the archipelago, probably in the context o f their professional activities (fishing, trading).
6 .2  M a in  c o h o r t :  s t u d y  p o p u la t io n
6 .2 .1  C o v e r a g e  a t  b a s e l in e  a n d  c o m p le te n e s s  o f  fo llo w -u p
12.537 adults aged 15 - 54 years were enrolled to the study cohort during the baseline survey, 
representing 85%  of eligible individuals in the selected clusters. The great majority o f  non- 
attenders w ere on a journey away from the community, and the coverage was similar in 
intervention and comparison communities (data not shown).
At follow-up after 2 years, 8845 (71%) cohort members were seen again (table 6 .8 ) Losses to 
follow-up w ere 29%, and coverage was similar in men and women, and in intervention and 
comparison communities.
Reasons for non-participation were also similar in the intervention and comparison arms (table 
6.9), except for the category o f ‘other reasons' which occurred more frequently in the 
intervention communities. There were two explanations for this discrepancy: (i) at the beginning 
of the follow-up study, field workers did not record correctly some o f the reasons for non­
participation in one of the communities; (ii) heavy and long-lasting rainfall made parts o f  one 
intervention community- inaccessible for several weeks towards the end o f the follow-up survey.
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Table 6.8 Main cohort study: numbers recruited to cohort, and coverage at follow up
I n te rv e n t io n C o m p a r is o n T o ta l
M e n
Recruited at baseline 2881 2998 5879
Seen at follow-up 2052 2187 4239
Coverage 71 % 73 % 72%
W o m e n
Recruited at baseline 3261 3397 6658
Seen at follow-up 2243 2372 4606
Coverage 69% 70% 69%
T o ta l
Recruited at baseline 6142 6395 12537
Seen at follow-up 4286 4559 8845
Coverage 70% 71 % 71 %
Very few persons refused to participate in the follow-up survey The great majority o f  the losses 
to follow-up comprised cohort members who had moved permanently out of the community or 
who were temporarily absent during the time of the survey.
Table 6.9 Main cohort study: reasons for loss to follow-up
Intervention Comparison Total
Recruited at baseline 6142 6395 12537
Losses to follow up:
Moved out o f village 
Temporary absence 
Died 
Other
814 13%  
291 5 % 
87 1 % 
664 11 %
924 14 % 
459 7 % 
109 2 % 
344 5 %
1738 14 % 
750 6  % 
196 2  % 
1008 8  %
Total 1856 30 % 1836 29% 3692 29 %
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6.2.2 Baseline characteristics of the study population
The average ages o f the men and women were 30.9 and 29.9 years, respectively. The male-to- 
female ratio was 1:1.13. 61% of the men and 6 8  % o f the women were married. More men than 
women reported having had a school education o f standard 4 or above (71% as compared to 
47%). 80%  of the men and 95% of the women reported farming as their main occupation.
About 19% of the men were circumcised. Female circumcision is not practised among the ethnic 
groups resident in Mwanza Region.
The baseline survey confirmed that STDs were highly prevalent in this population. 15% o f the 
men and 6 % of the women reported having suffered from a genital ulcer at least once in their life. 
For genital discharge, the corresponding figures were 28%  and 8 %. Blood tests performed during 
the baseline survey revealed a TPHA prevalence o f 15% in men and 16% in women, indicative 
of past or present syphilis infection. 1 1 %  o f the men had the laboratory signs o f  urethritis, and at 
least 2.8 %  were infected with Neisseria gonorrhoeae and/or Chlamydia trachomatis.
HIV test results were available for 12500 (99.7%) out of 12537 enrolled individuals (table 
6.10). Overall seroprevalence was 3.7% (95% Cl: 3.3 - 4.2%) in men and 4.4%  (95% Cl: 3.9- 
4.9%) in women. HTV prevalence was highest in the roadside communities (7.7%), moderate in 
lakeshore and rural communities (3.8%), and low in the two island communities (1.8%).
Peak prevalences were found in the 25-34 year age group for both sexes (men 5.7% and women 
6.2%) Prevalence in women aged 15-24 years was more than twice that in men o f the same age 
group (4.1%  as compared to 1.8 %). In contrast, prevalence in men aged 35-54 years was higher 
than in women o f the same age (4.2% and 3.1% respectively).
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Table 6.10 Main cohort study: HIV seroprevalence at baseline, by stratum, age and sex
Men Women Overall
Stratum/age Total HIV+ (%) Total HIV+ (%) Total HTV+ (%)
R o a d s id e
15-24 309 1 1 (3.6) 343 25 (7.3)
25-34 246 27 ( 1 1 .0 ) 348 41 (118)
35-44 175 14 (80) 2 1 0 14 ( 6  7)
45-54 174 16 (9.2) 179 5 (28)
Total 904 6 8 (7.5) 1080 85 (7.9) 1984 153 (7.7)
R u r a l / la k e s h .
15-24 1410 2 0 (1.4) 1766 6 8 (3.9)
25-34 1170 63 (54) 1327 75 (5.7)
35-44 705 33 (4.7) 732 28 (38)
45-54 610 16 (2 .6 ) 641 15 (2.3)
Total 3895 132 (34) 4466 186 (4.2) 8361 318 (38 )
I s la n d s
15-24 378 6 ( 1 .6 ) 436 1 1 (25)
25-34 300 7 (2.3) 294 6 (2 .0 )
35-44 185 5 (2.7) 234 2 (0.9)
45-54 195 1 (0.5) 133 1 (0 .8 )
Total 1058 19 (18) 1097 2 0 ( 1 .8 ) 2155 39 (1 8 )
O v e r a l l
15-24 2097 37 (18) 2545 104 (4.1)
25-34 1716 97 (5.7) 1969 1 2 2 (6 .2 )
35-44 1065 52 (4.9) 1176 44 (3.7)
45-54 979 33 (3.4) 953 2 1 (2 .2 )
Total 5857 219 (3.7) 6643 291 (44) 12500 510 (4 1)
6 .3  C o m p a r a b i l i ty  o f  i n te r v e n t io n  a n d  c o m p a r is o n  c o m m u n itie s
6 .3 .1  H I V  p r e v a le n c e
Baseline HIV prevalences in the intervention and comparison communities are shown in table 
6.11 Prevalences in the intervention group were somewhat lower than in the comparison group, 
and were therefore adjusted for in the impact analysis on HIV incidence (see section 6.4.1). 
However, these differences were small both overall (3.7% versus 4.4%) and within each pair o f 
communities. Imbalances between pairs were equally distributed: HIV prevalence was higher in 
the intervention community in three pairs, and in the comparison community in the other three 
pairs.
145
6 .3 .2  P re v a le n c e  o f  ST D s
Distribution of confirmed laboratory diagnoses of STDs within the two groups are shown in 
table 6.12. Again, there was little difference between intervention and comparison communities.
TPHA test results were available for 12487 (99.6%) and RPR test results for 12437 (99.2%) of 
study participants. Prevalence o f TPHA seropositivity (indicating past or present syphilis 
infection) was slightly higher in the intervention than in the comparison group (15.8% versus 
15 .1%). The prevalence o f ’active’ syphilis (TPHA+ and RPR+ combined) was identical in both 
groups (6 .2 %).
1569 (27%) men, who were LED test positive or who reported current symptoms were examined 
and swabbed. This procedure was used to establish minimum prevalences o f urethritis, which 
were very similar in the two groups (10.2% versus 10.7%). Few men with urethritis reported 
symptoms, (but the minimum prevalence of symptomatic urethritis was again similar in the two 
groups (1.0% versus 1.2%). The minimum prevalence o f infection with Neisseria gonorrhoeae 
and/or Chlamydia trachomatis was somewhat lower in intervention than in comparison 
communities (2.4% versus 3.2%).
6 .3 .3  D e m o g r a p h ic  c h a r a c te r i s t i c s  a n d  r i s k  f a c to r s  f o r  H I V  in fe c tio n  a n d  S T D s
With respect to demographic characteristics, there was little difference between intervention and 
comparison communities in age and sex distribution, marital status, educational level and 
occupation (table 6.13).
However, some factors known to increase the risk o f HIV infection were not distributed equally 
(table 6.13). The proportion o f  men who reported ever having a genital discharge or ulcer was 
lower in intervention communities (31% versus 38%). In the comparison communities rather 
more individuals reported travelling outside their district during the past year, and this was 
particularly so in women (men 44% versus 49%; women 24%  versus 35%). The proportion of 
men who were circumcised was lower in intervention communities (14% versus 23%).
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With regard to sexual behaviour, comparability of the two trial groups could be assessed through 
the baseline sexual behaviour survey Self-reported behaviour is always subject to recall bias; 
however, there was no reason to assume that this bias was differential between intervention and 
comparison communities. For both men and women, reported numbers o f  lifetime sex partners 
and o f sex partners during the past year were similar in the intervention and comparison groups 
(table 6.14).
6 .3 .4  R e s u l t  o f  m a tc h in g  a n d  r a n d o m is a t io n
In summary', the matching and randomisation procedure provided intervention and comparison 
groups that were generally similar at baseline with respect to HIV and STD  prevalence and most 
of the factors known to increase the risk of HTV and STD transmission. However, some 
imbalances occurred for reported history o f STDs (ever), travel away from the village and male 
circumcision. These variables were therefore adjusted for in the impact analysis. Adjustments 
were also made for the slight imbalances in baseline prevalences of HIV infection and STDs.
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T a b ic  6.11 M a in  cohort study baseline p revalence o f  H I V  infection by co m m un ity , sex and trial arm , ordered by m atched pairs
Men Women Overall
Intervention Comparison Intervention Comparison Intervention Comparison
Prev Prev. Prev Prev. Prev. Prev
N H1V+ (%) N HIV+ (%) N HIV+ (%) N HIV+ (%> N HIV+ (%) N HIV+ (%)
Matched pair /
stratum
1 rural 415 14 (3.4) 479 18 (3.8) 500 18 (36) 568 11 (1.9) 915 32 (3.5) 1047 29 (2.8)
2 islands 512 12 (2.3) 546 7 (13) 548 9 (16) 549 9 (16) 1060 21 (2.0) 1095 16 (1.5)
3 roadside 441 31 (7.0) 465 37 (80) 555 37 (6.7) 524 49 (9.3) 9% 68 (6.8) 989 86 (8.7)
4 lakeshore 502 19 (3.8) 473 17 (3.6) 561 38 (6.8) 557 27 (4.9) 1063 57 (5.4) 1030 44 (4.3)
5 lakeshore 489 10 (2.0) 548 26 (4.7) 509 18 (3.5) 570 26 (4.6) 998 28 (2.8) 1118 52 (47)
6 rural 512 9 (18) 480 16 (33) 578 11 (1.9) 622 36 (5.8) 1090 20 (1.8) 1102 52 (47)
Overall 2871 95 2991 121 (4 1) 3251 131 (4.0) 3390 158 (4.7) 6122 226 (3.7) 6381 279 (4.4)
Table 6.12 Main cohort study: baseline prevalence of STDs by trial arm
I n te r v e n t io n C o m p a r is o n
N pos
Prev.
(%) N pos.
Prev.
(%)
S y p h ilis  s e ro lo g y 1
TPHA+ 6115 968 (158) 6372 961 (15.1)
TPHA+/RPR>= 1:8 6088 380 (6 .2 ) 6349 391 (6 .2 )
U r e th r a l  in fe c tio n  in
m e n
LED test positive2 2846 728 (25.6) 2990 849 (2 8 4 )
Urethritis3 2881 294 ( 1 0 .2 ) 2998 321 (10.7)
Symptomatic urethritis3 2881 27 GO) 2998 36 ( 1 -2 )
NG and/or CT infection3 2881 69 2998 96
TPHA — Treponema pallidum haemagglutination assay 
RPR = Rapid plasma reagin test; 1:8 = titre of RPR test 
LED = Leukocyte esterase dipstick
NG = Neisseria gonorrhoeae, CT = Chlamydia trachomatis
Urethritis = NG and/ or CT infection and/or > 5 polymorpho-nuclear cells per high power field 
on microscopy
' TPHA missing for 27 individuals in intervention and 23 in comparison communities, 
TPHA/RPR missing for 54 individuals in intervention and 46 in comparison communities;
2 LED test result missing for 35 men in intervention and 8  in comparison communities 
5 Prevalences of urethritis, symptomatic urethritis and NG/CT infection refer to men only, and 
are minimum prevalences (because men without symptoms or signs and with negative LED 
result were not swabbed
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Table 6.13 Main cohort study: demographic characteristics and risk factors at baseline by sex 
and trial arm
M e n W o m e n
Intervention Comparison Intervention Comparison
N = 2881 N = 2998 N = 3261 N = 3397
D e m o g r a p h ic
c h a r a c t e r i s t i c s n % n % n % n %
Age (years)
15-24 1008 35% 1095 37% 1227 38% 1326 39%
25-34 851 30% 869 29% 975 30% 999 29%
35-44 533 19% 536 18% 588 18% 592 17%
45-54 489 17% 498 17% 471 14% 480 14%
M arital status
married 1799 62% 1779 59% 2311 71% 2 2 2 2 65%
single 819 28% 962 32% 434 13% 591 17%
separ./divor./widowed 263 9% 257 9% 516 16% 584 17%
Education 1 
Standard 4 and above 1948 6 8 % 2192 73% 1476 45% 1670 49%
R i s k  f a c to rs
STD ever 903 31% 1147 38% 371 1 1 % 435 13%
Used formal health sector 
for STD treatment2
692 77% 927 81% 2 0 0 54% 238 55%
Circumcision in m en 3 403 14% 6 8 6 2 3 % NA NA
Travel outside district 1255 44% 1482 49% 783 24% 1195 35%
(past 1 year) 
Received blood 2 0 0.7% 2 2 0.7% 8 8 3% 73 2 %
transfusion (past 5 years) 
Received injections 
(past 1 year)
927 32% 991 33% 1538 47% 1592 47%
1 D ata missing for 1 woman in comparison communities; * for cohort members reporting STD 
ever; 3 Data missing for 6  men in intervention and 5 men in comparison communities 
NA not applicable
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Tabic 6.14 Baseline sexual behaviour survey: numbers of sexual partners reported in
M e n
Intervention Comparison
W o m e n
Intervention Comparison
No. o f lifetime partners N  = 232' N  = 2 7 9 ' N  = 2872 N - 2882
n % n % n % n %
0 2 1 % 9 3% 9 3 % h 4%
1 16 7% 13 5 % 80 28% 75 26%
2-4 42 18% 61 2 2 % 136 47% 152 53%
5-19 1 0 1 44% 123 44% 54 19% 47 16%
2 0 + 71 31% 73 26% 8 3 % 3 1%
No. o f partners past year N  = 2375 N  = 281’ N  = 2974 N  = 2 9 9 “
n % n % n % n %
0 16 7 % 27 1 0 % 27 9% 29 1 0 %
1 104 44% 1 0 0 36% 231 78% 247 83%
2 51 2 2 % 69 25% 26 9% 19 6 %
3-4 42 18% 62 2 2 % 1 0 3% 4 1%
5+ 24 1 0 % 23 8 % 3 1 % 0 0 %
Total number of survey participants: 1117, 1 data missing from 5 men in intervention and 2 in
comparison communities, : data missing from 11 women in intervention and 13 in comparison 
communities: ’ no data missing; 4 data missing from 1 woman in intervention and 2 women in 
comparison communities; for further information on sexual behaviour survey sec section 6 4.6
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6.4 Impact of the intervention
6.4.1 Main cohort study: im pact on HIV infection
HIV results were available at both baseline and follow-up for 8825 of the cohort members. 
These were 8825/8845 (99.8%) o f all those seen at follow up. 276 (3.1%) were already HTV 
positive at baseline. HTV incidence calculations were therefore based on 8549 initially 
seronegative individuals, 4149 in intervention communities and 4400 in comparison 
communities.
Over the 2 years o f follow-up there were 130 seroconversions in the cohort, 48 (1.16%) in the 
intervention group and 82 ( 1 .8 6 %) in the comparison group, equivalent to annual incidences of
0.58%  and 0.93%.
HIV incidence varied considerably between matched pairs, but was consistently lower in the 
intervention community than in the comparison community in all matched pairs (table 6.15 and 
figure 6 . 1 ).
Table 6.15 HIV incidence over 2 years in intervention and comparison communities, and crude 
and adjusted relative risks
H IV  seroconversions Relative risks
Intervention Comparison Crude '
(95% Cl)
Adjusted : 
(95% Cl)
Matched pair / 
stratum
1 mral 5/568 (0.9%) 10/702 (1.4%) 0.62 0.55
2  islands 4/766 (0.5%) 7/833 (0.8%) 0.62 0.62
3 roadside 17/650 (2 6 %) 20/630 (3.2%) 0.82 1.07
4 lakeshore 13/734 (1 8 %) 23/760 (3 0%) 0.59 0.54
5 lakeshorc 4/732 (0.5%) 12/782 (1.5%) 0.36 0.43
6  mral 5/699 (0.7%) 10/693 (14% ) 0.50 0 69
Overall 48/4149 (1.2%) 82/4400 (1.9%)
0.57 (0.42-0 76) 
p = 0 004’
0.62 (0.45-0 8 6 ) 
p = 0.013’
1 Ov erall RR was calculated as the geometric mean of the RRs in matched pairs;
2 Adjusted for age, sex, travel during follow-up period, history of STD (ever) at baseline, circumcision 
in m en and baseline HIV prevalence; 'paired t-test on logarithms of Rrs
The crude relative risk (RR) for seroconversion in intervention compared to comparison 
communities varied from 0.36 to 0.82 The overall crude RR, calculated as the geometric mean
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o f the RRs in the matched pairs, was 0.57 (95% Cl 0.42-0.76, p=0.004). After adjustment for 
variables showing an imbalance between the two groups at baseline, the RR was 0.62 (95% Cl 
0.45-0.85, p=0.013). The unadjusted RR was equivalent to a reduction of HIV incidence in the 
intervention communities as compared to the comparison communities of 43%. F o r the adjusted 
analysis, the reduction was 38%. A non-parametric test (Wilcoxon sign test) gave similar results 
for both the unadjusted analysis and after adjustment for all factors except baseline HTV 
prevalence (two-sided p=0.03). This test was no longer significant (p=0.1I) when a term for 
baseline HIV prevalence was included, as one of the six pairs showed an adjusted RR>1.
Seroconversion rates by age and sex are shown in table 6.16 and figure 6.2. T he reduction in 
incidence was consistent for all age and sex groups. However numbers of seroconversions in 
each sex and age sub-group were small, and therefore most of the differences were not 
statistically significant. Regarding the differences in effect between age/sex groups, there was no 
significant interaction (test for interaction obtained by logistic regression, ignoring between- 
community variation: X2 =2.69, 5 df, p=0.75).
In the comparison group, HIV incidence was highest in women aged 15-24 years and men aged 
25-34 years In the intervention group, the greatest reduction was observed in the  same age and
sex groups.
Tabic 6  16 HIV incidence over 2 years by sex and age groups in intervention and comparison 
groups, with crude and adjusted relative risks
HIV seroconversions Relative risks
Intervention Comparison Crude 1
(95% Cl) p
Adjusted 2 
(95%  Cl) p
Sex / age
group
Women
15-24 years 
25-34 years 
35-54 years 
Men
15-24 years 
25-34 years 
35-54 years
8/721 (1.1%) 
8/646 (1.2%) 
7/795 (0.9%)
7/661 (1.1%) 
6/650 (0.9%) 
12/766 (1.6%)
17/817 (2.1%) 
11/666 (1.7%) 
8/793 (1.0%)
13/760 (1.7%) 
15/611 (2.5%) 
18/753 (2.4%)
0.53 (0.39-0.73) <0.01 
0.71 (0.27-1 8 8 ) 0.41 
0.82 (0.45-1.49) 0.43
0.76(0.37-1.54) 0.39 
0 52 (0.27-1.01) 0.05 
0.65 (0.21-2.02) 0.38
0.66(0.47-0.92) 0 02 
0 .77  (0.28-2 12) 0 54 
0 .83 (0.46-1 48) 0.44
0.77(0.39-1.51) 0.36 
0 .7 2 (0  49-1.08) 0 09 
0 .60(0 .23-160) 0 24
1 The RR for each age/sex group was calculated as the geometric mean of the RRs in matched pairs;
2 Adjusted for travel during follow-up period, history of STD (ever) at baseline, circumcision in men 
and baseline HIV prevalence.
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Figure 6 .1
Seroconversion over two years in the 6  matched pairs of intervention and comparison communities
S e r o c o n v e r s i o n  o v e r  tw o  y e a r s
Figure 6.2
Seroconversion over two years by sex and age group, in interv ention and comparison communities
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6.4.2 M a in  c o h o rt s tu d y : im p ac t on  se lf-re p o rte d  S T D  sym ptom s
4239 men were seen at follow-up, 2052 in intervention communities and 2188 in comparison 
communities. Data are missing for 1 man from the comparison group. In intervention 
communities, 236 men (11.5%) reported a genital discharge or genital ulcer during the past 
year. The corresponding figure in comparison communities was 269 men (12.3% ). The crude 
relative risk (RR) was 0.90 (95% Cl: 0.51-1.59). After adjustment for imbalances including 
reported symptoms (ever) at baseline, the RR was 0.94 (95% Cl: 0.57-1.56). T he difference was 
not significant.
4606 women seen at follow-up, 2234 in intervention and 2372 in comparison communities. In 
intervention communities, 137 women (6.1%) reported a genital discharge or genital ulcer during 
the past year, and 155 women (6.5%) in comparison communities. The crude RR was 0.96 
(95% Cl: 0.54-1.72), and the adjusted RR was 1.00 (95% Cl: 0.58-1.72). Again the difference 
was not significant
6 .4 .3  M a in  c o h o r t  s tu d y :  im p a c t  o n  s e ro lo g ic a l  sy p h ilis
Availability o f  serological test results fo r  syphilis
8845 cohort participants were seen at follow-up O f these, 20 participants refused to give blood, 
and for a further 53 an unambiguous TPHA result could not be obtained Thus a definite TPHA 
and RPR follow-up test result was available from 8772 (99.2%), with 4244 residing in 
intervention and 4528 in comparison communities. From these individuals, three overlapping 
categories could be formed, to study different aspects o f syphilis serology (tables 6.17 and 6  18): 1
1. Persons who were TPHA negative at baseline: from the 8772 individuals, 1339 were 
deducted as they were TPHA positive at baseline and a further 11 as they had no  TPHA result at 
baseline This provided a group of 7422 persons, 3558 from intervention and 3864 from 
comparison communities, in whom the seroincidence o f  TPHA could be studied (table 6.17).
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2. T he whole group of 8772, that is all persons with a definite TPHA and RPR result, to 
study the follow-up prevalence o f  active syphilis (TPHA+, RPR+) at different titres and to 
compare it with the prevalence at baseline (tables 6.17 and 6.18).
3. Persons who were RPR negative at baseline: from the 8772 individuals, 709 were 
deducted who had a positive RPR result at baseline. This provided a group o f 8063 persons to 
study the prevalence o f  ‘new cases o f  active syphilis', 3893 from intervention and 4170 from 
comparison communities (table 6.17).
Incidence o f  TPHA seroconversion
Over the 2 years of follow-up there were 266 seroconversions in the cohort, 108 (3.0%) in the 
intervention group and 158 (4 1%) in the comparison group, equivalent to annual incidences of 
1.5% and 2.0% (table 6.17).
The crude relative risk (RR) was 0.70. After adjustment for factors showing an imbalance at 
baseline, and for the community prevalence o f active syphilis at baseline, the RR was 0.64 (95% 
Cl 0.33-1.25). This represented a reduction o f 36% in intervention compared with comparison 
communities, but the difference was not statistically significant at the 5% level (p=0.15).
Prevalence o f  active syphilis
Active syphilis was defined by a combination o f a positive RPR and a positive TPHA test. The 
analy sis was conducted using different RPR titres to define the cut-off for “positivity” (table 
6.17).
The prevalence of seropositive cases at follow-up was lower in intervention than in comparison 
communities. For example, if a titre o f >=1:8 was chosen as cut-off, the crude relative risk was 
0 69 (95%  Cl: 0 46-1.05, p= 0  07) After adjustment for factors showing an imbalance at 
baseline including baseline prevalence of active syphilis, the relative risk indicated a statistically 
significant reduction o f  33% in the intervention communities (RR=0.67, 95% Cl: 0.47-0.96, 
p=0.04).
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Whichever titre was chosen, the prevalence was lower in intervention than in comparison 
communities, and the adjusted relative risks all showed a statistically significant reduction The 
relative risk decreased with increasing titre, from 0.89 at a titre of >=1:2 to 0.54 at a titre of 
>=1:32 The latter result was equivalent to a reduction of 46%.
The prevalence of active syphilis varied considerably between matched pairs (table 6.18), but 
was almost always lower in intervention than in comparison communities. Taking an RPR titre 
> = 1 : 8  again as an example, the prevalence was lower in the intervention community than in the 
comparison community in 5 of the 6  matched pairs, the RR ranging from 0.40 to  1.12 (table 
6.1.8). After adjustment for factors showing an imbalance at baseline including baseline 
prevalence o f active syphilis, the RRs indicated a reduction in all pairs, the RR ranging from 
0.36 to 0.84 A non-parametric test (Wilcoxon sign test) gave results (p=0.11 for the  crude, and 
p=0 016 for the adjusted RR) which were similar to those of the t-test
Prevalence o f  new cases o f  active syphilis
An RPR titre of 1:8  or greater was chosen for the definition o f a ‘new active case’. At follow-up, 
there were 226 persons with positive results for both tests, who were previously RPR negative, 
85 in the intervention group and 141 in the comparison group, representing prevalences of 2.2% 
and 3 4% respectively (table 6.17).
The crude relative risk was 0 60. After adjustment for factors showing an imbalance at baseline, 
and for the community prevalence o f active syphilis at baseline, the RR was 0.56 (95%  Cl: 0.30- 
1.02), equivalent to a reduction o f 44% in the intervention as compared to the comparison 
communities, a result o f borderline significance (p=0.06).
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Table 6.17 Serological markers for svphilis in intervention and comparison groups, with relative risks for results at follow-up
B aseline p reva lence F ollow -up incidence / p revalence R ela tive  risks (R R s)
Intervention C om parison Intervention C om parison C m d c '
P3 A d ju s te d 1,2STD marker RR (95% Cl) RR (95% Cl) P3
TPHA scro- 
incidence 968/6115 (158) 961/6372 (15 1) 108/3558 (3.0) 158/3864 (41) 0.70 (0.32-1.50) 0.28 0.64 (0.33-1.25) 0.15
Prevalence of: 
Active syphilis
RPR>=1:2 536/6115 ( 8  8 ) 530/6372 (8.3) 452/4244 (10.7) 525/4528 (116) 0.90 (0.76-1.06) 0.15 0.89 (0.80-0 99) 0.03
RPR>=1:4 450/6115 (7.4) 455/6372 (71) 316/4244 (7 4) 428/4528 (9.5) 0 77 (0.60-0.98) 0.04 0.75 (0 62-0 91) 0 .0 1
RPR>=1 8 382/6115 (6.3) 394/6372 (6 .2 ) 214/4244 (5.0) 315/4528 (7.0) 0.69 (0.46-1 05) 0.07 0.67 (0.47-0.96) 004
RPR>=1:16 291/6115 (4.8) 299/6372 (4.7) 136/4244 (3.2) 224/4528 (4.9) 0.62 (0.38-1.02) 0.06 0.59 (0.39-0.90) 0 . 0 2
RPR>=1:32 200/6115 (33) 215/6372 (34) 91/4244 (2 .1) 168/4528 (37) 0.56 (0.36-0 87) 0 0 2 0.54 (0.37-0.79) 0 .0 1
New cases of 
active syphilis NA NA 85/3890 (2 .2 ) 141/4168 (3.4) 0.60 (0.29-1.25) 0 13 0.56 (0 30-1.02) 0.06
(RPR>=I 8 )
1 RRs were calculated as the geometric mean of the relative risks in matched pairs;
‘ adjusted for age. sex, travel during follow-up period, history of STD (ever) at baseline, circumcision in men and baseline prevalence of active syphilis, 
paired t-test on logarithms of relative risks 
NA not applicable
1
5
3
Table 6.18: Prevalence of active syphilis (RPR titre >=1:8) by community pair at follow-up
Prevalence o f ac tive  syphilis 
a t fo llow -up '
R ela tive  risks
Intervention Comparison Crude2 Adjusted2-3
RR (95% Cl) p4 RR (95% Cl) p4
M atched p a ir
/  stratum
1 rural 31/579 (5.4%) 52/712 (7.3%) 0.73 0.84
2  islands 7/777 (0.9%) 19/845 (2.2%) 0.40 0.36
3 roadside 43/678 (6.3%) 55/671 (8.2%) 0.77 0 . 8 6
4 lakeshorc 43/762 (5.6%) 94/775 (12.1%) 0.47 0.56
5 lakeshore 47/744 (6.3%) 56/811 (6.9%) 0.91 0.79
6  rural 43/704 (6.1%) 39/715 (5.5%) 1 .1 2 0.79
Overall 214/4244 (5.0%) 315/4529 (7.0%) 0.69 (0.46-1.05) p=0.07 0.67 (0.47-0.96) p=0.04
1 defined as TPHA+RPR+(RPR titre >=1:8)
2 overall RR was calculated as the geometric mean of the RRs in matched pairs;
3 adjusted for age. sex. travel during follow-up period, history of STD (ever) at baseline, circumcision in men, baseline prevalence of active syphilis;
4 paired t-test on logarithms of RRs.
6.4.4 Main cohort study: impact on urethritis in men
Of the 4239 men seen at follow-up, 1195 (28%) were eligible for taking urethral swabs, because 
they were LED  test positive (1095), reported urethral discharge at the time o f the interview 
without being LED test positive (6 6 ), or were found to have urethral discharge on an 
examination performed for other reasons (34). 1144 specimens were collected (96% o f those 
eligible), w ith 29 refusals in the intervention and 22 in the comparison group. A further 6  men 
did not provide urine, so that it is not clear whether they were eligible for swabbing. The 3095 
men from whom swabs were not taken were considered negative in the subsequent analysis, the 
results reported in this section therefore represent minimum prevalences.
The prevalences of different markers o f urethral infection are shown in table 6.19. Observations 
at follow-up showed that the prevalence of urethritis, defined as the presence of Neisseria 
gonorrhoeae (NG) and/or Chlamydia trachomatis (CT) infection and/or five or more 
polymorpho-nuclear cells per high power field in the Gram-stained sample, was lower in 
intervention than in comparison communities, but this difference was not significant.
The prevalence of symptomatic urethritis, defined as presence o f biological markers as listed 
above plus urethral discharge reported either during the past year or reported present at the time 
of the interview, was lower in the intervention communities. After adjustment for factors showing 
an imbalance at baseline and for baseline urethritis prevalence, the relative risk was 0.51 for both 
parameters, equivalent to a halving in the prevalence o f these symptomatic infections The results 
were statistically significant at the 10% level (p=0.06 and p=0.08 respectively). The modest 
reduction in the overall prevalence o f urethritis is mostly accounted for by the reduction in 
symptomatic cases. The prevalence o f  asymptomatic urethritis, calculated by deducting 
symptomatic cases from overall urethritis, shows little difference between intervention and 
comparison communities (4.2% versus 4.5%).
The prevalence of infection with NG/CT was also lower in the intervention communities, both 
for symptomatic and asymptomatic infections, but numbers o f infections were very small 
especially fo r symptomatic NG/CT infections, and the differences were not statistically 
significant. T he crude relative risks reflected a reduction, but this was no longer observed after 
adjustment fo r factors showing an imbalance at baseline including baseline prevalence o f 
NG/CT
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Table 6  19: Prevalences of urethral infections in men in intervention and comparison groups, with relative risks
STD parameter
Baseline prevalence Follow-up prevalence Relative risks
Intervention Comparison Intervention Comparison Crude 1
RR (95% Cl) p6
Adjusted2
RR (95% Cl) p6
Urethritis1 
Symptoms past year 
Svmptoms now
294/2881 (10.2) 
39/2881 (1 4) 
27/2881 (1.0)
321/2998 (10.7) 
52/2998 (1.8) 
35/2998 (1.3)
119/2052 (5.8) 
37/2052 (1.8) 
32/2052 (1.6)
152/2187 (7.0) 
70/2187 (3.2) 
54/2187 (2.5)
0.84(0.31-2.26) 0.68 
0 48 (0 20-1.01) 0.06 
0.48(0.25-1.03) 0.07
0.92 (0.53-1.61)4 0.73 
0.51 (0.25-1.03)4 0.06 
0.51 (0.24-1.10)4 0.08
NG and/or CT infection 
Symptoms past year 
Svmptoms now
69/2881 (2.4) 
13/2881 (0.4) 
8/2881 (0.3)
96/2998 (3.2) 
18/2998 (0.7) 
14/2998 (0.5)
52/2052 (2.5) 
21/2052 (1.0) 
19/2052 (0.9)
66/2187 (3.0) 
33/2187 (1.5) 
26/2187 (1.2)
0.68 (0.27-1.68) 0.32 
0.48 (0.09-2.39) 0.29 
0 60 (0.14-2.63) 0.41
0.95 (0.49-1.83)* 0.84 
1.12 (0.45-2.77) 5 0.77 
1.29 (0.54-3.07)5 0.48
NG = Neisseria gonorrhoeae, CT = Chlamydia trachomatis 
' RRs were calculated as the geometric mean of the relative risks in matched pairs
2 adjusted for age, community pair, travel during follow-up period, history of STD (ever) at baseline, circumcision
3 defined as NG and/or CT infection and/or >5 polymorpho-nuclear cells in microscopy from urethral swab
4 also adjusted for overall baseline prevalence of urethritis (symptomatic and asymptomatic)
5 also adjusted for overall baseline prevalence of NG and/or CT infections (symptomatic and asymptomatic)
6 paired t-test on logarithms of relative risks
6.4.5 Studies in pregnant women: Impact on STDs in ANC attenders
Study population and coverage
For the two cross-sectional studies performed on pregnant women, the target was to recruit 100 
women from each of the 1 2  antenatal clinics in the intervention and comparison communities.
During the first survey, a total of 1149 women were enrolled. O f these, eight (0.7%) refused to 
be examined, and were excluded from the analysis. O f the remaining 1141 women, 575 were 
from intervention and 566 from comparison communities. Mean age was 25.0 years in both 
groups
During the second survey, 1239 women were recruited, all o f whom agreed to be examined. 614 
resided in intervention and 625 in comparison communities Their mean ages were 25.0 and 24.9 
years respectively.
Prevalence o f  STDs
In both groups of communities, and in both surveys, a very high proportion o f the women 
suffered from an STD (table 6.20): At baseline, 8.4% of women were infected with Neisseria 
gonorrhoeae (NG) and/or Chlamydia trachomatis (CT), 28.6% with Trichomonas vaginalis 
(TV), and 8.0% had active syphilis (TPHA+, RPR+ titre >=1:8). 448/1141 (39.3%) had at least 
one of these STDs During the second survey, the corresponding prevalences were 6  6 %, 24 6 %, 
6  6 % and 412/1239 (33.3%).
Only 17% of the women with NG and/or CT infection complained about discharge when asked 
about symptoms before they were examined These proportions were similar in intervention and 
comparison communities and in both surveys, and did not differ significantly from women with 
active syphilis or those who were free of infection (18% and 16% respectively reported having 
discharge) 26% of the women with TV complained about discharge When vaginal itching was 
included in the symptoms indicating a possible STD infection, the proportion o f women who 
complained about discharge or itching was 42% among those with NG/CT, 55% among those 
with TV, 49% among those with active syphilis, and 38% among those with no infection
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The results for the intervention and comparison communities are compared in table 6.20. There 
was no significant difference between intervention and comparison groups in the prevalence of 
any of the STD markers investigated, at either survey. The same w as true when different titres 
for RPR were used to define RPR positivity (data not shown). There was an overall trend for a 
decrease o f STDs in both trial groups, when comparing the data between the two cross-sectional 
surveys.
6 .4 .6  I m p a c t  o n  se x u a l b e h a v io u r
Study population and coverage
For the baseline sexual behaviour survey, a random sample of 1 in 8  of the main cohort was 
selected from each community. 1498 persons were eligible, and 1117 (75%) were interviewed, 
535 from intervention and 582 from comparison communities. Only 7 people (1.8%) refused to 
be interviewed. The main reasons for non-participation were that subjects had moved away from 
the village since the baseline survey (38%) or were travelling at the time the sexual behaviour 
survey was conducted (21%). A further 10% were excluded on the basis of doubts as to the 
correct identity of the individual, 1 0 % could not be traced, 2 % had died, and 17% were excluded 
for other reasons. The numbers and the reasons for non-attendance were similar in intervention 
and comparison groups (data not shown).
The age and sex distribution o f  the study population was very sim ilar to that o f the main cohort 
from which the sample was taken.
For the follow-up sexual behaviour survey, a random sample o f 1 in 8  was selected from each 
community, from all those seen at the cohort follow-up survey. 1 106 persons were eligible, of 
whom 987 (89%) were interviewed, 464 from intervention and 523 from comparison 
communities Nobody refused to be interviewed Again, having moved away (35%) and 
temporary absence (51%) were the main reasons for non-participation, 0.5 % had died and 13% 
could not be traced. The coverage was higher than previously because the second survey was 
conducted much sooner after the corresponding survey in the main cohort (average delay 5
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Sexual behaviour
Data from the baseline sexual behaviour survey are shown in table 6.14. As described in section 
6.3.3, reported numbers of lifetime sexual partners and partners during the past year were 
similar in intervention and comparison groups.
At the follow-up sexual behaviour survey, the numbers o f partners reported for the past year 
were still similar in the two trial groups, and had not changed substantially since the baseline 
sexual behaviour survey (table 6 .2 1 ).
Various other parameters of sexual behaviour studied at follow-up did not show any material 
difference between intervention and comparison communities (table 6 .2 1 ), including reported 
sexual intercourse in the presence o f STD symptoms, or the use o f condoms with casual 
partners Some people reported occasional condom use with such partners, but overall condom 
use was low. Only 3 people (0.3%) reported regular use of condoms, and only 11 (6 %) persons 
of 197 with an STD reported condom use whilst they had the infection.
m onths versus 9 m onths) A gain the coverage and reasons for non-partic ip a tio n  w ere sim ilar in
both groups.
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Table 6  20: Prevalence of STD markers in intervention and comparison groups in two cross-sectional surveys of ANC attenders,
with relative risks for the second survey, conducted about 18 months after start of the intervention in the intervention communities
STD marker
Prevalences at first ANC survey Prevalences at second ANC survey Relative risks for second survey
Intervention
N=575
Comparison
N=566
Intervention
N=614
Comparison
N=625
Crude 1 
(95% Cl)
Adjusted u  
(95% Cl)
NG and/or CT infection’ 
TV infection 
Active svphilis4 
Anv STD5
34/486 (7.0) 
164/575 (28.5) 
44/575 (7.7) 
215/575 (37.4)
47/478 (9.8) 
162/566 (28.6) 
47/566 (8.3) 
233/566 (41.2)
41/614 (6.7) 
156/6144 (25.4) 
42/614 (6 .8 ) 
210/614 (34.2)
41/625 (6 .6 ) 
145/625 (23.2) 
40/625 (6.4) 
202/625 (32.3)
0.91 (0.48-1.73)
1.08 (0.92-1 28)
1.08 (0.68-1.73) 
1.11 (0.88-1.39)
0.93 (0 49-1.75) 
1.09 (0 92-1.28) 
1 08 (0 66-1.79) 
1.07 (0.79-1.43)
NG = Neisseria gonorrhoeae, CT = Chlamydia trachomatis, TV = Trichomonas vaginalis 
1 RRs were calculated as the geometric mean of the relative risks in matched pairs 
: adjusted for age
5 NG/CT diagnosis during the first survey was based on n=964 only, because 177 gonococcal cultures were contaminated
4 defined as TPHA+ / RPR+, RPR titre of >=1:8
5 defined as any of NG, CT, TV or active syphilis
Table 6.21: Results of follow-up sexual behaviour survey
Self-reported sexual 
behaviour
Men Women
Intervention Comparison Intervention Comparison
No. of partners N = 213 N = 263 N = 246 N = 249
past year
0 10 (5%) 10 (4%) 25 ( 1 0 %) 26 ( 1 0 %)
1 90 (42%) 120 (46%) 199 (81%) 187 (75%)
2 58 (27%) 67 (26%) 17 (7%) 29 ( 1 2 %)
3-4 39 (18%) 51 (19%) 4 (2 %) 6 (2 %)
5+ 16 (8 %) 15 (6 %) 1 (0.4%) 1 (0.4%)
No. of casual partners N = 213 N = 264 N = 245 N = 248
past 2  years
0 133 (62%) 146 (55%) 218 (89%) 215 (87%)
1 29 (14%) 44 (17%) 14 (6 %) 18 (7%)
2 2 1  ( 1 0 %) 30 (11%) 7 (3%) 7 (3%)
3+ 30 (14%) 44 (17%) 6 (2 %) 8 (3%)
Reported being N = 216 N = 268 N = 248 N = 255
faithful to spouse
very faithful 69 (32%) 83 (31%) 119 (48%) 118 (46%)
quite faithful 82 (38%) 105 (39%) 74 (30%) 67 (26%)
not faithful 20 (9%) 19 (7%) 5 (2 %) 8 (3%)
no partner 45 (21%) 61 (23%) 50 (2 0 %) 62 (24%)
Sex during dances. N = 216 N = 268 N = 248 N = 255
weddings (past year)
no 193 (89%) 244 (91%) 243 (98%) 250 (98%)
yes 23 (11%) 24 (9%) 5 (2 %) 5 (2 %)
Sex whilst travelling N = 213 N = 263 N = 246 N = 252
(past year)
no 180 (85%) 222 (84%) 239 (97%) 239 (95%)
yes 33 (15%) 41 (16%) 7 (3%) 13 (5%)
Sex whilst having an N = 216 N = 268 N - 248 N - 255
STD (past year)
had no STD 164 (76%) 197 (74%) 209 (84%) 216 (85%)
had no sex 27 (13%) 48 (18%) 23 (9%) 2 1 (8 %)
had sex 25 (12%) 23 (9%) 16 (6 %) 18 (7%)
Condom use with N = 216 N m 268 N - 248 N = 255
casual pa. (past year)
no such partner 185 (8 6 %) 219 (82%) 234 (94%) 247 (97%)
no condom use 28 (13%) 46 (17%) 6 (2 %) 5 (2 %)
used condoms 3 (1%) 3 (1%) 8 ___sm . 3 ( 1%)
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C h a p te r  7 D iscussion
7.1  C h o ic e  o f  s tu d y  p o p u la t io n  a n d  s i te
For a trial o f the impact of STD control on HTV transmission, a study population was needed 
which fulfilled three conditions: a high prevalence of STDs, a well established but still expanding 
HIV epidemic, and a stable population (section 3.2.1).
In rural Mwanza, these preconditions were met. The baseline survey confirmed that STDs were 
indeed highly prevalent in the region (tables 6 . 1 2  and 6.17) and represented a major public health 
problem. For example, more than 15% of the study population had serological markers of past or 
present syphilis, and more than 6 % had an active untreated infection. The prevalence o f HTV 
mfection in the study population had reached about 4% on average at the beginning of the trial 
with peak prevalences in roadside communities of about 7.5% (table 6.10). With regard to 
mobility, only 14% o f the cohort had moved out of the community during the two-year follow-up 
period (table 6.9).
The project area was very large, covering six different districts. The western- and easternmost 
study communities were situated more than 2 0 0  kilometres apart, with a distance of about 150 
km in a north-south direction The ongoing Rakai and M asaka trials, the only other trials o f STD 
treatment for HIV prevention, are both being conducted within much smaller project areas, each 
covering only one district of Uganda (table 7.1, Kengeya-Kayondo et al 1996, Wawer et al 
1996).
The disadvantages o f a large project area were the strain it put on field workers and the logistic 
organisation o f the trial, and a comparatively large between-community variation in baseline 
HIV prevalence (see below). However, it had the advantage that the study communities were well 
separated, and that only very few subjects from comparison communities gained access to 
intervention health units, thus minimising contamination (section 6.11). Contamination can 
represent a major problem for community randomised trials (Mertens et al 1990). The Rakai trial 
attempted to overcome this problem by means o f detailed pilot studies to map geographical 
patterns of social interaction and sexual networks, and by careful definition o f community 
boundaries. In Masaka, as in Mwanza, geographical separation was chosen to minimise 
contamination, but distances between separated communities are small
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Another choice which had to be made was whether the trial was to be conducted in a rural or an 
urban environment. Management and logistics would have been easier in a city, but the 
implementation of the community randomised design would have been more difficult, and 
contamination probably inevitable. The preparation of a randomised trial of STD treatment for 
HIV prevention was well underway in the city o f  Harare/Zimbabwe in 1993, but had to be given 
up because pilot studies demonstrated the impossibility o f avoiding contamination (Ahmed Latif, 
personal communication). Besides, most Africans still live in rural areas, which therefore 
represent a much larger at-risk population than the cities, and it was important to study the 
operational feasibility and impact o f an intervention which, if successful, could potentially bring 
great benefit to the large rural populations o f this continent.
7 .2  I n te r v e n t io n
7.2 .1  C h o ic e  o f  in te r v e n t io n  s t r a te g y
Referring to the Piot model of the oucome o f STDs in the community (figure 2.1), a range of 
different STD intervention options could be identified. The decision was made to choose a 
combination of three strategies: the main focus was on improvement o f STD case management, 
but supported by improvement o f treatment seeking behaviour and improvement o f partner
notification.
This meant putting the emphasis on the last steps of the model, whilst the majority o f persons 
with an STD might not reach the improved services According to Laga, the initial steps o f the 
model might be more crucial in determining the success o f a control programme (Laga 1994).
Alternative strategies for STD control could have included: primary prevention, screening for 
asymptomatic or neglected infections, targeted interventions in the core group or mass treatment. 
Why was none of these alternative options chosen for the trial?
Primary prevention programmes are certainly o f  great importance. However, a trial o f a primary 
prevention programme would focus on modifying sexual behaviour and would therefore not have 
facilitated investigation of the STD/HIV co-factor hypothesis At the time when the trial was 
initiated, the place o f  primary prevention efforts in AIDS control programmes was universally
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accepted, while the role of STD control was still unclear. Interestingly, even after two decades of 
the AIDS epidemic, there are no published results o f  any trial to measure the impact on HIV 
transmission o f  primary prevention at the general population level. The ongoing Masaka trial is 
the first to address this issue (Kengeya-Kayondo et al 1996).
Ideally, whole communities might be screened for STDs in order to treat all those infected. 
However, this is logistically very difficult; and simple and cheap screening tests are not yet 
available. Also, at the time the trial was planned, the  size of the asymptomatic carrier problem 
was not yet appreciated. For example, the baseline survey results in the main cohort, showing 
that 85% o f men with gonococcal and/or chlamydial infection had no symptoms or signs, were 
unexpected (Grosskurth et al 1996). A further obstacle to the establishment o f  STD screening 
programmes was that in the early 1990s, health policy makers in Tanzania and elsewhere were 
not yet ready to integrate STD services into family planning, antenatal and MCH services, 
although this had been suggested as a priority (Wasserheit 1989). The exception was syphilis 
testing o f pregnant women, which was being performed in some places. However, whilst the 
treatment o f syphilis in pregnancy is certainly an important health intervention (Hira et al 1990, 
World Bank 1993), latent syphilis does not usually lead to sexual transmission, and so the 
relevance o f a latent syphilis screening programme for HIV prevention is unclear.
Over and Piot have emphasised the importance of intervening in the “core group” (Over and Piot 
1993). A core group of sorts may have existed in the Mwanza study communities. In the two 
sexual behaviour surveys, for example, about 3% o f  women and 15% of men reported more than 
2 casual partners during the follow-up period However, in rural communities in Tanzania it is 
very difficult to identify those individuals who are part of the core group There are no bars or 
hotels in these communities, and open prostitution does not exist. The feasibility and value of 
core group interventions in these rural areas are therefore unclear. For ethical reasons, the 
intervention capacity of the programme was used to  launch a core group intervention project in 
Mwanza town independent of the trial The effect o f  this on the rural study communities, if any, 
was in protecting rural visitors to the town. T his applied equally in the intervention and 
comparison communities, and the likely effect would be a dilution o f the measured impact o f the 
rural programme
Periodic mass treatment of STDs for HIV prevention is an appealing option which might have a 
substantial impact However, it is a controversial approach, and for the time being would not
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offer a sustainable intervention which could realistically be provided on a  large scale in Tanzania 
and most other African countries. It is however very important to test this concept, and this is 
presently being done in the Rakai trial (Wawer 1996).
Lastly, an intervention through the improved case management o f STDs was in line with the 
expectations of the Government of Tanzania, and with the recommendations o f WHO at the time 
when the trial was designed (Meheus 1990, W HO 1991).
7 .2 .2  I n te r v e n t io n  d e s ig n
The intervention comprised six components: training of health workers, drug supply, syndromic 
case management o f STDs, regular supervision, the establishment o f a reference clinic with 
laboratory for monitoring and training purposes, and campaigns aimed to improve treatment 
seeking behaviour. Some of these components are discussed below.
Training
We decided on a one week classroom training course in combination with a practical training 
period of two weeks at the STD reference clinic. During the course of the intervention, it proved 
to be extremely helpful that trainers were also regularly involved in the supervision o f  peripheral 
health services, as they could feed their field experience directly into the training. Training thus 
became more practical and linked with the reality of the daily routine.
It is debatable how long STD training courses should last. The intervention team experimented 
with a shorter course duration of only two or three days, to reduce costs and to increase the 
output o f trained health workers. This attempt was soon given up, because the short time 
available did not permit adequate training in health education, condom promotion, and partner 
notification, and there was too little time for exercises on syndromic management Follow-up of 
the trainees showed that health workers with this type of short training found it more difficult to 
apply in practice what they had learned.
The practical training period was also rather lengthy. However, shorter training periods could 
not ensure that trainees would see all syndromes which occur, and get a chance not only to
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observe their tutors at work, but to manage STD cases themselves under supervision. In clinics 
where more STD patients are seen per day, th e  practical training can probably be shortened, and 
this would increase cost-effectiveness. This is an argument for not decentralising STD case 
management training to too peripheral a level.
Antimicrobial drugs and the role o f  the reference clinic
The success of STD case management depends largely on the choice o f the right drugs, correct 
prescription practices, and compliance of patients with the treatment prescribed.
Ideally, drugs should be chosen which allow  single dose oral treatment, which are highly 
effective, and which cover different infections with the same antibiotic, as is the case for example 
with azithromycin. Single dose treatment would allow use o f directly observed treatment which 
would increase patient compliance dramatically. Unfortunately, such drugs are very expensive, 
and cannot be afforded in most programmes in developing countries. On request o f the Ministry 
of Health, but also to protect the programme against accusations of unsustainability, it was 
decided to use a comparatively cheap but less than optimal drug, trimethoprim-sulfamethoxazole 
(TMP-SMX) to treat gonococcal infections and chancroid.
The study has recently been criticised for th is (O'Farrell 1998), mainly based on the argument 
that the failure of the intervention to achieve an impact on the prevalence of male urethritis, and 
specifically of gonococcal infection (table 6.19) was caused by the choice o f this drug The 
impact on urethritis is discussed in section 7 .5, but the argument as such is of general interest as 
it highlights the importance for any STD control programme of the services o f a reference clinic 
and laboratory.
The antibiotic sensitivity of Neisseria gonorrhoeae to the drugs used for the case management 
of urethral discharge, vaginal discharge and lower abdominal pain syndromes (table 5.2) needs to 
be monitored regularly In the Mwanza trial, this was performed at Sekou Toure clinic in 
Mwanza town and the Department of Microbiology o f  the National Institute of Medical 
Research. Mwanza Other important functions of the reference clinic were to monitor the 
aetiologies of STDs in the area and to provide practical training for health workers.
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Monitoring of the sensitivity of Neisseria gonorrhoeae in Mwanza at the beginning of the 
programme showed intermediate resistance for TMP-SMX, but it was possible to overcome this 
problem by prescription of a comparatively high dose. This was confirmed not only through 
antibiotic sensitivity tests but also through the documentation o f cure rates at the reference clinic 
(Philippe Mayaud, personal communication, 1992-95). Over time, the proportion of fully 
sensitive strains declined from 96% in 1992 to 89% in 1996 (table 6.7).
Unfortunately, resistance patterns may vary widely within the same country or larger region. For 
example, in 1992, resistance to Tetracycline had already reached 35% in Mwanza, which 
rendered it obsolete; but the level was only 5%  in the STD control programme in Mbeya, in 
Southern Tanzania, and the drug was still in use in 1995 (Gabriele Riedner, personal 
communication, 1992 and 1995). By 1994, full resistance to TMP-SMX had reached 60% in 
neighbouring Uganda (Beryl West, personal communication, 1994).
For the management o f an STD control programme, an important question is at what level of 
resistance treatment algorithms should be changed. If the new' first line drug is more expensive 
than the previous one, one would like to wait as long as possible before the algorithm is adjusted 
Conversely, if many patients are not cured on first line treatment, they may lose confidence in the 
programme and the credibility of the programme may be damaged. Furthermore, the need to 
prescribe 2nd or 3rd line treatments more often will increase overall costs. It is difficult to define 
the optimal threshold for the decision. Within the Mwanza intervention team, it has been 
suggested to switch to a new treatment scheme once the level o f resistance to TMP-SMX reaches 
20%.
Syndromic case management
The rationale for syndromic STD case management is very compelling. Islam demonstrated that 
this approach is highly cost-effective and superior to the laboratory and clinical approaches in 
the developing country context (WHO 1993) Patients are treated at the time and place of their 
first presentation to a health facility. The sensitivity of the approach is high by definition Side 
effects o f unnecessarily prescribed drugs (because several aetiologies are treated simultaneously) 
occur at an acceptably low frequency, if algorithms are designed carefully
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However, syndromic management also has some disadvantages which have been highlighted by 
various authors (Vuylsteke et al 1993i, Laga 1994), and which also became evident during the 
course of the intervention programme in Mwanza
(i) Health workers were trained to treat women with lower abdominal pain as cases of pelvic 
inflammatory disease (PID), provided that there was no reason to suspect a surgical condition. It 
is likely that some of the patients with this syndrome had other conditions, particularly recurrent 
pain due to peritoneal adhesions as a result of previous PID episodes. Syndromic STD case 
management would lead to overtreatment in such cases. Studies involving more sophisticated 
diagnostic methods (ultrasound, laparascopy, bacterial cultures) are needed to establish what 
proportion o f this syndrome is associated with genuine PID. Because of the difficulties with the 
diagnostic assessment of this syndrome, it was excluded from the evaluation o f  treatment 
effectiveness (section 6.1.3).
(ii) The main dilemma for syndromic case management lies with the vaginal discharge syndrome. 
Vaginal symptoms are a poor predictor for the much more dangerous but often asymptomatic 
cervical infections due to Neisseria gonorrhoeae and Chlamydia trachomatis. If the treatment of 
cervical infections is routinely included in the syndromic management of vaginal discharge (as m 
the Mwanza programme), many women will be treated unnecessarily. If the treatment decision is 
based on a risk assessment step, as recommended by WHO (WHO 1994), women will be both 
under- and overtreated, as the sensitivity and specificity o f this method were only about 50%, as 
shown during an evaluation in Mw anza on behalf of WHO (Mayaud et al 1997Ü). Simple and 
cheap diagnostic tests are urgently needed to address this diagnostic dilemma
(iii) The operational implementation o f the syndromic approach is not straightforward 
(Wilkinson 1997). This was confirmed in Mwanza: the initial resistance among some health 
workers, particular those of higher cadres, against the syndromic approach was substantial. Even 
after the approach became generally accepted, health workers frequently deviated from the 
algorithms, and fell back into previous habits of treating by clinical impression and with 
prescriptions which were often underdosed.
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Support supervision and the situation o f health workers
Supervisory visits revealed that such relapses in treatment practices were often unintentional, and 
health workers were ready to return to the syndromic algorithms once the issue was discussed 
with them by the intervention officer. This observation underlines the importance o f a 
functioning supervisory system for the success o f the programme.
Supervision became the backbone o f the intervention for several other reasons. Supervisors 
provided in-service training which was as important for the success o f the programme as the 
formal training. They saw complicated cases together with the peripheral health workers, and 
therefore sometimes provided a means of referral. They organised the drug supply and ensured 
that drugs were used for the purpose they were meant for.
For some of the health workers, the temptation to sell drugs for other purposes was considerable, 
and without supervision this problem might have jeopardized the whole programme. In the early 
1990s, a pilot programme was launched by the Government of Tanzania, to establish syndromic 
STD treatment services in 20 health facilities in various areas o f the country. Health workers 
were trained, and supplied with drugs. Supervision was conducted, but only erratically and 
infrequently An evaluation after 2 years revealed the failure o f this programme: hardly any 
drugs could be traced at the health facilities although the supply had not been interrupted, and 
few records had been kept to document the treatment of STD patients (Felix Ndyetabura, 
personal communication, 1994).
This problem has to be viewed against the difficult socio-economic position of health workers in 
Tanzania (and many other developing countries). Health workers are grossly underpaid and live 
under extremely difficult economic circumstances which also explain why in rural health 
facilities one usually cannot find health workers at their working places after the morning hours. 
From a health policy point o f view, it may be questionable whether a programme to improve the 
services for a particular health problem, in this case STDs, should be launched, unless structural 
measures are taken to improve the health sector as a whole, or o f the public services in general
174
7.2.3 Operational performance o f the intervention
Acceptance and coverage
At the follow-up cohort survey, about 12% of the men and 6 % o f the women in intervention 
communities reported that they had an STD during the past year (section 6.4.2). About 11400 
patients with 11632 syndromes w ere actually treated at the intervention health facilities during 
the two years o f follow-up. If these figures are compared on the basis of the estimated size of 
catchment population (about 75000 adults in total), a cautious estimate can be made of the 
coverage o f STD cases achieved by the intervention. This suggested that about 85% of 
symptomatic STD patients made use of the improved services. This suggested also that the 
population had still some confidence in the governmental health care system in Tanzania, in spite 
of the many difficulties it had been through during the past 10 years. It is difficult to decide 
whether this result was due to the campaigns aimed at the improvement of treatment seeking 
behaviour, or to the improvement o f service quality, or both. In the study o f non-returners 
(section 6.1.8), 83% of the patients reported that they were satisfied with the STD treatment 
services.
Besides the uncertainty around this estimate because of the imprecise definition o f the catchment 
population, the above proportion o f  service utilisation may be an overestimate, as there was no 
record of how mans' patients experienced more than one STD episode dunng the year. It may 
also have been overestimated for another reason: it is possible that the overall incidence o f  STDs 
in the intervention communities m ay have been higher in the first year of the intervention than in 
the second, as suggested by the decrease in prevalence o f symptomatic urethritis and active 
syphilis (sections 6  4.3 and 6  4 4 ). The net effect of these two possible errors on the estimated 
utilisation rate is difficult to assess.
There is evidence that many patients made use o f  alternative treatment outlets Pharmacies did 
not exist in these rural study communities, but traditional healers were frequently consulted 
(Lwihula and Grosskurth 1994, Newell et al 1993), either instead o f or in addition to the formal 
services Furthermore, anecdotal evidence showed that some patients delayed treatment seeking 
up to 9 months. Similar observations were made in the Masaka district o f Uganda, where 
patients reported delays of up to 1 year before seeking STD care. For genital ulcers, delays until 
onset of treatment were shorter, but were still up to 4 weeks (Mulder 1994). It is important that
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the improvement o f services is accompanied by health education messages to the public to 
encourage appropriate treatment seeking behaviour.
Fewer women than men reported having had a genital discharge or genital ulcer during the past 
year when interviewed in the cohort survey. This was consistent with the observation that fewer 
women than men presented with genital ulcers or with genital discharge. Many infections in 
women probably went unnoticed or were genuinely asymptomatic. In areas with high prevalences 
of reproductive tract infections, women often perceive milder symptoms as 'normal’ (Mulder 
1994) Again, this demonstrates the need for health education.
Overall services were utilised almost equally by men and women (table 6.2), with the non­
specific lower abdominal pain syndrome compensating for the shortfall o f discharge and ulcers in 
women.
Treatment effectiveness
In general, overall clinical cure rates observed at health facilities were high, at 97 to 99%, and 
did not deteriorate during the two years o f the trial. Cases of definite treatment failure were 
extremely rare (table 6.3). Particularly for genital ulcers, this may change in future, as many 
more HIV-positive patients progress to higher degrees of immunodeficiency.
Taking into account that the urethral discharge syndrome was treated with less than optimal 
antimicrobials, the first line treatment cure rate for this syndrome was encouraging.
The cure rates after first line treatment o f ulcers may have been underestimated because ulcers 
did not always heal within one week, and health workers sometimes used second line treatment 
even in cases where an improvement was seen, recording these cases as first line treatment 
failures This was probably the reason why patients with ulcers received 2nd/3rd line treatment 
more often than patients with discharge syndromes (table 6.3).
On the other hand, overall cure rates in genital ulcer patients may have been overestimated for 
several reasons: ulcers due to Herpes simplex virus type-2 infection are not treatable with the
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antimicrobial drugs in use, but will normally heal spontaneously Similarly, syphilitic ulcers will 
heal spontaneously, even i f  not correctly treated
With regard to 1st line treatment, the drug used to treat chancroid (Trimethoprim- 
Sulfamethoxazole) might no t have been fully effective any longer. However, this seems unlikely, 
since at the reference clinic in Mwanza town, no case of culture-proven chancroid was reported 
which did not respond to  first line treatment, except for one patient with AIDS (Philippe 
Mayaud, personal communication 1994). There was no option to study the sensitivity pattern of 
Haemophilus ducreyi in Mwanza. For syphilitic ulcers, resistance to benzathine penicillin has 
not been described in the medical literature to date (Tartaglione and Russo 1990, Mabey and 
Richens 1996).
Clinical cure rates could only be determined in patients who returned for follow-up visits until a 
definite outcome (cured, referred, definite treatment failure) was established. Such patients may 
not be representative of all patients: cure rates may have been over- or underestimated, if a 
disproportionate number o f  those patients who failed to improve either stayed away because of 
disappointment or came forward as they expected additional treatment The proportion of 
patients for whom complete follow-up data were available, was only about 33%. The most likely 
interpretation was that the other patients were cured and thought that an additional visit to the 
health unit was unnecessary', and too demanding in terms of time and money
However, since this was uncertain, an attempt was made to collect information from the non- 
retumers as described in section 5.3.3. This was probably the first community based study in 
which STD patients were followed up at their homes in order to collect data on the performance 
of a control programme
Almost 90% of the non-retumers had been free o f  symptoms after treatment Unfortunately, the 
11% who had not improved had not sought second line treatment This observation emphasises 
again the need for careful health education However, it is encouraging that cure rates in non- 
retumers were not substantially lower than in patients with complete follow up, thus indicating 
that the algorithms in use were appropriate.
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Reinfection and recurrence o f symptoms
It is disappointing that more than a quarter o f the non-retumers reported that they became 
symptomatic again some weeks after the initial treatment, and that these patients did not seek 2 nd 
or 3rd line treatment (table 6.5). It was not possible to distinguish between recurrence of 
symptoms after initial improvement or genuine reinfection after initial cure. The latter is more 
likely, taking into account the rather low rate o f  successful partner notification and the high 
prevalence o f asymptomatic infections in these communities (Grosskurth et al 1996, Mayaud et 
al 1995).
The fact that 31% of the non-retumers who had originally been treated for genital ulcers either 
still had these ulcers, or had acquired a new ulceration, was of particular concern.
Partner notification
Only for 34% of the index cases was at least one partner treated, thus putting two thirds o f  STD 
patients at risk o f reinfection. The reasons are difficult to understand and may include 
embarrassment, fear o f matrimonial conflicts, the casual nature o f the sexual relationship or 
failure of health workers to provide the necessary information. However, most patients in this 
study confirmed that they were requested to notify their partners.
Low partner treatment rates have been reported from various STD control programmes in 
developing countries (Wellington 1993), and are also a well known phenomenon in industrialised 
countries (Cowan 1996).
Referrals
Very few cases (0.8% o f all syndromes treated) needed referral, which underlines the fact that 
peripheral health units are well placed to manage STDs.
Unfortunately, only a minority of the referred patients could be traced at the facilities they were 
referred to. This is worrying, as such patients may often carry resistant strains. Those who did
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not report -probably as a result of the high opportunity costs related to time and transport- fell 
out o f the health care chain, and are likely to spread the infection further in the community.
STD patients should be treated at the place and time of first contact, and drugs for all lines of 
treatment should be made available at all levels o f care. The referral o f STD patients should be 
avoided whenever possible. A genuine alternative for the health worker is to present difficult 
cases to the supervisor, and to make firm arrangements that such patients can be seen at the 
specialised reference clinic.
7 .2 .4  P e r f o r m a n c e  o f  h e a l th  w o r k e r s
During the training of health workers, great emphasis was laid on correct case management, the 
necessity for health education regarding risk reduction and treatment compliance, and condom 
promotion In spite of this, when non-returners were followed up and interviewed about their 
experience, it became clear that all these parameters showed results below expectation. Only 
74% of the patients reported that they had been examined, only 57% received health education, 
and only 30% w ere offered condoms (table 6 .6 ). In women, the latter proportion was as low as 
19%. Although it is difficult to assess this through an interview which was conducted weeks or 
months after treatment, it seems that only 63% of the patients had been treated according to the 
syndromic algorithms
These observations are consistent with results o f a study from South Africa, which showed even 
worse performance of health workers. For example only 9% of the prescriptions written for STD 
patients provided adequate treatment, and none followed official guidelines (Wilkinson 1997). 
The observations in non-retumers are also consistent with findings by Buve and colleagues who 
observed health workers’ performance at four intervention health centres in Mwanza region, in 
order to arrive a t more precise estimates for the model described in section 2.1.7. (Buve et al: 
unpublished data, 1998). This study was conducted about 2 years after the end o f the trial. The 
evaluators observed 84 patients who presented with an STD syndrome O f these 74 (8 8 %) were 
diagnosed correctly by the health centre staff, and 48 (65% o f 74) received a correct 
prescription Assessment of drug stocks revealed that failure to issue a correct prescription was 
not due to drug shortages
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The reasons for these failures are not fully understood, but may be multifactorial: there may be 
waning of the effect o f training, but lack of time and motivation in the context of health w orkers’ 
economic situation may also play a role. These results underline again the crucial importance o f 
good quality supervision.
7 .2 .5  I n t e g r a t i o n ,  s u s ta in a b i l i ty  a n d  u p s c a l in g
The intervention was to be applied in the general population. Specialist care was not available 
for the majority of the population of Mwanza Region. The task was therefore to design an 
intervention which made improved STD care accessible to rural villagers. It was much more 
cost-effective to achieve this through integration o f STD services into the existing primary health 
care structure, than to attempt a vertical approach for example through outreach services. Most 
people in Mwanza Region can reach a dispensary or health centre within two to three hours.
The principle o f integration into the existing services was also in line with the official policy o f 
the Ministry o f Health It fitted into the process o f health sector reform in Tanzania, which 
started around 1992, and aimed at decentralisation and strengthening of district health 
management teams.
Could the district health system cope with the additional demand? STD services were integrated 
into the existing primary health care facilities, without additional requirements regarding 
personnel and physical structure At the district headquarters, one medical assistant was trained 
for the post o f District STD Control Coordinator (DSCC). All in all, the additional burden was 
negligible.
Certain components o f the intervention were organised vertically, notably the training o f health 
workers, the drug supply, and at least initially the supervision component. There were two 
reasons for this Firstly, to investigate the co-factor hypothesis, it was important to keep essential 
elements of the intervention under control, so that operational success was ensured. This would 
have been debatable if a system was created which was not sustainable and would not be 
replicable elsewhere However, this was not the case: the personnel routinely involved in these 
components comprised medical assistants and nurses only. Training courses were short and
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unsophisticated. The drugs used were inexpensive, and the drug supply was coordinated with the 
supervision visits.
Secondly, even in a completely integrated programme, unrelated to research, district level health 
services in developing countries would usually not be in a position to ensure sufficient manpower 
and expertise for good training and low-cost drug procurement. The few other large scale STD 
intervention programmes in Africa (see section 2.1.8) have chosen a similar approach for their 
training and supply components (Bastos dos Santos et al 1992). In Uganda, STD training is 
being provided for 1 0  districts through a mobile team of training experts supported by a non­
governmental organisation (Dean Shuy, personal communication 1994).
An economic analysis o f the Mwanza intervention showed that the single most expensive 
component in the recurrent costs was the supervision system, as this required transport including 
fuel and maintenance and outstation allowances for supervisors (Gilson et al 1997). Because 
regular supervision and in-service training proved to be of paramount importance for the success 
of the intervention, these costs are unavoidable.
Despite this, the improvement o f STD services cost only $0.39 per capita annually, or $10.15 
per syndrome treated of which only $2.11 were drug costs (Gilson et al 1997). Both can be 
further reduced by upscaling the intervention
Meanwhile, two years after the end o f  the trial, the intervention has been extended to about 190 
health facilities in total, without the need for additional capital investment or personnel at central
level.1
' For completeness, it should be mentioned that in 1996, the drug supply was disconnected from the 
central project office in Mwanza, and taken over by the Ministry of Health, with funding from the EC. 
Because of organisational and managerial problems, the supply became erratic soon afterwards, and in 
1997, 6 years after the beginning of the intervention, health facilities in Mwanza Region ran out of 
drugs.
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7 .3  S tu d y  d es ign  a n d  im p lem en ta tio n
7 .3 .1  C o m m u n i ty  r a n d o m is a t io n
A randomised controlled trial was chosen as the most appropriate study design to assess whether 
improved STD services had an impact on HIV and STD transmission.
The impact o f STD control could, in principle, be tested by individually randomising HIV 
negative subjects to an STD intervention or to a comparison group. However, if STD treatment 
is to be provided through existing health services, a  community randomised design is dictated by 
the intervention design.
This design feature had important advantages: STDs are likely to enhance HIV transmission by 
increasing both the infectiousness o f  HIV infected individuals and the susceptibility of HTV 
uninfected individuals (Mertens et al 1990). Randomisation by individual subjects would only 
measure the effect on HIV acquisition, and therefore fail to capture the full impact of the 
intervention In addition, randomisation by community captures the ‘mass effect’ on transmission 
which is achieved when whole communities are covered by an intervention against an infectious 
disease, and which is analogous to the herd immunity which may be observed in immunisation 
trials (Hayes et al 1997).
7 .3 .2  S a m p le  s iz e  a n d  m a tc h in g
Randomisation by community had two important consequences each o f which required careful 
consideration and had a major influence on the details of the trial design and the strategy for data 
analysis (Donner et al 1987).
Firstly, standard sample size formulae for individually randomised trials could not be applied as 
it could be expected that the main outcome measure would vary between communities, thus 
introducing an extra component of random error in addition to the binomial variation caused by 
the random sampling o f individuals within the communities. Sample size calculations needed to 
take account of both types of random error.
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Secondly, community randomisation meant that the outcome o f interest would have to be 
analysed a t the level o f the community as well. In spite o f the recruitment o f a  large cohort o f 
individuals within each community, the trial was based on only 12 communities. With so few 
units o f randomisation, there was a high probability of baseline imbalances between the two trial 
groups which could have influenced the results. Because HTV incidence was the primary 
endpoint o f  the trial, this problem would ideally be addressed through stratification o f 
communities by baseline HTV incidence. The most extreme form of stratification is to form 
matched pairs o f communities.
Sample size
The trial w as designed to  have 80% power o f detecting a reduction of HIV incidence from 1% to 
0.5% as statistically significant at the 5% level. The number o f communities required for each 
group and the number o f  person-years o f observation required within each community were 
calculated using the computation described in chapter 5.1.5.
The key quantity in this computation is k, which is a measure o f  the degree o f  variation o f the 
true incidence between communities. Because prior data for k were not available, an assumption 
had to be made We assumed that the true incidence without the intervention varied between 
approximately 0.5 and 1.5%, implying that k=0.25. Under this assumption, the computation 
showed that at least 5 communities would be required for each group for the trial to give 
conclusive information (fig 5.1). We decided to choose 6  communities per group, and calculated 
that 2000 person years o f observation (PYO) would be needed for each community, in total 
24,000.
Why were 6  communities chosen per group? There was a trade-off between the number of 
communities and the number of PYO: if  only 5 communities per group had been chosen, a much 
larger cohort would have been required (fig 5.1). The latter would have been logistically 
difficult, and in some o f  the communities it might have been difficult to identify a sufficient 
number o f  adults within the cohort recruitment zone of a study community (figure 5 4).
On the other hand, there were several reasons not to exceed six communities per group: Firstly, 
again from a logistic point of view it was easier to operate in a smaller number of communities
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Secondly, a smaller number o f communities reduced the chance of contamination. Thirdly, 
although for a given value o f k, a larger number of small clusters is preferred to a  small number 
of large clusters, since this reduces the design effect resulting from between community variation 
and increases power for a given total sample size (Gail et al 1996), it was expected that k might 
be reduced if clusters were larger.
Lastly, it is clear from fig. 5.1, that the required number of communities is more sensitive to 
losses to follow-up if the choice is made on the left rather than the right side o f  the diagram: 
losses to follow-up will in any case lead to a loss of study power, but with a larger number of 
communities in the study and a smaller number of PYOs in each community, it can more easily 
lead to inconclusive trial results, as the number of communities may more easily turn out to be 
insufficient at the time of the follow-up survey.
Matching
The ideal approach -matching on baseline incidence- was not feasible. Matching on baseline 
HIV prevalence would have been the second best choice as it could be expected that HTV 
incidence was closely associated with HIV prevalence, as the epidemic in Mwanza Region was 
still far from reaching saturation. However even that was not possible, as HIV prevalence data 
were not available from the study communities when the trial was designed. Instead, matching 
factors had to be chosen which were known from previous studies to be closely correlated with 
HIV prevalence in this Region (Barongo et al 1992): community' location in high versus low 
prevalence districts, and geographical relationship to main roads, the lakeshore and the islands 
(tableó 1 0 ).
All three East-Affican trials employed similar matching strategies (table 7.1). In the Mwanza 
trial, communities were allocated to six matched pairs. In the Masaka tnal -a trial with three 
arms conducted in 18 parishes- six matched triplets o f parishes were formed on the basis of 
known HIV prevalence (Kengeya-Kayondo et al 1996). In the Rakai trial, the 10 study 
communities were grouped into 3 strata using projected HIV prevalences (Wawer et al 1996)
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The baseline survey in Mwanza confirmed that the matching was highly effective. The variation 
o f HIV prevalence was much smaller within pairs than between pairs (table 6.3.1). This resulted 
also in a substantial increase in study power.
As described above, the initial sample size calculation for the Mwanza trial was based on an 
assumed value o f k=0.25 for the between community variation o f  baseline HIV incidence. 
Because incidence figures were not available before the trial, prevalence had to be used as a 
proxy instead, although this required more caution, since for a trial with HIV incidence as the 
main outcome measure, HIV incidence was the really important variable. When the baseline 
survey was completed, the actual size o f k calculated over all 1 2  communities was found to be 
0.49, substantially larger than expected (Grosskurth et al 1995i). The potential consequence can 
be assessed from figure 7.1 which shows the number o f communities required for different 
values of k for given numbers of person-years o f follow-up. Without the matched design, the 
number of communities in each trial arm would not have been sufficient anymore, as for k=0.49 
at least 13 communities would be required (fig. 7.1), and the trial would have been inconclusive. 
However, k was only 0.28 when computed within pairs, a result close to the original estimate.
In the Masaka trial, a similar observation was made (table 7.1): k was originally estimated at 
0.25, proved to be 0.30 overall, but was only 0.19 when analysed within matched triplets 
(Kegeva-Kayondo et al 1996, Hayes et al 1997) These figures may still change to some extent, 
as the calculation was made before the baseline survey was completed In the Rakai trial, no pre­
trial estimate o f k was made, but it was recorded as 0.16 at the baseline survey (Hayes et al 
1997).
The fact that the Masaka and Rakai trials operate in a comparatively small geographical area - 
in principle a disadvantage because of the danger o f contamination - gave them the advantage of 
much more homogeneous communities resulting in lower values o f k and an increase in study 
power for a given number o f  communities.
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Table 7.1: Key characteristics of three trials of STD treatment for HIV prevention*
Kiu/anza trial Kiasaka trial Rakai trial
Design RCT RCT RCT
Clusters 1 2  communities 
(groups of villages)
18 parishes 1 0  superclusters 
(groups of villages)
Stratification 6  pairs
of communities
6  triplets 
of parishes
3 strata with 2 or 4 
superclusters each
Clusters per arm 6  communities 6  parishes 5 superclusters
Study population 75,000 50,000 1 2 , 0 0 0
(sexually active)
Size of cohort 1 2 , 0 0 0 18,000 1 2 , 0 0 0
Coefficient of variation (k)
assumed 0.25 0.25 NA
observed 1 : - overall 0.49 0.30 0.16
- within pairs/strata 0.28 0.19 ?
Activities in intervention 
arm
Improved syndromic 
case management
1. IEC only
2. ŒC + improved 
svndromic case man
Periodic mass treatment
Activities in comparison Continuation of Community Treatment of STDs at
arm(s) traditional treatment 
of STDs
development
intervention
study clinics (self 
reported or if found 
infected during survey)
Outcome variables In cohort:
HIV incidence, 
incidence of syphilis, 
prevalence of
- active syphilis
- male urethritis
- NG/CT in men
In pregnant women: 
prevalence of 
- TV, CA, NG/CT
In cohort:
HIV incidence, 
incidence of syphilis, 
prevalence of
- active syphilis
- NG/CT in both 
sexes
In cohort:
HIV incidence, 
incidence of syphilis and 
genital ulcers, 
prevalence of
- TV in women
- BV + CA in women
- NG/CT in both sexes
In pregnant women + 
offspring:
- all maternal STDs
- premature delivery
- low birth weight
- ophthalmia neonat
STD laboratory In cohort: In cohort: In cohort:
methodologies used NG: gram stain 2,
CT : antigen detection 
EIA 2,
urethritis gram stain2. 
Syphilis: RPR, TPHA
NG + CT: LCR on 
urine.
Syphilis: RPR, TPHA
NG + CT: LCR on urine 
TV: culture \
BV + CA: gram stain 3, 
Syphilis: Trust, TPHA, 
Ulcers: multiplex PCR 
for TP, HD and HSV-2
RCT Randomised controlled trial. ŒC Information, education, communication, NG Neisseria gonorrhoeae, 
CT Chlamydia trachomatis. TV Trichomonas vaginalis, BV Bacterial vaginosis. CA Candida albicans.
HSV-2 Herpes simplex virus-2, EIA Enzyme immunoassay, RPR Rapid plasma reagin test, TPHA 
Treponema pallidum hacmagglutination assay, LCR Ligase chain reaction, PCR polymerase chain reaction; 
'regarding HIV prevalence at baseline; 2on urethral swabs from men; 3using self administered vaginal swabs 
"(Kengcya-Kayondo et al 1996, Wawer et al 1996, Hayes et al 1997, J. Whitworth: personal communication)
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Figure 7.1 Number of communities required in each group for different values of the coefficient of 
variation of H IV  incidence (k), for given numbers of person-years of observation (Hayes et al 1995ii)
Person-years ol observation h  each corrmrity
7.3.3 Randomisation and comparability
From each matched pair, one community was randomly allocated to  the intervention group. 
Within communities, study participants were selected through the random cluster sampling 
scheme described in section 5.4.3.
The randomisation process was successful in providing intervention and comparison groups that 
were generally similar with respect to HIV and STD prevalence at baseline (tab 6 .11 and 6 .12). 
In three of the community pairs, HIV prevalence was lower in the intervention community, whilst 
it was lower in the comparison community in the other three pairs
Imbalances in baseline HIV and STD prevalences
However, small overall imbalances occurred for all HIV and STD prevalences at baseline, and 
these could potentially act as confounders for the impact variables. In the analysis of each 
outcome, an adjustment was therefore made for the appropriate corresponding baseline 
prevalence. For example, overall baseline HIV prevalence was 3.7% in intervention and 4 4% in 
comparison communities (table 6 . 1 1 ), potentially resulting in an exaggeration of the measured 
impact of the intervention, and therefore a term for baseline HIV prevalence was included in the 
logistic regression model for the analysis of HIV incidence
Imbalances in other potential confounding variables
Most factors known to be associated with the risk of HIV infection and other STDs in this 
population, including sexual behaviour, were also distributed similarly in the treatment groups 
(tables 6.13 and 6.14).
The only variables for which there were appreciable differences at baseline between intervention 
and comparison groups were travel outside the district during the past year in both sexes, 
circumcision in men and reported STDs (ever) in men
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How could these imbalances influence the results of the impact evaluation? A lack of 
circumcision has been shown to increase the risk of HIV acquisition in some African studies (de 
Vincenci et al 1994). Only 14% o f the men in intervention communities were circumcised, versus 
23% in comparison communities. This difference could potentially lead to a higher incidence in 
intervention communities, and would therefore reduce the measured impact o f the intervention.
Conversely, only 44% of the men and 24% o f the women in intervention communities reported 
having travelled outside of their district during the last 1 2  months before the baseline survey, 
whilst the corresponding figures for comparison communities were 49% and 35% respectively. If 
similar differences also occurred during the follow-up period, this would expose the comparison 
population to higher risk, as mobility was associated with HIV infection in an earlier study in the 
Region (Barongo et al 1992).
The same applied to a reported history o f STDs. Only 31% of the men in intervention 
communities reported previous STDs (ever), but 38% of the men in comparison communities. In 
women, this was more evenly distributed Because a history o f STDs was associated with HIV 
infection (Barongo et al 1992), and because it could be assumed that a history of STDs would 
predispose to future infection, the risk of HIV infection was potentially higher in the comparison 
group
Thus, imbalances in the history o f  travelling outside o f the district, and history of previous STD 
episodes, could potentially exaggerate the measured impact o f the intervention. Terms for these 
factors as well as for male circumcision were therefore included in the logistic regression model 
used in the impact analysis.
7 .3 .4  C o m p l ia n c e  a n d  lo s s e s  t o  fo llo w -u p
Compliance
The compliance o f the local population was remarkably high The great majority o f eligible 
individuals who were not recruited during the baseline survey, were travelling away from their 
community. Very few people refused to participate in the study, and the same observation was 
made during the follow-up survey.
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The trial made considerable efforts to encourage compliance through community mobilisation, 
meetings with official and unofficial representatives, home visits to eligible persons if they failed 
to present to the study team, and a final revisit to clusters where compliance was below average, 
before the study team moved on to the next community.
The fact that all interviewers and most o f the field team leaders belonged to the Sukuma tribe, 
the main ethnic group inhabiting Mwanza Region, helped to ensure a positive response. Their 
training included sessions on how to approach study participants respectfully, and how to 
address common questions and problems. The survey teams treated any STD and other minor 
ailments on the spot. This service was not limited to study participants only, but was also 
provided to people from neighbouring unsclectcd clusters or to people outside the eligible age 
band Occasionally quick and effective help was provided m real emergencies As a result, the 
programme was generally viewed by villagers as providing good medical care in times of a 
deteriorating health system. Because it was known that the programme would try to upgrade 
government health facilities to some extent, and because study teams interacted regularly with 
the local health staff, the authority of these health workers was not undermined
Losses to follow-up
Overall losses to follow-up were 29 - 30% in both trial groups, with 14% due to moving away 
and 6 % due to temporary absence of more than two months Both were fewer than expected, 
reflecting the relative stability of the population
However, losses to follow-up were not negligible, and had some implications for the expected 
power of the study: The actual number o f person years of observation (PYOs) was based on only 
8549 initially seronegative individuals, from whom 17098 PYOs were obtained, about 71% of 
the 24,000 o f the original sample size calculation This implied a reduction in the power of the 
study from about 80% to 74%, a fairly modest reduction (Hayes et al 1995ii)
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7.3.5 Quality control
The quality control procedures used within the trial were extensive. They included frequent 
supervision and support visits to field research teams, measures to shift teams between 
intervention and control communities during the course of the surveys, and various checks 
performed at the steps of specimen and data collection and at computerisation Rapid local data 
entry and processing facilitated the identification of errors which had not been detected in the 
field These were then eliminated in collaboration with the field team leaders, usually within two 
to three weeks after collection of the original data. For the laboratory work, a system of both 
external and internal quality control was in place (section 5.4.8).
Similar quality control measures were in place for the supplementary studies on antenatal clinic 
attenders and the sexual behaviour surveys (sections 5.4.6 and 5.4.7).
7 .4  I m p a c t  o n  H I V  in f e c t io n
7 .4 .1  V a lid i ty  o f  im p a c t  e s t im a te
The crude relative risk (RR) of HIV infection in the cohort was 0.57 for persons living in 
intervention communities when compared to those living in the comparison communities Thus 
the improved STD treatment services reduced HIV incidence by 43% over 2 years o f follow-up 
After adjustment for baseline imbalances of possible confounding factors between intervention 
and companson communities, including differences in baseline HIV prevalence, the RR was 
0.62, equivalent to a reduction in incidence o f 38%. The 95% confidence interval for the 
reduction in HIV incidence ranged from 15% to 55%.
The crude reduction occurred in both sexes, and was observed consistently in all matched pairs 
of study communities (table 6.15 and figure 6.1). A reduction was also consistently observed in 
all age groups. It was particularly large in young women and in men aged 25-34 years, the same 
groups which showed the greatest HIV incidence without the intervention (figure 6.2). After 
adjustment for baseline HIV prevalence, a reduction was no longer observed in one o f the pairs 
(table 6.15)
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The observed annual incidence of 0.9% in the comparison communities was close to the 1% 
assumed in the study design, and similar to the incidence o f 0 .8 % observed in the rural 
population o f neighbouring Kagera Region (Killewo et al 1993).
The overall reduction was highly statistically significant, both for the crude and the adjusted 
relative risks (p=0.004 and p=0.013, respectively). It is therefore very unlikely that chance could 
explain the observed difference in HTV incidence.
Are there any sources of bias which might account for the observed reduction?
The results might be explained by a lack of comparability between the intervention and the 
comparison communities. Although this problem should have been minimised by the matching 
and randomisation process, it possible that with only 1 2  communities some differences could 
have occurred. However, as shown in section 6.3, matching and randomisation succeeded in 
providing intervention and comparison communities that were generally similar at baseline with 
respect to HIV and STD prevalences and most o f the risk factors known to increase the risk of 
HIV and STD transmission. The most important potential confounding variable, sexual risk 
behaviour, was evenly distributed between the two groups o f communities, at least as far as can 
be determined with a survey using a structured questionnaire (table 6.14). Some imbalances of 
baseline variables were identified, but these were adjusted for in the analysis. This adjustment 
changed the estimated impact on HTV incidence very little.
Losses to follow-up are another potential source o f  bias. It could be that those lost may differ in 
their risk from those who were seen at follow-up. However, 71% of the cohort members were 
seen at follow up, and this proportion did not differ substantially between intervention and 
comparison communities (table 6 .8 ). These coverage rates are within the range generally 
considered acceptable in population based studies. Reasons for loss to follow-up were also 
broadly similar in intervention and comparison communities. It is therefore very unlikely that the 
comparability o f  the two groups of communities has been impaired substantially by losses to 
follow-up.
The testing algorithm used to establish the HIV status o f the study participants was highly 
sensitive and specific However, a small number o f  misclassifications are likely to have occurred, 
as in other studies (see section 2.3.2). There is no reason to assume that this misclassification
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was differential with respect to the two study groups The effect o f this misclassification would 
be to underestimate the impact o f  the intervention (Mertens et al 1990).
Another possible bias may be caused by study participants in comparison communities travelling 
to intervention communities in order to seek improved treatment for STDs. The origin of STD 
patients was carefully monitored. Records showed that only 59 patients (about 0.5% of all STD 
patients) were residents o f comparison communities. Any bias caused by this contamination 
effect would have been small, and would again lead to a dilution o f the measured impact of the 
intervention.
It can be concluded that the observed reduction in incidence reflects a valid result and can 
confidently be attributed to the intervention. The question remains whether the impact was 
caused by the improved case management o f STDs or by other effects which stemmed from the 
intervention.
It was possible that the intervention might have changed the sexual behaviour o f the population 
Public campaigns in the villages focused on the importance of seeking treatment promptly and on 
publicising the availability o f improved services. However, questions on risk factors for STDs 
and HIV infection came up in discussions with the public, and the responses o f the intervention 
team included advice on how to reduce risk behaviour. In addition, STD patients were educated 
by health workers on how to reduce their risk in future, and although only 57% of patients in the 
study o f non-returners reported having actually been exposed to this health promotion, this 
component o f  the intervention could have led to a change in the sexual behaviour o f the 
population in the intervention communities.
Unfortunately it did not. For example, only 0.9% of the STD patients accepted condoms, and 
reported condom use in the study cohort in intervention communities was very low as well. Die 
reported sexual behaviour o f the cohort with respect to condom use, number o f casual partners 
during the follow-up period, number of partners during the past year and other parameters 
measuring risk behaviour did not differ substantially in the two groups o f communities, neither 
did it change over time in either arm o f the trial.
It is therefore very likely that the observed reduction in HIV incidence reflected an impact of the 
STD treatment intervention itself, rather than by changes in sexual behaviour
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When the trial was designed, it was questioned whether health promotion should be included in 
the intervention, because the objective of the trial was to contribute evidence for or against the 
STD co-factor hypothesis. For ethical and pragmatic reasons this question was answered in the 
affirmative. If sexual behaviour adaptation had occurred, this would have to be regarded as part 
and parcel of the intervention. From a public health perspective it was disappointing that sexual 
behaviour changes were not achieved. From an epidemiological point o f view this strengthened 
the evidence for the co-factor hypothesis, and for the importance o f launching STD control 
efforts in order to prevent HIV transmission.
Interestingly, during the public discussion o f the trial, some commentators thought it had proven 
the ineffectiveness o f STD and AIDS related health promotion. This can certainly not be 
concluded from the results of this trial The intervention was not targeted at sexual behaviour 
changes and it is not easy to influence sexual behaviour. The time required to achieve such an 
impact is probably much longer than just tw o years, and would need much more intensive 
intervention efforts (Slutkin 1993, Adler et al 1996).
7 .4 .2  I m p lic a tio n s  f o r  th e  c o - fa c to r  h y p o th e s is
The results of the trial provided additional evidence for the hypothesis that STDs enhance the 
transmission of HIV infection, and that the control of symptomatic STDs can substantially 
reduce HIV transmission in populations where STDs are highly prevalent.
They are consistent with the various observational studies described in sections 2.3.3 and 2.3.4, 
which had suggested that both genital ulcers and non-ulcerative STDs (notably gonorrhoea, 
chlamydia infection and trichomoniasis) increase HIV transmission (Cameron et al 1989, 
Plummer et al 1991, Laga et al 1993). However, the evidence produced by the trial was much 
stronger than for these previous studies, because the randomised controlled design o f the trial 
made it possible to overcome the problem o f  confounding which is inherent in observational 
studies, as described in detail in section 2.3.2 (Mertens et al 1990, Laga et al 1991, Laga et al 
1994i).
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The results o f the Mwanza trial are also consistent with studies demonstrating increased HTV 
shedding in the semen, or cervical or vaginal secretions, o f HTV infected persons in the presence 
o f bacterial STDs (Cohen et al 1997, Mostad et al 1997), and a decrease in viral load in semen 
after the treatment o f  urethritis (Cohen et al 1997).
Taking all these findings together, the STD/HIV co-factor hypothesis has now been confirmed 
beyond reasonable doubt.
The trial was not in a position to shed light on the exact size of the STD/HTV co-factor effect for 
individual STDs (Hayes et al 1995ii).
The size o f the reduction in STD incidence which can be achieved through improved STD case 
management depends on a variety of factors. The reduction depends not only on the size o f the 
co-factor effect, but also on the prevalences of STDs and HIV infection in the community, the 
proportion o f STDs which are asymptomatic, the treatment seeking behaviour o f  the population, 
the compliance o f patients, the proportion of partners which can be reached and treated, the 
effectiveness of the drugs used, and the performance o f the health workers involved. This list is 
probably not exhaustive. It is therefore quite possible that the same type o f  intervention may 
have a greater or lesser impact in another setting. There is also some uncertainty about the size 
o f the impact, as the true HIV incidence reduction may have fallen anywhere between 15% and 
55%, if the 95% confidence interval around the measured relative risk for HIV transmission is 
considered.
It would be o f great interest to compare the results o f the three trials in East Africa, perhaps with 
the help of computer simulations, in order to arrive at more reliable predictions of how to 
optimise an STD intervention for HIV prevention in different environments.
7 .4 .3  I s s u e s  o f  c o s t-e f fe c tiv e n e s s
The cost-effectiveness of the Mwanza intervention was evaluated in an associated economic 
study (Gilson et al 1997) The study related the costs spent on STD control in the intervention 
communities to the benefit generated by these improved services. This approach took into 
account that some STDs were also treated successfully through the existing health services in
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the comparison communities. Cost-effectiveness was therefore calculated based on incremental 
costs, that is by deducting an estimate of costs spent on STD treatment in comparison 
communities from the total costs o f the intervention. This incremental expenditure prevented 
about 250 new HIV infections per annum in the catchment population of the intervention 
communities at a cost of US $ 0.39 pier head of population served.
The amount spent to prevent one case o f HIV infection was $ 218. Prevented cases o f HIV 
infection were related to the number o f  disability adjusted life years (DALYs) saved Using the 
life expectancy for Tanzania, it was estimated that the intervention costs were $ 10.33 per 
DALY saved. A sensitivity analysis was conducted by combining various favourable and 
unfavourable assumptions for the factors influencing cost-effectiveness. In this analysis, the cost 
per DALY saved ranged from $ 2.50 to $ 48.00.
Even at the unfavourable extreme, this compared favourably with other cost-effective public 
health interventions (World Bank 1993). It should be noted that the cost-effectiveness estimates 
did not include the direct benefits obtained by treating STDs and by preventing STD sequelae 
The economic burden of STDs is substantial (World Bank 1993).
As discussed in section 7.2.5, the intervention has meanwhile been upscaled and covers about 
190 health facilities, without major additional capital investment It is possible that the quality of 
the intervention has decreased somewhat, but it is likely that during this process cost- 
cffcctivcncss has increased substantially, as long as the drug supply remains reliable.
7 .5  Im p a c t o n  S T D s
7 .5 .1  S u m m a ry  o f  im p a c t r e s u l t s
A The following parameters were significantly reduced in intervention communities at the 
5% or 10% level of significance:
(i) the prevalence of active syphilis, for different cut-offs of the RPR titre The adjusted relative 
risk (RR) decreased with increasing titre, ranging from 0.89 (at a titre o f >=1:2) to 0.54 (at a 
titre o f >=1:32) (tabic 6.17), equivalent to a reduction of active syphilis o f up to 46% P-valucs
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ranged from 0.04 to 0.01. For higher titres, the reduction was observed consistently in all pairs 
o f communities.
(ii) the prevalence o f  new cases of active syphilis, that is o f  cases which were RPR-negative at 
baseline. The adjusted RR was 0.56 (p=0.06).
(iii) the prevalence o f symptomatic urethritis in men. The adjusted RR was 0.51 both for 
persons reporting symptoms during the past year (p=0.06) and those reporting symptoms at the 
time o f the interview (p=0.08), equivalent to a halving o f the prevalence.
B The incidence of syphilis (TPHA+) during the two years o f follow-up was reduced by 
36%. The RR after adjustment was 0.64, but this finding was not statistically significant 
(P=0 15)
C No impact at all was observed (i) on the prevalence of asymptomatic urethritis in men, 
(ii) on gonococcal and/or chlamydial urethritis in men, even if symptomatic, (iii) on history of 
self-reported STD symptoms in both sexes in the main cohort study; (iv) and on cervical or 
vaginal infections in the cross-sectional study at antenatal clinics.
7 .5 .2  P e r f o r m a n c e  o f  d ia g n o s tic  t e s t s
General considerations
False positive or false negative test results would lead to misclassification o f the infection status 
o f some of the study participants What effect would these misclassifications have on the impact 
estimates? If the misclassification is non-differential with respect to  the intervention or 
comparison groups, as could usually be expected if the laboratory personnel are entirely unaware 
o f the origin o f the specimens, the result o f this type of misclassification would be a dilution of 
the measured effect of the intervention, thus biasing the study results towards finding no 
association (Mertens et al 1990) None of the diagnostic tests used in this trial for the diagnosis 
o f the various STDs had a sensitivity or specificity o f  100%. It is therefore likely that the 
observed impact estimates seen in this trial are biased towards under- rather than an 
overcstimation.
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I f  the misclassification is differential, the association may be biased in either direction (Mertens 
et al 1990). This may have been the case with self-reported symptoms (see below section 7.5.4).
Serological tests fo r  syphilis
Syphilis versus non-syphilitic treponematosis: Both TPHA and RPR tests may lead to a false 
positive diagnosis of syphilis in persons with non-syphilitic treponemal infections, notably yaws 
(Schulz et al 1990, Arya 1996). This could potentially result in the diagnosis o f an exaggerated 
prevalence and incidence o f syphilis. The effect on the impact of the intervention would be 
difficult to predict without detailed data on the distribution of yaws in the two trial groups. It is 
likely that this distribution would have been equal in the two groups o f the trial because of the 
randomization, and that therefore the misclassification o f  yaws as syphilis would have led to a 
dilution of the measured impact (see above). However, yaws was probably eradicated through 
mass treatment programmes in Tanzania conducted in the 1950s and 1960s, and is believed to no 
longer exist in Tanzania. No clinical case of yaws was observed during the surveys in any of the 
12 communities. Seroscars of old yaws, if they existed at all, may have influenced the prevalence 
figures of syphilis in the older age groups, probably non-differentiallv.
Syphilis incidence: The incidence of syphilis was measured by TPHA seroconversion. Even 
after successful treatment of syphilis, the TPHA test result remains positive throughout life in 
most cases (Jaflfe and Musher 1990, Larsen et al 1995). TPHA incidence can therefore only 
detect a proportion of all new syphilis cases. Individuals who acquired a fresh syphilitic infection 
during the follow-up period, but who were already TPHA positive at baseline because of a 
previous episode, could not be detected.
Persons in whom a new infection was treated as soon as signs and symptoms appeared, may not 
have seroconverted. Prompt treatment would thus favour the intervention group: true syphilis 
incidence would be underestimated, and the estimate of the impact on syphilis incidence 
somewhat exaggerated.
The above observations may imply some inaccuracy in the impact estimate for syphilis 
incidence.
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Active syphilis: Active syphilis was defined by a combination of a positive RPR and a positive 
TPHA test. Whilst the TPHA test result remains positive after treatment, the RPR test usually 
reverts to negative within a few months (Jaffe and Musher 1990, Larsen et al 1995). However, 
this is not always the case, particularly if treatment is given during the late latent phase (Goeman 
J et al 1995). In such circumstances the RPR titre will usually be low. If cases with low titres arc 
included in the assessment, the measured reduction in the prevalence of active infection will be 
diluted Lower titres therefore underestimate the true impact. This was the main reason why the 
measured impact was found to be smaller for lower titres (table 6.17).
Another reason for this phenomenon may be the fact that the RPR test occasionally leads to false 
positive results, particularly in areas with a high prevalence o f malaria and other parasitic 
infections In such cases titres are usually not high (Jaffe and Musher 1990). If false positive 
RPR test results were observed in conjunction with long-standing positive TPHA results, this 
would exaggerate the prevalence estimate for active syphilis at low RPR titres in both arms of 
the trial The measured impact would be reduced, because persons with active infection would 
present a smaller proportion of overall RPR-positive individuals
On the other hand, the RPR titre in persons with untreated long-standing latent infection may 
also decrease to lower levels (Goeman ct al 1995). This would result in an underestimate of the 
prevalence o f active syphilis in both trial groups, if only higher titres are included However, 
because long lasting latent cases of syphilis are not associated with symptoms, it is unlikely that 
this would lead to a differential effect between the two groups, and therefore it is unlikely that the 
impact estimate would be biased in cither direction.
The determination o f new cases of active syphilis was based on persons who were RPR negative 
and cither TPHA positive or negative at baseline For this reason, the denominator for this 
category is larger than for TPHA seroconversion (table 6.17). Conversely, the number of new 
cases o f active syphilis is much smaller than the total number o f active syphilis cases, because 
even at higher titres there would be cases who were already infected at baseline and who would 
therefore be excluded from the new cases (it is likely that these cases experienced fresh infections 
during the follow-up period which boosted their RPR titre, since all RPR+ cases observed during 
cohort recruitment had been treated on the spot by the survey team) The impact on the 
prevalence of new cases was substantial but because the total number o f new cases was
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comparatively small for the reason given above, the impact estimate was not quite significant at 
the 5% level.
Tests employed fo r  the diagnosis o f  gonococcal and chlamydial infections in men
Probably the most sensitive and specific tests available for the diagnosis o f infections with 
Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) are the polymerase and the 
ligase chain reactions (PCR and LCR). For logistical and financial reasons, it was not possible 
to make use of these methods in the trial Gonococcal culture was also not performed in the main 
cohort, again for logistical reasons. The tests used (urethral swabs with microscopy on Gram- 
stained smear to identify intracellular gram-negative diplococci for the diagnosis of NG, and 
antigen detection assay for the diagnosis o f CT) have a comparatively high specificity, but are 
likely to miss some mild infections (Mardh and Danielsson 1990).
Furthermore, it was not possible to perform urethral swabbing on all men m the cohort. Men 
were only swabbed if they complained o f urethral symptoms, if a discharge was observed by the 
clinician, or if the LED test was positive. The last o f  these criteria provided most o f the
specimens.
The infection rates seen therefore represented only minimal prevalences o f NG and CT infection. 
There is. however, no reason to  assume that the prevalence underestimate was differential in the 
two groups of the trial.
7 .5 .3  V a lid i ty  o f  im p a c t  e s t im a te s
The observed differences in the prevalences of active syphilis and male urethritis were 
substantial, and were significant both on crude and adjusted analysis It is therefore unlikely that 
chance could explain these reductions.
As discussed for the impact on HIV, however, there might be sources of bias which may explain 
the observed reduction in syphilis and symptomatic urethritis, or the lack o f reduction in the 
other STD parameters.
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Any lack o f  comparability between intervention and comparison arms should have been 
minimised by the matching and randomisation process. Nevertheless there were differences in 
some of the risk factors at baseline which could potentially influence the transmission of STDs. 
These were identical with those for HIV infection, and are discussed in section 7.4 The 
differences were adjusted for in the impact analysis for all STD parameters measured in the mam 
cohort study.
The prevalence of NG and/or CT infection, both symptomatic and asymptomatic, was lower in 
intervention communities (table 6.12). This might have exaggerated the impact if there had been 
any.
In the impact analysis for each STD parameter, adjustment was made for baseline differences in 
the parameter under consideration. For symptomatic urethritis, the baseline prevalence of all 
urethritis was used for adjustment, since the numbers o f cases o f  symptomatic urethritis were 
small
Some other potential sources of bias were the same as for HIV incidence: losses to follow-up and 
contamination As discussed in 7.4, losses to follow-up were not differential between the two 
trial arms, and contamination was minimal. It is unlikely that these factors influenced the impact 
results.
The potential effects o f misclassification due to the diagnostic tests used arc discussed in section
7.5.2 The net effect of the various misclassifications is likely to have been a modest 
underestimation of the impact o f the intervention on STDs.
An alternative explanation for the observed impact (or lack o f impact) could be differential 
changes in sexual behaviour in the two trial arms, as discussed for HIV infection. However, as 
described in section 6 4.6, the sexual behaviour survey did not show any evidence for such 
changes
It can be concluded that the observed estimates for the impact o f the intervention on STDs were 
valid, and that it is unlikely that the reductions in syphilis and symptomatic urethritis observed in 
the main cohort were due to changes in sexual behaviour or other sources of bias
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7.5.4 Interpretation of the STD impact results
Self-reported STD symptoms
The intervention showed no impact on the incidence o f self-reported symptoms in the past year 
in either men or women. In the case of women, it is well known that there is a poor correlation 
between symptoms and the presence o f STD pathogens (Mulder 1993, Mosha et al 1993, 
Mayaud et al 1997). In the case of men, it seemed more surprising that improved STD case 
management services failed to reduce the incidence o f reported STDs. There are several 
explanations for this observation.
It is likely that the health educational campaigns conducted at community level as part o f the 
intervention and the improved health education given to individual patients resulted in increased 
awareness of STDs and thus differential recall bias in the intervention communities. Men (and 
women) in intervention communities may therefore have reported symptoms more often at the 
follow-up survey, so that the true impact, if  any, may have been masked.
A further explanation is that the intervention was more likely to influence STD duration and 
prevalence than incidence, and that the incidence of self-reported STD episodes did not show a 
reduction therefore.
There were also many cases who reported symptoms but in whom no STD pathogen could be 
found For example, only 27%  of men in the main cohort who reported discharge and in whom 
this discharge was clinically confirmed, had a proven gonococcal and/or chlamydial infection, 
and of the men who reported discharge, and in whom this discharge could not be clinically 
confirmed, only 13% had a proven infection (Grosskurth et al 1996). Similar observations were 
made in an independent cross-sectional survey conducted in another large rural community in 
Mwanza Region in 1996, where pathogens were found in only 17% o f  304 men complaining of 
urethral symptoms (Buve et al 1996). The same study revealed that urethral symptoms were 
significantly associated with Schistosoma haematobium infection, which is endemic in the region 
(OR 2.7, p=0.02) An STD intervention cannot have an impact on schistosomiasis In the trial, 
the prevalence of schistosomiasis was not investigated, but it is likely that the failure of the 
intervention to show an impact on reported STD symptoms in men was due partly to the 
presence o f this parasitic infection.
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Urethritis in men
The baseline survey revealed that asymptomatic gonococcal and chlamydial infections were 
highly prevalent in this rural population, and that many more infections were asymptomatic than 
symptomatic (Grosskurth et al 1996, Mayaud et al 1995). This means that there is a large 
reservoir o f  asymptomatic infections in both men and women which keeps STDs in the 
population at a high level of endemicity. For example, 85% o f  gonococcal and chlamydial 
infections in men, and about 90% of the cases o f urethritis were asymptomatic at baseline (table 
6 . 12) .
It is thus unlikely that an intervention which is designed to improve the management of 
symptomatic cases, and which only reaches a small proportion o f  sexual partners, can have a 
significant impact on the overall prevalence and incidence of urethral infections.
However, the situation was different for symptomatic cases of proven urethritis. A reduction of 
about 50% was observed. This observation suggests that the timely treatment o f symptomatic 
cases in the intervention communities shortened the duration o f these infections and thus reduced 
their prevalence. The (non-significant) reduction in prevalence o f  overall urethritis was mostly 
accounted for by this reduction in symptomatic urethritis.
Unexpectedly, a similar reduction in the prevalence o f symptomatic infection with Neisseria 
gonorrhoeae and Chlamydia trachomatis could not be demonstrated. It seems that a substantial 
proportion o f symptomatic urethritis was caused either by non-specific infections, or by specific 
infections where the urethral pathogens were missed due to the comparatively low sensitivity of 
the diagnostic tests used in this trial, whilst microscopy was sufficiently sensitive to demonstrate 
the accompanying increase in polymorpho-nuclear cells (see section 7.4.2). Failure to show a 
reduction o f symptomatic gonococcal and chlamydial infection may have been due also to small 
numbers and the correspondingly low power of the study to detect such a reduction.
Syphilis
The impact of the intervention on syphilis was considerable There was a 36% reduction of 
syphilis incidence, though statistical significance was not reached. The prevalence of active
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syphilis was significantly reduced by up to 46%, depending on the cut-off chosen for the RPR 
titre, and the prevalence of new cases of active syphilis was significantly reduced by 44%. Issues 
o f potential biases caused by the tests used in this study are discussed in section 7.5.2.
The prevalence and the incidence o f  syphilis in this population are high (table 6.17). It is possible 
that the overall incidence increased in both groups o f communities during the trial as comparared 
to the time before the trial, since the treatment o f  all RPR positive individuals at baseline may 
have rendered many persons with latent infections susceptible to new infections.
Prevalence o f  STDs in antenatal clinic attenders
The failure of the intervention to show any impact on the prevalence o f STDs in the antenatal 
population after one year of intervention is disappointing What were the possible reasons?
As mentioned above, cervical infections due to Neisseria gonorrhoeae (NG) and Chlamydia 
trachomatis (CT) are frequently asymptomatic (Holmes 1990), making it unlikely for an 
improved case management intervention to have any impact. The prevalence o f  NG and CT 
infection was identical in those who did and those who did not complain of vaginal discharge 
(Mayaud 1995).
Trichomonas vaginalis infection is frequently symptomatic. Even for this condition no reduction 
could be achieved It is possible that this is due to inadequate treatment seeking behaviour. 
Vaginal discharge is so common that it is often regarded as something inevitable or even 
‘normal’ (Mulder 1993). In the ANC attender study, many women, when directly prompted, 
admitted to vaginal discharge, but only few mentioned this complaint spontaneously (Philippe 
Mayaud, personal communication 1994).
This is consistent with the observation that only a minority o f the many women in the community 
with symptoms of vaginal discharge voluntarily presented to a health facility For example, only 
46% of the 383 women who reported discharge during the past 2 years at the follow-up survey of 
the main cohort reported that they had sought treatment from a health facility This lack of 
appropriate treatment seeking behaviour did not differ significantly between intervention and
The intervention led to a substantial and significant impact on active syphilis in the main cohort. 
Why did it not show a similar impact among antenatal clinic attenders? In the case of antenatal 
clinic attenders, a cohort was not followed, and different women were seen at follow-up than at 
baseline. Whereas in the main cohort, RPR-positive subjects were all treated at baseline, the 
antenatal clinic attenders seen in the second cross-sectional survey had not been treated in this 
way. Thus at the second survey in the main cohort, most subjects presented infections which they 
acquired during the past two years, whereas many o f the seropositive results in antenatal women 
will have been due to long-standing infections. This observation emphasises the importance of 
regular antenatal syphilis screening and treatment. Although this measure has been promoted for 
a considerable time, it is not routinely performed in most parts o f  Africa (Hira et al 1990, 
Temmcrman et al 1993), including Mwanza Region.
comparison communities (50% versus 43%, p=0.17), and did not show an improvement from
baseline (46% versus 51%).
7 .6  I m p l ic a t io n s  o f  th e  t r i a l
7 .6 .1  I m p lic a t io n s  f o r  th e  c h o ic e  o f  S T D  c o n t r o l  s t r a te g ie s
In conclusion, the intervention for the improved case management o f symptomatic STDs 
achieved a substantial and significant impact on syphilis in the general population and on 
symptomatic urethritis in men
Unfortunately, the intervention failed to show any impact on STDs in women, partly because 
these infections were asymptomatic and partly because it was not possible to improve the 
treatment seeking behaviour o f women for symptomatic infections.
It follows that only through comprehensive screening programmes can a reduction in the 
prevalence o f STDs be achieved in the female population. Unfortunately even screening for 
syphilis is not yet routinely practised in most antenatal clinics in sub-Saharan Africa, as 
discussed earlier.
Cheap and simple screening tests for NG and CT infections are not available. To overcome this 
problem, attempts have been made to identify women at risk for such infections through a simple
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questionnaire focusing on demographic and other risk factors Unfortunately, this attempt was 
not very successful: the sensitivities and specificities o f  the risk scores developed to detect NG or 
CT cervicitis ranged between 50%  and 70% (Vuylsteke et al 1993i, Mayaud et al 1995).
Another option to reach asymptomatic patients or those who do not seek treatment on their own, 
would be the treatment o f sexual partners. However, in this trial the treatment o f  only 35% of 
partners of men with STDs and only 33% of the partners of women with STDs was recorded
Thus the development of simple and cost-effective screening tests remains an urgent priority; and 
once such tests become available, screening programmes should be launched on a large scale in 
addition to programmes for the improved management o f symptomatic STDs.
Presumptive treatment of either the whole population or of populations at high risk have been 
suggested (Over and Plot 1993, Wawer et al 1996). However both approaches have not yet been 
validated sufficiently, are likely to be expensive, and are still controversial. Preliminary results 
from the trial in Rakai show that STD prevalences can be significantly and substantially reduced 
through mass treatment. For example, Trichomonas vaginalis infection in women was reduced 
from 25% in intervention communities to 9% in intervention communities (RR 0.4, 95%CI 0.3 - 
0.5), and a significant impact on syphilis was suggested by declining RPR titres (Wawer et al 
1996) Data on the impact on HIV transmission are not yet available.
These initial successes argue for more intensive research on mass treatment and presumptive 
treatment, in different settings and under less than optimal conditions Because mass treatment is 
very expensive, it has also been suggested that the impact of a single round of mass treatment in 
the general population in combination with improved case management services should be 
investigated (Hayes et al 1997).
7 .6 .2  Im p lic a tio n s  f o r  A I D S  c o n t r o l  p r o g r a m m e s
This intervention achieved a substantial reduction in the incidence of HIV infection in 
conjunction with a major reduction of the prevalence of active syphilis, and o f symptomatic 
urethritis in men It had little impact on asymptomatic infections These observations suggest that 
symptomatic STDs arc of particular importance for HIV transmission The study does not allow
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us to determine whether the ulcerative or non-ulcerative infections played the more important 
role Whilst the co-factor effect o f genital ulcers may be particularly high (Hayes et al 1995i), 
the attributable risk o f HIV infection due to non-ulcerative STDs is considerable and may even 
be higher, since these STDs are usually much more prevalent (Laga et al 1993). The observed 
impact on STDs in the Mwanza trial seems to be consistent with the suggestion that both types 
o f STDs are important for HIV transmission.
Rational health policy decisions depend on reliable data on the cost-effectiveness of different 
health interventions. Because o f the urgency o f the AIDS epidemic, interventions had to be 
launched without the benefit of such data The Mwanza trial has helped to close this gap
How gencralisablc are the trial results to other rural populations in Africa? With an adult HIV 
prevalence o f around 4% and an annual HIV incidence of around 1%, the rural population of 
Mwanza Region is fairly typical of many other parts o f sub-Saharan Africa. STD prevalences in 
Mwanza Region were high, but this is also the case in many other parts o f the continent, as has 
been described in section 2.1.4
The intervention strategy was chosen for its potential replicability in low-income countries, and 
was designed to be implemented through routine primary health care services
In conclusion, the trial has provided evidence to justify the allocation of substantial resources to 
the control o f STDs through improved treatment services in countries with high STD 
prevalences. This includes most countries in Africa, but is probably highly relevant for some 
developing countries in Asia and Latin America as well
It is therefore suggested that STD control should assume a key place within AIDS control 
programmes in developing countries, together with health promotion for risk reduction and other 
measures which have a proven efficacy to contain the AIDS epidemic.
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Chapter 8 Conclusions and recommendations
8.1 C o n c lu s io n s
Public health importance o f  H IV  infection and STDs
The incidence of HIV infection in the absence o f the STD intervention was considerable in the 
adult population in Mwanza Region at around 1% per year. It was particularly high in young 
women. STDs were highly prevalent and represented an important public health problem.
Impact o f  the intervention
The improvement o f STD treatment services in Mwanza Region led to a reduction in HIV 
incidence in the study population o f 43%. After adjustment for possible confounding factors, the 
reduction was 38% (95% Cl = 15% - 55%).
The intervention also had a considerable impact on STDs: The prevalence of active syphilis was 
significantly reduced by 11% - 46%, depending on the cut-off chosen for the rapid plasma reagin 
(RPR) test. Symptomatic urethritis in men was reduced by about 50%.
No impact was observed on the prevalence o f asymptomatic urethritis in men, suggesting that 
symptomatic STDs seem to be o f  particular importance for HIV transmission.
There was no impact on cervical or vaginal infections in pregnant women, whether symptomatic 
or asymptomatic, suggesting that comprehensive screening programmes would be needed to 
achieve a reduction in the prevalence of STDs in the female population.
STD H IV  co-factor hypothesis
The trial provided additional evidence for the hypothesis that STDs enhance the transmission o f 
HIV infection, and that the control of STDs can substantially reduce HIV transmission in 
populations where STDs are highly prevalent. The results are consistent with observational
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studies and studies demonstrating increased HIV shedding in cervical or vaginal secretions, or in 
semen o f HIV infected persons in the presence o f bacterial STDs, and a decrease in viral load in 
semen after the treatment o f urethritis. Taking all these findings together, the STD/HTV co-factor 
hypothesis has now been confirmed beyond reasonable doubt.
Design and operational performance o f  the intervention
These results were achieved through improved STD services which were integrated into the 
existing primary health care system. Syndromic case management as recommended by WHO and 
adopted by the Government of Tanzania, was shown to be feasible and effective. The study 
showed that a reference clinic and laboratory are required to monitor the antibiotic susceptibility 
of Neisseria gonorrhoeae. It was shown that the referral o f STD patients leads to low cure rates, 
because many patients are lost to follow-up.
A reliable supply o f drugs and frequent support supervision with a strong in-service training 
component were essential to achieve satisfactory performance o f health services. Factors which 
seem to impair the performance of health workers include time pressure and difficult socio­
economic conditions
Policy implications
With respect to the control of both STDs and HIV infection, the trial has provided strong 
evidence to justify the allocation of substantial resources to the control o f symptomatic STDs 
through improved treatment services in countries with high STD prevalences.
An intervention aimed at improving STD case management through the official health sector will 
be sustainable only if the health services are functional For example, serious underpayment of 
health workers is a major obstacle for the improvement o f  health services including STD 
treatment services It is therefore recommended that the introduction of improved STD services 
should be embedded in measures to improve the situation o f  health workers and the quality of 
health services in general, wherever this is necessary.
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8.2 Recommendations
Recommendations with respect to A ID S  control
Interventions to reduce STDs should form an integral part o f AIDS control programmes, 
particularly in populations with high STD prevalences. Such interventions should be 
complemented by health promotion aiming at a decrease o f risky sexual behaviour, and other 
measures of proven efficacy to contain the AIDS epidemic.
Recommendations with respect to strategies fo r  STD control
Interventions aimed at a reduction o f  symptomatic STDs should be a priority.
STD case management services should be integrated into the existing primary health care 
structure wherever possible.
The s>ndromic approach for STD diagnosis and case management is preferred whenever other 
diagnostic methods are not routinely available at low cost.
Regular and frequent support supervision visits to health workers are absolutely essential for the 
success of the control programme.
STD patients should be referred to higher levels o f care only under exceptional circumstances. 
Instead, health care facilities and - i f  existent in the community- private providers should have 
the capacity for second and third line STD treatment, so that all necessary options are available 
at the place o f the first encounter between the STD patient and the health system.
Recommendations fo r  future research
The size of the reduction in STD prevalence and incidence which can be achieved through 
improved STD case management depends on the size o f the co-factor effect, on the initial 
prevalences o f STDs and HIV infection in the community, the proportion of STDs which arc
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asymptomatic, the treatment seeking behaviour o f the population, the compliance of patients, the 
proportion o f partners which can be reached and treated, the effectiveness o f the drugs used, and 
the performance o f the health workers involved. It is therefore likely that the same type of 
intervention may have a greater or lesser impact in other settings. It would be of interest to 
compare the results o f the three trials in East Africa with the help o f a computer simulation 
programme, in order to arrive at more reliable predictions o f how to optimise an STD 
intervention for HTV prevention in different environments.
The development o f simple and cost-effective screening tests, particularly for the diagnosis of 
STDs in women, remains an urgent priority. Once such tests become available, screening 
programmes should be piloted, and their impact evaluated in randomised controlled trials. If  their 
cost-effectiveness can be proven, screening programmes should be launched on a large scale in 
addition to interventions for the improved management o f  symptomatic STDs.
The control o f STDs in core groups may be a particularly effective strategy for HIV prevention. 
STD control programmes should be established in sex workers and other high risk behaviour 
groups, and their impact on the prevalence of STDs and the incidence o f HIV infection in the 
general population should be rigorously evaluated, for example through a randomised controlled 
trial.
The mass treatment o f STDs may possibly represent a promising option for HIV prevention in 
the general population A randomised controlled trial should be performed to investigate the 
impact o f a replicable strategy, for example the combination of a single round o f mass treatment 
with improved STD case management services Such a trial should be conducted in a population 
with high STD prevalences and an immature HIV epidemic, marked by increasing HIV 
prevalences The reduction in STD prevalences, and the time taken for prevalences to return to 
their original level, should be recorded
The Mwanza trial has demonstrated high STD and HIV prevalences in adolescents, particularly 
in girls and young women. The design and implementation of appropriate interventions to 
improve the sexual and reproductive health of adolescents through educational programmes and 
improved access to health services is of high priority. So far there are no data on the efficacy of 
such interventions in reducing HIV incidence. Trials o f such interventions are urgently needed
211
Reference!!
Adler MW: Sexually transmitted disease control in developing countries. Genitourin Med 1996; 72:83- 
88
Adler M, Foster S, Richens J, Slavin H: Sexual health and care: Sexually transmitted infections. 
Guidelines for prevention and treatment. ODA Health and Population. Occasional Paper; London, ODA
1996
AIDSCAP/FH1, National Reference Centre for STDs of the South African Institute for Medical 
Research, Institute of Tropical Medicine Antwerp, Harmony Hospital, Virginia, SA: Periodic 
presumptive treatment of women at high risk, an intervention to reduce the prevalence of curable STDs 
in a South African Mining Community: Project final report 1997
Arya OP, Nsanzumuhire H, Taber SR: Clinical, cultural, and demographic aspects of gonorrhoea in a 
rural community in Uganda Bull WHO 1973; 49: 587-595
Arya OP: Endemic trcponcmatoses In: Cook GC: Manson's Tropical Diseases Saunders, London, 20th 
edition, 1996
Asnmwe-Okiror G, Opio AA, Musinguz.i J, Madraa E, Tembo G, Caracl M: Change in sexual 
behaviour and decline in HIV infection among young pregnant women in urban Uganda AIDS 1997; 
11: 1757-1763
Asuzu MC, Ogubanjo BO, Ajayi IO, Oyediran ABO, Osoba AO: Contact tracing in the control of STD 
in Ibadan, Nigeria. Br J Vener Dis 1984; 60: 114-116
Bagarukayo H, Babishangirc B, Shuey D: Impact of a sex education programme in Kabalc District, 
Uganda IXth International Conference o f AIDS and STD in Africa, Kampala, Uganda 1995, abstract 
WcD858
Bagenda D, Mmiro F, Mirembe F, Nakabilo, Mugenyi D, Musaka L: HIV-1 scroprcvalence rates in 
women attending prenatal clinics in Kampala, Uganda Presentation at the IXth Inetmational 
Conference on AIDS and STD in Africa, Kampala, Uganda 1995, abstract M0COI6 
Barongo L, Borgdorff M, Mosha F, Nicoll A, Grosskurth H, Senkoro K, Newell J, Changalucha J, 
Klokkc A, Killewo J, Vclcma J, Hayes R. Dunn D, Muller L, Rugcmalila J: The epidemiology of HIV-1 
infection in urban areas, roadside settlements and rural villages in M wan/a Region, Tanzania; AIDS
1992,6 1521 - 1528
212
Barre-Sinoussi F, Chermann JC, Rcy F, Nugeyre MT, Chamaret S, Gruest J, Daguet C, Axler-BIin C, 
Verinez-Brun F, Rouzioux C, Rozenbaum W, Montagnier L et al: Isolation of a T lymphotropic 
retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220: 
868-871
Barreto J, Liljestrand J, Palha-de-Sousa C: HIV-1 and HIV-2 antibodies in pregnant women in the City 
of Maputo, Mozambique. A comparative study between 1982/1983 and 1990. Scand J Infect Dis. 1993; 
25(6): 685-8
Bastos dos Santos R, Folgosa EM, Fransen L: Reproductive tract infections in Mozambique: a case 
study of integrated services. In: Germain A et al (eds.): Reproductive tract infections. Plenum Press, 
New York, 1992
Belsey MA: The epidemiology of infertility: a review with particular refemce to sub-Saharan Africa. 
Bull WHO 1976, 54:319
Bontinck M. Bruenger W, Fransen L, Kataaha P, Okware S, Watson Williams J, Winsbury R: Safe 
blood in developing countries The lessons from Uganda European Commission. Directorate for 
Development, Brussels. 1995
Bowie WR: Urethritis in males In: Holmes KK, Mardh P, Sparling PH, Wiesncr PJ (eds.): Sexually 
transmitted diseases. 2nd cd New York: McGraw-Hill, 1990
Brabin L. Kemp J. Obungc OK, Ikimalo J, Dollimore N, Odu NN. Hart CA, Briggs ND: Reproductive 
tract infections and abortion among adolescent girls in rural Nigeria Lancet 1994; 344: 300-304
Brunham RC. Holmes KK, Embrec JE: Sexually transmitted diseases in pregnancy. In: Holmes KK, 
Mardh P, Sparling PH. Wiesner PJ (cds ): Sexually transmitted diseases. 2nd cd New York: McGraw- 
Hill, 1990
Brunham RC: The concept of core and its relevance to the epidemiology and control of sexually 
transmitted diseases. Sex Transm Dis 1991 (April): 67-68
Bureau of Statistics. Presidents Office and Planning Commission: Population Census 1988, Mwanza 
Regional Profile, Dar es Salaam, Tanzania 1992
Bureau of Statistics, Presidents Office and Planning Commission, and Macro International 
Incorporation: Tanzania Demographic & Health Survey 1996, Calvcrton, Maryland, August 1997, Dar 
cs Salaam. Tanzania and Calverton, Maryland. USA 1997
213
Buve A, Laga M, Crabbe F, Vuylsteke B, Van Lerberghe W: A model for the operational assessment of 
case detection and management o f  STDs. VUIth International Conference on AIDS in Africa, 
Marrakech. 1993, abstract WRT 015.
Buve A, Mosha F, Watson-Jones D, Mugeye K, West B, Gabone R, Gavyole A, Todd J, Hayes R, 
Grosskurth H, Mabey D, Laga M, Mayaud P: Is asymptomatic urethritis in men an obstacle to effective 
STD control? A community study in  Mwanza, Tanzania. XIth International Conference on AIDS, 
Vancouver, Canada, July 7-12, 1996, abstract Mo.C.341.
Bucyendore A, Van de Perre P, Karita E, Nziyumvira A, Sow I, Fox E: Estimating seroincidence of 
HIV-1 in the general adult population in Kigali, Rwanda. AIDS 1993; 7: 275-7
Cameron DW, Simonsen JN, D'Costa LJ, Ronald AR, Maitha GM, Gakinya MN, Cheang M, Ndinya- 
Achola-JO, Piot P, Brunham RC, Plummer FA: Female to male transmission of human 
immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet. 1989 Aug 19; 2(8660): 
403-7.
Chilongozi DA, Daly CC, Franco L, Liomba NG, Dallabetta G: Sexually transmitted diseases: a survey 
of case management in Malawi. Int J STD & AIDS 1996; 7: 269-275
Clavel F. Guetard D, Brun-Vezinet F  et al: Isolation of a new human retrovirus from West African 
patients with AIDS. Science 1986; 233: 343-6
Clements ML: Clinical trials of human immunodeficiency vims vaccines. In: DeVita VT, Heilman S, 
Rosenberg SA: AIDS; Lippincott-Raven, Philadelphia. 4th ed., 1997
Clemetson DBA. Moss GB. Willerford DM, Hensel M, Emonyi W, Holmes KK, Plummer F, Ndinya- 
Achola J, Roberts PL. Hillier S, Kreiss JK: Detection of HIV DNA in cervical and vaginal secretions. 
JAMA 1993; 269: 2860-2864
Cohen MS, Hoffman IF, Royce RA, Kazembe P, Dyer JR, Daly CC, Zimba D, Vemazza PL, Maida M. 
Fiscus SA, Eron JJ: Reduction of concentration of HIV-1 in semen after treatment of urethritis: 
implications for prevention of sexual transmission of HIV-1. Lancet 1997; 349: 1868-1873
Corey L: Genital herpes. In: Holmes KK, Mardh P, Sparling PH, Wiesner PJ (eds ): Sexually- 
transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990
Cowan F: The role and effectiveness o f  partner notification in STD control: a review. GUM 1996; 72: 
247-52
214
Dangor Y, Ballard R, Exposto FL, Fehler G, Miller SD, Koomhof HJ: Accuracy of clinical diagnosis of 
genital ulcer disease. Sex Transm Dis 1990; 17:184-189
D ’Costa LJ, Plummer FA, Bowmer 1, Fransen L, Piot P, Ronald AR, Nsanze H: Prostitutes are a major 
reservoir of sexually transmitted diseases in Nairobi, Kenya. Sex Transm Dis 1985; 12: 64-67
De Cock KM, Adjorlolo G, Ekpini E, Sibailly T, Kouadio J, Maran M, Brattegaard K, Vetter-KM, 
Doorly-R, Gayle-HD: Epidemiology and transmission of HIV-2 - why there is no HIV-2 pandemic. 
JAMA 1993; 270: 2083-2086
Denis F, Barin F, Gershy-Damet G, Rey JL, Lhuillier M, Mourner M, Leonard G, Sangare A.Goudcau 
A, M'Boup S: Prevalence of human T-lymphotropic retroviruses type III (HIV) and type IV in Ivory 
Coast. Lancet 1987 I: 408-11
De Schryver A, Meheus A: Epidemiology of sexually transmitted diseases: the global picture. Bull 
WHO 1990; 6 8 : 639-654
De Schryver A, Meheus A: Sexually transmitted diseases in Africa Africa Focus 1992; 6:45-71
de Vincenci I, Mertens T: Male circumcision: a role in HIV preventuion? AIDS 1994; 8 : 153-160
Donner A, Donald A: Analysis of data arising from a stratified design with the cluster as unit of 
randomisation. Stat Med 1987; 6:43-52
Easmon CSF, Hay PE, Ison CA: Bacterial vaginosis: a diagnostic approach Genitourin Med 1992; 
68:134-138
Ettiegne-Traore V, Ghys PD, Diallo MO, Yeboue KM, N’Gbichi JM, Soroh D, Radio JC, Coulibaly IM, 
Greenberg AE, Laga M: HIV seroincidence and STD prevalence during an intervention study among 
female sex workers in Abidjan, Cote D’Ivoire: preliminary findings. Xlth International Conference on 
AIDS, Vancouver, Canada, July 7-12, 1996, abstract Mo.C.442
Fox E. Haberbcrger RL. Abbatte EA, Said S, Polycarpe D, Constantine NT: Observations on sexually 
transmitted diseases in promiscuous males in Djibouti. J Egypt Public Health Assoc 1989; 64: 561-569
Fransen L: Can STD control contribute to the control of HIV infection in developing countries? Meet 
the experts session. IXth International Conference on AIDS, Berlin 1993
215
French JI, McGregor: Bacterial vaginosis: history, epidemiology, microbiology, sequelae, diagnosis, and 
treatment; in: Borchardt KA, Noble MA: Sexually transmitted diseases, CRC Press, New York, 1997
Friedmann PS, Wright DJM: Observations on syphilis in Addis Ababa. Prevalence and natural history. 
Br J Vener Dis 1977: 276-280
Friedmann-Kien AE: Disseminated Kaposi's sarcoma syndrome in young homosexual men. J Am Acad 
Dermatol 1981; 5: 468-471
Gail MH, Mark SD, Carroll RJ, Green SB, Pee D: On design considerations and randomisation-based 
inference for community intervention trials. Stat Med 1996; 15: 1069-92
Gelmon LJ, Moses S: Prevention and treatemnt of sexually transmitted diseases in developing countries. 
Curr Opin Inf Dis 1994; 7: 48-54
Goeman J, Kivuvu M, Nzila N, Behets F, Edidi B, Gnaore E, Van-Dyck E, St.-Louis M, Piot P, Laga 
M: Similar response to conventional therapy for syphilis among HIV positive and HIV negative women. 
Genitourin Med 1995; 71:275-9.
Gilson L, Mkanje R, Grosskurth H, Mosha F, Picard J, Gavyole A, Todd J, Mayaud P, Swai R, Fransen 
L. Mabey L, Mills A, Hayes R: Cost-effectiveness of improved treatment services for sexually 
transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. The Lancet 1997; 
350: 1805-09
Gottlieb MS, Schroff R, Schankler HM et al: Pneumocystis carinii pneumonia and mucosal candidiasis 
in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N E J 
Med 1981; 305:1425-1431
Grosskurth H, Mayaud P, ka-Gina G, Mosha F, Todd J: Risk assessment for the diagnosis of sexually 
transmitted diseases. In: Prevention and management of sexually transmitted diseases in Eastern and 
Southern Africa: current approaches and future directions. NARESA Monograph No.3: Network of 
AIDS Researchers in South and East Africa (NARESA), Nairobi, 1994
Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K, Mayaud P, Changalucha J, Nicoll 
A, ka-Gina G, Newell J, Mugeye K, Mabey D, Hayes R: Impact of improved treatment of sexually 
transmitted diseases on HIV Infection in rural Tanzania: randomised controlled trial The Lancet 1995; 
346: 530-36.
216
Grosskurth H, Mosha F, Todd J, Senkoro K, Newell, J, Klokke A, Changalucha J , West B, Mayaud P, 
Gavyole A, Gabone R, Mabey D, Hayes R: A community trial of the impact of improved STD treatment 
on the HIV epidemic in rural Tanzania 2. Baseline Survey Results. AIDS 1995; 9: 927-34.
Grosskurth H, Mayaud P, Mosha F, Todd J, Senkoro K, Newell J, Gabone R, Changalucha J, West B, 
Hayes R, Mabey D: Asymptomatic gonorrhoea and chlamydial infection in rural Tanzanian men. 
British Medical Journal 1996; 312: 277-80
Hahn BH, Shaw GM, Arya SK, Popovic M, Gallo RC, Wong-Staal F, Molecular cloning and 
characterization of the HTLV-III virus associated with AIDS. Nature 1984; 312: 166-169
Hayes R (i), Schulz KF, Plummer FA: The cofactor effect of genital ulcers on the per-exposure risk of 
HIV transmission in sub-Saharan Africa. J Trop Med Hyg 1995; 98: 1-8
Hayes R (ii), Mosha F, Nicoll A, Grosskurth H, Todd J, Newell J, Killewo J, Rugemalila J, Mabey D: 
A Community Trial of the Impact of Improved STD Treatment on the HIV Epidemic in Rural 
Tanzania: 1. Design. AIDS 1995; 9: 916-26.
Hayes R, Wawer M, Gray R, Whitworth J, Grosskurth H, Mabey D, and HIV/STD Trials Workshop 
Group: Randomised trials of STD treatment for HIV pretention, report of an international workshop. 
Genitourin Med. 1997; 73: 432-443
Hillier SL: Diagnostic microbiology o f bacterial vaginosis. Am J Obstet Gynecol 1993; 169: 455-459
Hira SK. Bhat GJ, Chikamata DM, Nkowane B, Tembo G, Perine PL, Meheus A: Syphilis intervention 
in pregnancy: Zambian demonstration project. Genitourin Med 1990; 66: 159-164
Holmes KX: Lower genital tract infections in women: cystitis, urethritis, vulvovaginitis, and cervicitis. 
In: Holmes KX, Mardh P, Sparling PH, Wiesner PJ (eds.): Sexually transmitted diseases 2nd cd. New 
York: McGraw-Hill, 1990
Hook EW. Handsfield HH: Gonococcal infections in the adult. In: Holmes KK, Mardh P, Sparling PH, 
Wiesner PJ (eds.): Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990
Jackson DJ. Rakwar JP, Richardson BA, Mandaliya K, Chohan BH, Bwayo-JJ, Ndinya-Achola-JO, 
Martin-HL, Moses S, Kreiss JK: Decreased incidence of sexually transmitted diseases among trucking 
company workers in Kenya: results of a behavioural risk-reduction programme AIDS. 1997; 11: 903- 
909
217
Jaffe HW, Choi K, Thomas PA, Haverkos HW, Auerbach DM, Guinan ME, Rogers MF, Spira TJ, 
Darrow WW, Kramer MA, Friedman SM, Monroe JM, Friedman-Kien AE, Laubenstein LJ, Marmor 
M, Safai B. Dritz SK, Crispi SJ, Fannin SL, Orkwis JP, Kelter A, Rushing WR, Thacker SB, Curran 
JW: National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in 
homosexual men: part 1. Epidemiologic results. Ann Intern Med 1983; 99: 145-51
Jaffe HW, Musher DM: Management of the reactive syphilis serology. In: Holmes KK, Mardh P, 
Sparling PH, Wiesner PJ (eds.): Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990
Kantharaj K, Mertens TE, Smith GD, Mugrditchian D, Van Dam CJ, Radhakrishnan-KM: Sexually 
transmitted disease services in Madras: could their role in AIDS prevention be strengthened? Indian J 
Public Health 1995; 39: 93-9
Kengeya-Kayondo JF, Nabaitu J, Malamba S, Whitworth J: A trial of IEC alone and with improved 
STD care on HIV incidence in Uganda: are study communities comparable? Xlth International 
Conference on AIDS. Vancouver, Canada. July 7-12, 1996. Abstract We.C.3527
Kigadye R, Klokke A, Nicoll A, Nyamuryekung' e K, Borgdorff M, Barongo L, Laukamm-Joslen U, 
Lisekie F, Grosskurth H, Kigadye F: Sentinel surveillance for HIV-1 among pregnant women in a 
developing country: 3 years' experience and comparison with a population serosurvey; AIDS 1993,7: 
849 - 855.
Killewo JZJ. Sandstrom A, Bredberg-Raden U, Mhalu FS, Biberfeld G, Wall S: Incidence of HIV-1 
infection among adults in the Kagera region of Tanzania. Int J Epidemiol 1993; 22: 528-536
Kirkwood R: Essentials of Medical Statistics. Blackwell, Oxford 1988
Kreiss JK. Koech D, Plummer FA, Holmes KK, Lightfoote M, Piot P, Ronald AR, Ndinya-Achola JO, 
D'Costa LJ, Roberts P: AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East 
Africa N Eng J Med 1986; 314 414-8
Kreiss J. Willerford DM. Hensel M, Emonyi W, Plummer F, Ndinya-Achola J, Roberts PL, Hoskyn J, 
Hillier S, Kiviat N. Holmes KK: Association between cervical inflammation and cervical shedding of 
human immunodeficiency virus DNA. J Inf Dis 1994; 170: 1597-1601
Kumar B. Handa S. Dawn G: Syndromic management of genital ulcer disease - a critical appraisal 
Genitourin Med 1995; 71: 197
Laga M, Nzila N, Goeman J: The interrelationship of sexually transmitted diseases and HIV infection: 
implications for the control of both epidemics in Africa. AIDS 1991; 5 (suppl 1): S55-S63
Laga M, Manoka A, Kivuvu M, Maleic B, Tuliza M, Nzila N, Goeman J, Behets F, Batter V, Alary M, 
Heyward WL, Ryder RW, Piot P: Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 
transmission in women: results from a cohort study. AIDS 1993; 7: 95-102
Laga M: Epidemiology and control of sexually transmitted diseases in developing countries. Sex 
Transm Dis 1994; 21 (suppl) S45-S50
Laga M (i), Diallo MO, Buve A: Inter-relationship of sexually transmitted diseases and HIV: where are 
we now? AIDS 1994; 8 (suppl 1): SI 19-S124
Laga M (ii). Alary M. Nzila N, Manoka AT, Tuliza M, Behets F, Goeman J, Stlouis M, Piot P: Condom 
promotion, sexually-transmitted diseases treatment, and declining incidence of HIV-1 infection in 
female Zairian sex workers. Lancet 1994; 344: 246-248
Larsen SA, Steiner BM, Rudolph AH: Laboratory diagnosis and interpretation of tests for syphilis Clin 
Microbiol Rex 1995; 8:1-21
Larson A Social context of human immunodeficiency vims transmission in Africa: historical and 
cultural bases of East and Central African Relations. Rev Inf Dis 1989; 11 (5): 716-731
Latif AS. Katzenstein DA, Bassett MT, Houston S, Emmanuel JC, Marowa E: Genital ulcers and 
transmission of HIV among couples in Zimbabwe. AIDS 1989; 3: 519-523
Leverenz J and Gover B (editors): Rand McNally New International Atlas, Georg Westermann, 
Braunschweig, Germany, 1997
Levi MH: Current concepts in the laboratory diagnosis of gonorrhea. In: Borchardt KA, Noble MA 
Sexually transmitted diseases, CRC Press, New York, 1997
Lind I: Antimicrobial resistance in Neisseria gonorrhoeae. Clin Infect Dis. 1997; 24 Suppl 1: S93-97
Kyungu ME: Condom social marketing and mass media in Zaire. In: Proceedings of the meeting on
effective approaches to AIDS prevention. WHO, Geneva 1992: 15-16
219
Lindstrand A, Bergstroem S, Bugalho A, Zanconato G, Helgesson AM, Hederstedt B: Prevalence of 
syphilis infection in Mozambican women with second trimester miscarriage and women attending 
antenatal care in second trimester. Genitourin Med 1993; 69: 431-433
London School of Hygiene and Tropical Medicine (LSHTM) and African Medical and Research 
Foundation (AMREF): Strategies for the prevention of HIV infection and the enhancement of 
reproductive health among adolescents in rural Tanzania. Proposal for the evaluation an intervention 
programme. LSHTM and AMREF, London and Dar es Salaam, 1996
Lwihula G, Grosskurth H: Peoples perceptions on STDs, their health care seeking behaviour and 
attitudes towards AMREF integrated STD clinics, Mwanza Region, Tanzania, including policy 
implications. Presentation at the VIHth International Conference on AIDS in Africa, Marrakech 1993.
Mabey DCW, Lloyd-Evans NE, Conteh S, Forsey T: Sexually transmitted diseases among randomly 
selected attenders at an antenatal clinic in The Gambia. Br J Vener Dis 1984; 60: 331-336
Mabey DCW, Ogbaselassie G, Robertson JN: Tubal infertility in the Gambia: chlamydial and 
gonococcal serology in women with tubal occlusion compared with pregnant controls. Bull WHO 1985; 
63: 1107
Mabey DCW: Syphilis in sub-Saharan Africa. African J of STD 1986; 2: 61-64
Mabey DCW: Sexually transmitted diseases in developing countries. Trans Roy Soc Trop Med Hyg
1996; 90: 97-9
Mabey D . Richens J: Sexually transmitted diseases excluding HIV. In: Cook GC: Manson’s Tropical 
Diseases. Saunders, London. 20th edition, 1996
Magazani K, Laleman G, Perriens IH: Low and stable HIV seroprevalence in pregnant women in Shaba 
province, Zaire I Acquir Immune Defic Syndr 1993; 6: 419-23
Mann J, Taramola D, Netter T (eds): AIDS in the World. Harvard University Press, ISBN 0-674-01266- 
6, Cambride, Massachusetts, USA, 1992
Mardh PA. Daniclsson D: Neisseria gonorrhoeae. In: Holmes KJC, Mardh P, Sparling PH, Wiesner PJ 
(eds ): Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill. 1990
220
Mayaud. ka-Gina G, Grosskurth H: STD case management. In: Prevention and management of sexually 
transmitted diseases in Eastern and Southern Africa: current approaches and future directions. NARESA 
Monograph No.3: Network of AIDS Researchers in South and East Africa (NARESA), Nairobi, 1994
Mayaud P, Grosskurth H, Changalucha J, Todd J, West B, Gabone R, Senkoro K, Rusizoka M, Laga M, 
Hayes R, Mabey D: Risk assessment and other screening options for gonorrhoea and chlamydial 
infections in women attending rural Tanzanian antenatal clinics. Bulletin of the World Health Organ
1995, 73 (5):621-630
Mayaud P (i), Uledi E, Comelissen J, ka-Gina G, Todd J, Rwakatare M, West B, Kopwe L, Manoko D, 
Grosskurth H, Hayes R, Mabey D: Risk scores to detect cervical infections urban antenatal clinic 
attenders in Mwanza, Tanzania. Submitted to Genitourinary Medicine, suppl. 1997
Mayaud P (ii), ka-Gina G, Comelissen J, Todd J, Kaatano G, West B, Uledi E, Rwakatare M, Kopwe L, 
Manoko D, Laga M, Grosskurth H, Hayes R, Mabey D: Validation of a WHO algorithm with risk- 
assessment for the clinical management of vaginal discharge in Mwanza, Tanzania. Accepted for 
publication in Genitourin Med 1997
Mbizvo MT, Machekano R, McFarland W, Ray S, Bassett M, Latif A, Katzenstein D: HIV 
seroincidence and correlates of seroconversions in a cohort of male factory workers in Harare, 
Zimbabwe AIDS 1996; 10: 895-901
Meda N, Sangare L, Lankoande S, Sanou PT, Compaore PI, Catraye J, Cartoux M, Soudre RB: Pattern 
of sexually transmitted diseases among pregnant women in Burkina Faso, West Africa. Genitourin Med 
1997; 73: 188-193
Meheus A, Van Dick UJP, Ballard RC, Piot P: Etiology of genital ulcerations in Swaziland. Sex 
TransmDis 1983; 10:33-35
Meheus A: Sexually transmitted pathogens in mother and newborn In: Impact on the fetus of parental 
sexually transmitted disease. Annals of the New York Academy of Sciences 1988, 549: 203-214
Meheus A, Schulz KF, Cates W: Development of prevention and control programs for sexually 
transmitted diseases in developing countries. In: Holmes KK, Mardh PA, Sparling PF, Wiesner PJ: 
Sexually transmitted diseases. 2nd edition, McGraw-Hill, New York 1990
Mcrtens TE, Hayes RJ, Smith PG: Epidemiological methods to study the interaction between HIV 
infection and other sexually transmitted diseases AIDS 1990; 4: 57-65
221
Mertens T, Burton T, Caracl M: Assessment of STD case managment: results of three field tests. IXth 
International Conference on AIDS, Berlin 1993, Abstract WS-D29.1
Mcrtcns T, Burton A: Estimates and trends of the HIV/AIDS epidemic. AIDS 1996; 10 (supplement A):
S221-S228
Miotti PG. Dalabctta G, Ndovi E, Liomba G, Saah AJ, Chiphangwi J: HIV-1 and pregnant women: 
associated factors, prevalence, estimate of incidence and role in fetal wastage in central Africa AIDS 
1990, 4: 733-6
Miyazaki M: Epidemiological characteristics of human immunodeficiency virus type-2 infection in 
Africa |editorial]. Int J STD AIDS 1995; 6(2): 75-80
Morgan D, Maude GH, Malamba SS, Okongo MJ, Wagner HU, Mulder DW, Whitworth JA: HIV-1 
disease progression and AIDS-dcfining disorders in rural Uganda Lancet 1997; 350: 245-250
Moses S, Plummer FA, Ngugi EN, Nagclkcrke NJD, An/ala AO, Ndinya-Achola JO: Controlling HIV 
in Africa: effectiveness and cost of an intervention in a high-frequency STD transmitter core group 
AIDS 1991; 5: 407-411
Mosha F, Nicoll A, Barongo L, BorgdorfT M, Senkoro K, Grosskurth H, Changalusha J, Klokkc A, 
Newell J. Killcwo J. Vclcma J, Muller A. Rugcmalila J, Hayes R, Mabcy D: A population-based study of 
syphilis and sexually transmitted disease syndromes in north-western Tanzania 1. Prevalence and 
incidence; Gcnitourin Med 1993; 69: 415-420,
Munguti. Grosskurth H, Newell J, Senkoro K, Mosha F, Todd J, Mayaud P, Gavyolc A, Quigley M, 
Hayes R Patterns of sexual behaviour in a rural population in North-Western Tanzania Social Science 
and Medicine 1997,44:1553-1561
Mostad SB, Ovcrbaugh J, DcVangc DM, Welch M, Chohan B, Mandaliya K, Nyangc P, Martin H, 
Ndinya-Achola J, Bwayo JJ, Krciss JK: Hormonal contraception, vitamin A deficiency, and other risk 
factors for shedding of HIV-1 infected cells from the ccrvic and vagina. Lancet 1997; 350: 922-927
Muir DG, Bclsey MA: pelvic inflammatory disease and its consequences in the developing world Am I
Obstcl Gynecol 1980; 138 913-926
Mulder D Disease perception and health-seeking behaviour for sexually transmitted diseases In 
Prevention and management of sexually transmitted diseases in Eastern and Southern Africa: current
222
Mulder DW, Nunn AJ, Kamali A, Nakiyingi J, Wagner HU, Kengeya-Kayondo JF: Two-year HIV-1- 
associatcd mortality in a Ugandan rural population Lancet 1994; 343: 1021-1023
Mulder DW, Nunn A, Kamali A, Kengeya-Kayondo J: Decreasing HIV-1 seroprevalence in young 
adults in a rural Ugandan cohort. BMJ 1995; 311: 833-836
Musher DM: Syphilis, ncurosyphilis, penicillin, and AIDS. J Inf Dis 1991;163:1201-1206
Mushinski M: Sexually transmitted diseases: United States 1995. Stat Bull Metrop Insur Co 1997; 78: 
10-17
Mwijarubi E, Grosskurth H, Mayaud P: Integration of STD control into a rural primary health care 
setting: experience from 25 health units in NW-Tanzania. VUIth International Conference on  AIDS in 
Africa, Marrakech, 1993, Abstract
Mwizarubi BK. Mwaijonga CL, Laukamm-Jostcn U, Lwihula G, Outwatcr A. Nyamwaya D: HIV/AIDS 
education and condom promotion for truck drivers, their assistants and sex partners in Tanzania. In: 
Focusing interventions among vulnerable groups for HIV infection: experiences from Eastern and 
Southern Africa Monograph no 2, Network of AIDS Researchers of Eastern and Southern Africa 
(NARESA). Nairobi 1994: 109-118
Nakashima AN. Rolfs RT, Flock ML, Kilmarx P, Greenspan JR: Epidemiology of syphilis in the United 
States. 1941-1993. Sex Trans Dis 1996,23: 16-23
Ndinya-Achola JO, Kihara AN, Plummer FA, Ronald A and Holmes KK. Presumptive specific clinical 
diagnosis of GUD in a primary health care setting in Nairobi. Int J STD & AIDS 1996, 7: 201-205.
Nduba J, Mabcy D: Self -instructional manual on sexually transmitted diseases Nairobi: African 
Medical and Research Foundation; 1991 (English and Kiswahili versions)
Newell J, Scnkoro K, Mosha F, Grosskurth H, Nicoll A, Barongo L, Borgdorff M, Klokkc A, 
Changalucha J, Killcwo J, Vclcma J, Muller A, Rugcmalila J, Mabcy D, Hayes R A population-based 
study of syphilis and sexually transmitted disease syndromes in north-western Tanzania 2 Risk factors 
and health seeking behaviour, Gcnitourin Med 1993; 69: 421 - 426
approaches and future directions. NARESA Monograph No.3: Network of AIDS Researchers in South
and East Africa (NARESA), Nairobi, 1994
223
N’galy B, Ryder R, Kamenga M et al: Suggestion of a stabilisation of HIV infection in selected 
populations in Zaire between 1986 and 1989. Presentation at the Vlth International Conference on 
AIDS, Montreal 1989, Abstract WGO 26
Nicoll A, Timaeus 1, Kigadye RM, Walraven G, Killewo J: The impact of HIV-1 infection on mortality 
in children under 5 years of age in sub-Saharan Africa: a demographic and epidemiologic analysis. 
AIDS 1994; 8: 995-1005
Nkowane BM: Prevalence and incidence of HIV infection in Africa: a review of data published in 1990. 
AIDS 1991; 5 (suppl 1): S7-S15
Noble MA: Sexually transmitted infections associated with Chlamydia trachomatis. In: Borchardt KA, 
Noble MA: Sexually transmitted diseases, CRC Press, New York, 1997
Nzila N, Laga M, Thiam MA, Mayimoma K, Edidi B, Van Dyck E, Behets F, Hassig S, Nelson A. 
Mokwa K. Ashley RL, Piot P, Ryder RW: HIV and other sexually transmitted diseases among female 
prostitutes in Kinshasa. AIDS 1991; 5:715-721
O'Farrell N. Hoosen AA, Kharsany AB, Van den Ende J: Sexually transmitted pathogens in pregnant 
women in a rural South African community. Genitourin med 1989; 65: 276-280
O'Farrell N: Cost-effectiveness of services for sexually transmitted diseases in prevention of HIV-1. 
Lancet 1998; 351: 681-682
Oriel D: Genital human papillomavirus infection In: Holmes KK, Mardh P, Sparling PH, Wiesner PJ 
(eds.): Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990
Osman Ismail S, lama Ahmed H, Abdi Jama M, Omer K, Omer FM, Brundin M, Olofsson MB, 
Grillncr L, Bygdeman S: Syphilis, gonorrhoea and chlamydial infection in a Somali village. Genitourin
Med 1990; 66: 70-75
Osoba AO: A review of sexually transmitted diseases and male infertility in sub-Saharan Africa 
African J STD 1984 (December): 67-70
Over M, Piot P: HIV infection and sexually transmitted diseases. In: Jamison DT, Mosley WH, 
Measham AR. Bobadilla JL, eds : Disease control priorities in developing countries New York: Oxford 
University Press, 1993, 455 - 527
Pantaleo G, Cohen O, Graziosi C, Vaccarezza M, Paolucci S, Demarest JF, Fauci: Immunopathogenesis 
of human immunodeficiency virus infection. In: In: DeVita VT, Heilman S, Rosenberg SA: AIDS; 
Lippincott-Raven, Philadelphia, 4th ed., 1997
Pepin J, Plummer FA, Brunham RC: The interaction of HIV infection and other sexually transmitted 
diseases: an opportunity for intervention. AIDS 1989; 3: 3-9
Penne PL, Osoba AO: Lymphogranuloma venereum. In: Holmes KK, Mardh P, Sparling PH, Wicsncr 
PJ (eds ): Sexually transmitted diseases. 2nd ed New York: McGraw-Hill, 1990
Plot P, Quinn TC, Taelman H, Feinsod FM, Minlangu KB, Wobin O, Mbendi N; Mazebo P, Ndangi K, 
Stevens W: Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet 1984
ii: 65-68
Plot P. Plummer F, Mhalu F, Lamboray JL, Chin J, Mann JM: AIDS: an international perspective 
Science 1988; 239: 537-579
Piot P, Laga M Genital ulcers, other sexually transmitted diseases, and the sexual transmission of HIV 
The first two may be important risk factors for the third BMJ 1989, 298: 623-4
Piol P, Plummer FA Genital ulcer adenopathy syndrome. In: Holmes KK. Mardh P, Sparling PH, 
Wicsncr PJ (eds ): Sexually transmitted diseases. 2nd ed New York: McGraw-Hill, 1990
Piot P. Laga M, Ryder R, Perricns J, Temmerman M, Heyward W, Curran JW: The global 
epidemiology of HIV infection continuity, heterogeneity, and change J Acqu Imm Defic Syndr 1990, 
3 403-12
Piot P and Islam M: Sexually transmitted diseases in the 1990s Global epidemiology and challenges for 
control Sex Transm Dis 1994, 21 Suppl S7 - S13
Plummer FA, Laga M, Brunham RC, Piot P, Ronald-AR, Bhullar-V, Mati-JY, Ndinya-Achola-JO, 
Chcang-M, Nsanzc-H Postpartum upper genital tract infections in Nairobi, Kenya epidemiology, 
etiology, and risk factors J Inf Dis 1987; 156: 92-98
Plummer FA, Simonscn JN, Cameron DW, Ndinya-Achola JO, Kreiss JK, Gakinya MN, Waiyaki P, 
Chcang M, Piot P, Ronald AR, Ngugi E: Cofactors in male-female sexual transmission of human 
immunodeficiency virus type l .J  Infect Dis 1991; 163:233-239
225
Quinn TC, Mann JM, Curran JW, Piot P: AIDS in Africa: an epidemiologic paradigm Science 1986, 
234: 955-963
Rein MF, Mueller M: Trichomonas vaginalis and trichomoniasis. In: Holmes KK, Mardh P, Sparling 
PH, Wiesner PJ (cds ): Sexually transmitted diseases 2nd ed New York: McGraw-Hill, 1990
Ratnam AV, Din SN, Hira SK: Syphilis in pregnant women in Zambia Br J Ven Dis 1982; 58: 355-358
Robinson NJ, Mulder DW, Auvert B, Hayes R: Proportion of HIV infections attributable to othjer 
sexually transmitted diseases in a rural Urgandan population: simulation model estimates. Int J Epidem 
1997; 26: 180-189
Ronald AR, Albritton W: Chancroid and Haemophilus ducreyi. In: Holmes KK, Mardh P, Sparling PH, 
Wiesner PJ (eds ): Sexually transmitted diseases 2nd ed. New York: McGraw-Hill, 1990
Rosenberg MJ. Schulz KF, Burton N: Sexually transmitted diseases in sub-Saharan Africa. Lancet ii 
1986: 152
Santos-Ferrcira MO, Cohen T, Lourenco MH, Almeida MJ, ChamarctS, Montagnier L: A study of 
scroprcvalcncc of HIV-1 and HIV-2 in six provinces of People’s Republic of Angola: clues to the spread 
of HIV infection J Acquir Immune Defic-Syndr 1990, 3: 780-6
Schmutzhard E, Fuchs D, Hcngstcr P, Hausen A, Holbauer J, Pohl P, Rainer J, Rcibneggcr G, 
Tibyampansha D, Werner ER: Retroviral infections (HIV-1, HIV-2, and HTLV-I) in rural north­
western Tanzania Clinical findings, epidemiology, and association with infections common in Africa 
Am J Epidemiol 1989; 130: 309-18
Schulz KF, Cates W, O ’Mara PR Pregnancy loss, infant death, and suffering legacy of syphilis and 
gonorrhoea in Africa Genitourin Med 1987; 63: 320-325
Schulz KF, Murphy FK, Patamasucon P, Mchcus AZ: Congenital syphilis. In: Holmes KK, Mardh P, 
Sparling PH. Wiesner PJ (cds ): Sexually transmitted diseases. 2nd cd New York: McGraw-Hill, 1990
Scrwadda D, Mugcrwa RD, Scwankambo NK, Lwcgaba A, Carswell JW, Kirya GB, Bayley AC, 
Downing RG, Tedder RS, Claydcn SA Slim disease A new disease in Uganda and its association with 
HTLV-III infection Lancet 1985Ü: 849-852
226
Sewankambo N, Tgray RH, Wawer MJ, Paxton L, McNaim D, Mangen FW, Senvadda D, Kjwanuka N, 
Hillier SL, Rabe L, Gaydos CA, Quinn TC, Konde-Lule J: HIV-1 infection associated with abnormal 
vaginal flora morphology and bacterial vaginosis. Lancet 1997; 350: 546-549
Siegal FP, Lopez C, Hammer G, Brown AE, Kornfeld SJ, Gold J, Hassen J, Hirschman SZ, 
Cunningham-Rundles C, Adelsberg BR: Severe acquired immunodeficiency in m ale homosexuals, 
manifested by chronic perianal ulcerative herpes simplex lesions. N Eng J Med 1981; 305: 1439-44
Simonsen JN, Cameron DW, Gakinya MN, Ndinya-Achola JO, D'Costa LJ, Karasira P, Cheang M, 
Ronald AR, Piot P, Plummer FA: Human immunodeficiency virus among m en with sexually 
transmitted diseases. Experience from a center in Africa. N Eng J Med 1988; 319: 274-278
Slutkin G: Effective interventions for prevention: key elements of success. Recommendations by the 
World Health Organisation, Global Programme on AIDS. Presentation at the VUIth International 
Conference on AIDS in Africa, Marrakech 1993
Sparling: Natural history of syphilis. In: Holmes KK, Mardh P, Sparling PH, Wiesner PJ (eds.): 
Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990
Spiegel CA: Bacterial vaginosis. Clin Microbiol Rev 1991; 4: 485-502
Stamm WE. Holmes KK: Chlamydia trachomatis infection of the adult In: Holmes KK, Mardh P, 
Sparling PH, Wiesner PJ (eds.): Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990
Stanecki KA. Way PO: The demographic impacts of HIV/AIDS. Perspectives from the world population 
profile: 1996. International Programs Center, Population Division, US Bureau of the Census: IPC Staff 
Paper No. 86. Washington, USA, 1997
Steen R, Soliman C, Bucyana S, Dallabetta G: Partner referral as a component o f  integrated sexually 
transmitted disease services in two Rwandan towns. Genitourin Med 1996 Feb; 72: 56-59
Stolz E. Menke HE, Vuzevski VD: Other genital dermatoses. In: Holmes KK, M ardh P, Sparling PH, 
Wiesner PJ (cds ): Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990
Taylor-Robinson D: the value of non-culture techniques for the diagnosis of Chlamydia trachomatis 
infections: making the best of a bad job. Eur J Microbiol Inf Dis 1992; 11: 499-503
227
Tartaglione TA, Russo ME. Pharmacology of drugs used in venereology. In: Holmes KK, Mardh P, 
Sparling PH, Wiesner PJ et al (eds ): Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 
1990
Telzak EE, Chiasson MA, Bevier PJ: HIV-1 seroconversion in patients with and without genital ulcer 
disease Ann Int Med 1993; 119: 1181-1186
Temmerman M, Mohamedali F, Fransen L: Syphilis prevention in pregnancy: an opportunity to 
improve reproductive and child health in Kenya. Health Policy and Planning 1993; 8: 122-127
Todd J, Balira R, Grosskurth H, Mayaud P, Mosha F, ka-Gina G, Klokke A, Gabone R, Gavyole A, 
Mabey D, Hayes R: HIV-associated adult mortality in a rural Tanzanian population. AIDS 1997, 11: 
801-807
Trichonova L, Borisenko K, Ward H, Mehaues A, Gromyko A, Renton A: Epidemic of syphilis in the 
Russian Federation trends, origins, and priorities for control. Lancet 1997; 350: 210-213
UNAIDS: Report on the global HIV/AIDS epidemic. UNAIDS, Geneva, December 1997.
UNAIDS. AIDSCAP and Francois-Xavier Bagnoud Center for Health and Human Rights: The status 
and trends of the global HIV/AIDS pandemic. Final report. Xlh International Conference of AIDS
Vancouver 1996.
Van dc PerTe P, Rouvroy D, Lepage P. Bogaerts J, Kestelyn P, Kayihigi J, Hekker AC, Butzler JP, 
Clumeck N: Acquired immunodeficiency syndrome in Rwanda. Lancet 1984 ii: 62-64
Van de Perre P, Lc Polain B, Carael M, Nzaramba D, Zissis G, Butzler JP: HIV antibodies in a remote 
rural area in Rwanda. Central Africa: an analysis of potential risk factors for HIV seropositivity. AIDS 
1987; 1: 213-5
Van dc Pcrrc P: The epidemiology of HIV infection and AIDS in Africa. Trends Microbiol 1995; 3: 
217-222
Vuylstekc B (i), Laga M, Alary M, Gemiers MM, Lebughe P, Nzila N, Behcts F, Van-Dyck E, Piot P: 
Clinical algorithms for the screening of women for gonococcal and chlamydial infection: evaluation of 
pregnant women and prostitutes in Zaire Clin-lnfect-Dis. 1993; 17(1): 82-8
228
Vuylsteke B (ii), Bastos R, Crucitti T, Folgosa E, Hcnkens M, Piot P, Laga M: Evaluation o f clinical 
algorithms for genital discharge: a pilot study in Mozambique. Xth International Meeting of the 
International Society for STD Research, Helsinki, 1993, Abstract no. 54
Vuylsteke B (iii), Bastos R, Barreto J, Crucitti T, Folgosa E, Mondlane J, Dusauchoit T, Piot P, Laga 
M: High prevalence of sexually transmitted diseases in a rural area in Mozambique. Genitourin Med
1993; 69:427-430
Wagner U, Van Dyck E, Roggcn E, Nunn AJ, Kamali A, Scott Schmid D, Dobbins JG, Mulder DW: 
Scroprevalence and incidence of sexually transmitted diseases in a rural Ugandan population. Int J STD 
& AIDS 1994, 5:332-337
Wasscrheit JN, Bell TA, Kivial NB: Microbial causes of proven pelvic inflammatory disease and 
efficacy of clindamycin and tobramycin. Ann Intern Med 1986; 104: 187
Wasscrheit J: The significance and scope of reproductive tract infections among Third World women 
Int J Gynecol Obstet 1989 suppl 3: 145-168
Wasscrhcit J: Epidemiological synergy Interrelationships between human immunodeficiency virus 
infection and other sexually transmitted diseases . Sex. Trans. Dis. 1992; 19:61-77
Wawer M, Scwankambo NK, Gray RH, Serwadda D, Paxton L, Quinn TC , Wabwire-Mangen F: 
Community-based trial of mass STD treatment for HIV control, Rakai, Uganda: preliminary data on 
STD declines. Xlth International Conference on AIDS, Vancouver, Canada. July 7-12, 1996. Abstract 
Mo.C.443
Wclgcmoed NC, Mahaffey A, Van den Ende J: Prevalence of Neisseria gonorrhoeae infection in 
patients attending an antenatal clinic South Afr Med J 1986; 69: 32-43
Wellington M Detection of asymptomatic carriers and partner notification. In: Prevention and 
management of sexually transmitted diseases in Eastern and Southern Africa: current approaches and 
future directions. NARESA Monograph No.3: Network of AIDS Researchers in South and East Africa 
(NARESA). Nairobi, 1994
West B, Changalucha J, Grosskurth H. Mayaud P, Gabonc R, Ka-Gina G, Mabcy D: Antimicrobial 
susceptibility, auxotype and plasmid content of Neisseria gonorrhoeae in Northern Tanzanbia: 
emergence of high level plasmid mediated tetracycline resistance Genitourinary Medicine 1995; 71:9- 
12
2 2 9
WHO: Analysis of the cost-cfTcctiveness of approaches to STD control. Informal Technical Working 
Group Meeting on STD activities in GPA Background paper No. 4, Geneva, WHO/GPA, February
1993
WHO: Management of sexually transmitted diseases. WHO/GPA/TEM/94.1. Geneva: WHO 1994
WHO: An overview of selected curable sexually transmitted diseases WHO/GPA/STD 95.1 WHO, 
Geneva, 1995
Wilkinson D: Syndromic management of sexually transmitted diseases in developing countries: what 
role in the control of the STD and HIV epidemics? Genitourin Med 1997; 73: 427-42
Winfield J. Latif AS: Tracing contacts of persons with sexually transmitted diseases in a developing 
country Sex Transm Dis 1985; 12: 5-7
Working Group on Mothcr-To-Child Transmission of HIV: Rates of mothcr-to-child transmission of 
HIV-1 in Africa, America, and Europe results from 13 perinatal studies J Acquir Immune Dcfic Syndr 
Hum Rctrovirol 1995; 8: 506-10
World Bank World Development Report 1993: Investing in Health New York: Oxford University
Press, 1993.
W H O : M a n a g e m e n t o f  p a tie n ts  w ith  sex u a lly  tr a n s m it te d  d is e a s e s  R epo rt o f  a  W H O  S tu d y  G ro u p
W o rld -H e a lth -O rg a n -T e c h -R e p -S e r . 1991 ; 810: 1 -103
2 3 0
Annex 1
STD training course for health workers: standardised timetable
Subject Teaching units (of 45 min) Subject Teaching units (of 45 min)
1. Public health importance of STDs
1.1 Burden on health caused by STDs
1.2 The STD/HIV cofactor effect
2. STD patients and health workers' attitude
2.1 Psy chological situation of an STD patient
2.2 How to ensure privacy and confidentiality at the clinic
2.3 Caring vs. blaming attitudes
2.4 Local perceptions of STDs and STD symptoms
2.5 Review
3. STD syndromes and their management
3.1 Introduction: syndromes and syndromic management 
(with slide presentation and quiz)
3.2 Components of good case management :
history taking, examination, health education, treatment 
3 3 STD syndromes:
introduction, brief discussion of aetiologies, complications, 
treatment algorithms:
3 .4 Issues o f  com pliance, directly observed treatment
3.5 Resistance dev elopment / ethics of correct prescription 
and drug dispensing
3.6 Review
4 Health education for STD patients
4.1 Importance of good health education
4.2 Elements of good health education / check list
4.3 Prevention of re-infection
4 4 Treatment compliance
4 5 Condom promotion_________________________________________________
18
4.6 Partner notification / contact slips
4 7 Role plays on health education incl. condom promotion 
and partner notification 
4.8 Review
5. Recording and reporting
5.1 STD patient register book
5.2 STD patients tally sheet
5.3 Operational self evaluation
5.4 STD report form
5.5 Review and practical exercises
6. Management of the clinic
6.1 Integration into routine work
6.2 Essential equipment for the management of STDs
6.3 How to organise the clinic room
6.4 How to organise the clinic
6.6 Review
7. Optional: AIDS
7 .1  Understanding A I D S
7.2 Clinical synopsis
7.3 Management of opportunistic infections at the health unit
7.4 Coping with AIDS in the family and community
7.5 Management of opportunistic infections in the home
7.6 Review
8. Administrative and other issues 
Total course duration
(8)
40 (48)
Annex 2
S T D / H I V  I n t e r v e n t i o n  M w a n z a  R e g io n  
P e r s o n n e l ,  e q u i p m e n t ,  p e r f o r m a n c e
S u p e r v i s i o n  f o r m :  p a r t  I
H e a l th  u n i t : D a te : Q u a r te r :
S u p e r v i s o r : _______________________________
1. P e r s o n n e l :  h e a l t h  w o r k e r s  w i t h  S T D  t r a i n i n g
N a m e  F u n c t io n :
N a m e : F u n c t io n :
N a m e : F u n c t io n :
p r e s e n t  a n d  w o r k i n g  Y  /  N  
p r e s e n t  a n d  w o r k i n g  Y  /  N  
p r e s e n t  a n d  w o r k i n g  Y  /  N
2 . E q u i p m e n t
I te m a v a i la b le  a n d  
in  o r d e r?
I te m a v a i la b le  a n d  
in  o r d e r ?
E x a m in a t io n  b e d Y  /  N T o r c h Y  /  N
B e d  s h e e t Y  /  N W a i t in g  b e n c h Y  /  N
S c re e n Y  /  N D e s k Y  /  N
S p e c u lu m Y  /  N 2  c h a i r s Y  /  N
P la s t ic  c o n ta in e r Y  /  N R e g is t e r  b o o k Y  /  N
W a te r  c o n ta in e r Y  /  N T r e a tm t  f l o w c h a r t s Y  /  N
P la s tic  m u g Y  /  N T ra in in g  m a n u a l Y  /  N
R e p a i r s  o r  r e p l a c e m e n t  n e e d e d :
3 . S u p e r v i s i o n  c h e c k l i s t
1 S t a f f  a v a i la b i l i ty :  a n y  p r e s e n t  o r  
a n t ic ip a te d  p r o b le m  ? Y  /  N
2  R e g is t e r  b o o k :  is  th e  in f o rm a t io n  
c o m p le te  a n d  c o n s i s t e n t  ?  W h ic h  
p r o b le m s  ?
Y  /  N
3 H a v e  a lg o r i th m s  b e e n  
fo l lo w e d  ?  W h a t  t y p e  o f  p r o b le m  d id  
y o u  o b s e r v e  ?
Y  /  N
4  A n y  d if f ic u l t  c a s e s  s e e n  jo in t ly  
w ith  t h e  H W s ?  W h ic h  o n e s  ? Y / N
5. F e e d - b a c k  a n d  t r a in in g :  W h ic h  
to p ic s  d id  y o u  d i s c u s s  t o d a y  w i th  th e  
H W s ?
2 3 2
1. S u m m a r y  n u m b e r s :  s y n d r o m e s  t r e a t e d ,  c l in ic a l c u r e s ,  r e f e r r a l s ,  p a r t n e r s  t r e a t e d
2 . D r u g  c o n s u m p tio n  ( ‘s h o u ld - b e  c o n s u m p tio n ’)
Annex 2
STD/HIV Intervention Mwanza Region Supervision form: part 2
Health unit: Month/year:
Nu of 
cases
Nu of 
partn 
treat.
TMS
forte
960mg
Doxy-
cycline
100mg
Metro­
nidazole
200mg
Benza.
Penicill.
2.4MU
Cipro-
floxac.
500mg
Erythro­
mycine
500mg
Nu
cured
Nu’1 of 
tr.fail. / 
referrals
Men:GUS 
Ist line
x8= xl-=
GUS 
2nd line
x21—
GUS 
3rd line
x3=
second.
svphilis
x l -
Bubo 
Ist line
x8= x28=
Bubo 
2nd line
x l2 - x3=
Women:
GUS Ist
x8= x l«
GUS 
2nd line
x21—
GUS 
3rd line
x3=
second.
svphilis
x l -
Bubo 
Ist line
x8= x28=
Bubo 
2nd line
x l2 - x3=
UDS 
Ist line
xlO - x l4 -
UDS 
2nd line
x l4 - x l0=
UDS 
3rd line
x l -
VDS 
Ist line
xlO - x l4 - xlO -
VDS in 
prcgn
xlO - x 2 1 -
VDS 
2nd line
xl4=
VDS 
3rd line
x l -
PID 
Ist line
xlO - x28= x28=
PID
2nd line
xl
Balanitis
*)
xlO - x l -
total
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C a lc u la t io n  o f  s u r p lu s  a n d  d e f ic it  /  c o n s u m a b le s  s u p p l ie d  /  n e w  s to c k  
H e a l th  u n i t :  M o n th /y e a r :
STD/HIV Intervention Mwanza Region Supervision form: part 3
old
stock
2
count
stock
3
real
consump
4
should-be
consump
5
-  (4 - 3) 
surplus: + 
deficit: -
6
reasons/
remarks
7
supplied
today
8
new
stock
TMS 
forte 
960 mg
Docy- 
cyclinc 
100 mg
Metro­
nidazole 
200 mg
Erythro­
mycin 
500 mg
Benza- 
Penicill 
2.4 MU
Cipro­
floxacin 
500 mg
Gentian 
violet 1% 
0.5 1
Syringes 
10 ml
Needles 
f. inject.
Cotton
wool
Antisept
solution
Batteries
Register
book
Pens
Dale: Supplied (name): Signature:
Received (name): Signature:
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F o llo w -u p  o f  r e f e r r a l s
STD/HIV Intervention Mwanza Region Supervision form: part 4
H e a l th  u n it: M o n th /y e a r
Name / sex Syndrome Reason for 
referral
Referred to 
(name o f HC, 
hospital)
Date of 
referral
Follow-up
results
L e g e n d  f o r  part 2 o f  s u p e r v i s io n  fo rm :
number o f total treatment failures recorded = F 
number o f referrals recorded = R
GUS = genital ulcer syndrome, UDS = urethral discharge syndrome, VDS = vaginal discharge 
SNTidromc, PID = pelvic inflammatory disease/lower abdominal tenderness. Bubo = bubo 
without ulcer, Balanitis = balanitis w foreskin not retractable
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Cluster:_____________
Balozi:______________
Person:_____________
Trip No:______________
A M R E F  S T D  I n t e r v e n t i o n  S t u d y :  Q u e s t i o n n a i r e  ( 1 )
I N T E R V I E W E R :  W e  w ould  like to a s k  you  le w  questions, w hich h a v e  b e e n
au th orised  b y  the party, y o u r  le a d e rs  a n d  a lso  y o u r ten  c e ll 
leader. A ll inform ation you  g iv e  us will b e  a  secret.
"Please, give me your full name": INTERVIEWER - use CAPITAL LETTERS
Religious name:_________ _— -----------------------
(NB. if no such name, put a dash)
Birth name:-------------- ------------------------------------
Surname:_______________________________
Full name of the household:__ ______________
Religious name:_____________ _____________
Surname:___________ ._______ ____________
C o m p le x :_______________
INTERVIEWER'S INITIALS: 
INTERVIEWER'S CODE: _
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Cluster: ____________________
Balozi:_________________
Person:_____________________
I N T E R V I E W E R :  p le a s e  c irc le  the response A N D  w rite the re levant letter
in the box. R e m e m b e r to put a  cross (X ) in the boxes for 
which a  rep ly  is not app licab le  (su ch  as  questions 4, 5, e tc .)
C o m p le x : __________________________
1 . Sex Male/Female 1.
2. How old are you (in years) 2.
3. Now are you married? No / Yes 3.
4. If answer to Q3 is YES, Are living together, or apart?
T ogether / Apart / X = n/a 4.
5. If answer to Q3 is NO, Have you ever married
No / Yes/X=not appl. 5.
6. If answer to Q5 is YES, Are you divorced / widowed?
Divorced/Widowed/X=n/a 6.
7. How many injections have you had within twelve months past?
I N T E R V I E W E R :  Explain  tha t it is the total n u m b er o f  injections from hospital a n d
from non-m edica l people.
N o n e / 1 / 2 / 3 / 4 / 5 o r  more 7 .______
8. Have you ever been transfused within the period of 5 years past?
No/Yes 8._____
9. What is your highest level of education?
A: Below 4 years of primary education (include no primary education - A) 
B: Four years or above primary education?
A /B  9. _
10. What is the furthest distance you have travelled within the period c‘ twelve 
months past?
A. Within this ward?
B. Within this division?
C. Witrhin this district?
D. Within this region?
E. Out of this region but within the country (Tanzania)
F. Out of the Country (Tanzania)
A / B / C / D / E / F  10.
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INTERVIEWER : A sk the in terv iew ee abo ut h is  /  h er g e n e ra l health. "W e a re
a w a re  that, there a re  s e v e ra l p eo p le  w ith d isease  p ro b le m s  in 
there  p riva te  parts. In o rd e r to  u nd ers tan d  the e x ten t o f the  
problem s, we w ould  like to  a s k  you fe w  questio ns  w hich  w ou ld  
e n a b le  us to kno w  w h e th e r y o u  have  h a d  o ne  o f th e s e  
pro blem s in the past. W e  w ill o ffer you  a  free  trea tm en t incase  
you r p ro b lem  is curable".
11. Do you have or have ever had an ulcer in your private parts?
No/ Yes  11.______
( I N T E R V I E W E R :  Show picture)
If answer to Q.11 is No, write X for Q.12 -14 and go to Q.15.
12. Did this ulcer start within the past twelve months?
No / Yes / X= n/a 12.______
13. Is the ulcer still there at present?
No / Yes /  X= n/a 13.______
14. Did you get any treatment?
No / Ye s / X  = n/a 14.______
15. Have you ever had
[MALES] pus or watery discharge from the penis
[FEMALE] vaginal pus or abnormal watery discharge, now or in the past?
If answer to Q.15 is No, write X for Q.16 - 18 and go to Q.19
16. Did the discharge start within the past twelve months?
No / Yes/X= n/a 16.______
17. Do you still have that problem up to now?
No / Yes / X= n/a 17.______
18. Did you get any treatment for that problem?
No/YesX = n/a 18.______
If the answer to either question 14 or 18 is YES,
19. Where did you get the treatment for your problem?
a) Traditional healers? No/Yes X= n/a 19a.
b) Drug shop? No/Yes X = n/a 19b.
c) Dispensary/Health Center/Hospital?
No/Yes/X=n/a 19c.
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( I N T E R V I E W E R )  If this includes a  coded  H ea lth  C enter/D isp ensary , 
e n te r code: o therw ise en te r X X X.
20. [MEN ONLY] Please may I ask you, are you circumcised?
No / Yes / Don't know / R = refused / X = n/a 20.______
I N T E R V I E W E R :  A sk the  in terv iew ee  if h e /s h e  has a n y  questions to ask. T h a n k
h im /h e r for h is /h er cooperation in answ erin g  your questions, 
then explain to h im  that we shall take s o m e  little b lood an d  urine  
(fo r m a le s  o n ly) to investigate  if h e /s h e  h as  d iseases  which w e  
can o ffe r trea tm ent a fte r a  while, as  s o m e  o f the S T D s  can b e  
d ia g n o sed  b y  investigating  b lood sam p le , a n d  exp la in  to 
h im /h e r that is h e /sh e  has an  infection w e  shall o ffe r treatm ent.
Explain we need an interval of 2 hours since urine was last passed.
INTERVIEWER: Attach blood sample sticker here ____________
and give 9 more stickers with the same number 
to the interviewee. Then send him / her to the 
laboratory.
REMEMBER to complete the 'current STD reported at interview' form.
Trip number:_________  Interviewer's code:________ Initials:________
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Best Copy 
Available
Compìex/Clus ter/Bal ozi/Person 1— 1— 1 / / / l _ L _ L .
1NTERVIBWER: Make sure of the identity of the person in front of
you. Copy the complex/cluster/balozi/number and the name from the Balozi list? COPY the check letter.
Name : Check letter •-
Check the age and sex of the person. Do age and sex agree with 
balozi list? If not report to team leader.
Sex Male/Female *- Age 1---1---1
Please check the following points are explained to 
the study participant.
Two years ago people kindly took part in a survey we conducted. 
This is a follow up to find out about people's health during the 
last 2 years .Treatment will be provided for persons with curable conditions. 
The study has been approved by the local / governmental leaders. 
All responses are totally confidential.We hope the participant will consent to answer the questions.
IN T E R V IE W E R :
A .
B.
C.
D. 
E . 
F .
Informed oral consent obtained. 
Interviewers signature ___ Code
INTERVIEWBR: Look at the Balozi list for this person. If the list
shows MARITAL STATUS = • M ’.
"When we visited the village 2 years ago you were married and living 
with your partner. Can you give us the name of your partner at that 
time." Ask about the spouse(s) of two years ago and if they belong 
to the same balozi find their person number on the list. If more 
than two wives are mentioned take the first two mentioned.
Hamel :ENTER PERSON NUMBER ONLY IF IN THE SAME BALOZI
Are they still living together Yes / NoIf Not, is the spouse dead Yes / No
Naroa2ENTER PERSON NUMBER ONLY IF IN THE SAME BALOZI
Are they still living togetherIf Not, is the spouse dead
Please place one sticker here,
put one on the link form,give another 8 to the participant
Yes / No
Yes / No
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Check letter
Compì ex/Cluster/Bal ozi / Person 1— 1— 1 / 1— 1 / 1— 1 / 1— 1— 1— 1
What is vour current occupation? '-- 1A Farmer B Student/school pupil
C Unskilled manual D Skilled manual
B Office work F Business
G Fisherman H Truck driver
I Gold miner J Bar-worker/pombe shop workerK Other (Specify . )
X No job
What is your Religion? i iA = Muslim B = Catholic
C « Protestant D = Other
What is your tribe •-- 1
A Sukuma B Gita
C Zinza D Mkara
B Mkerewe F Mhaya
G Other
4 .
of
Have you lived anywhere else, 
this village, during the past 2
for longer than 1 month, 
years. Yes/No
If YES to Q4,
L_ 5. Did you live in MwanzaAnother town 
Mining area 
Anywhere else
Yes/No/X
Yes/No/X
Yes/No/X
Yes/No/X
outside
I____I
"Now Z would like to ask you about your health now and in the past
two years" .. . . .6 . Do you have any health problem at present Yes/No ---
If YES to Q6 ,
I___ 7 . Please tell me about it. Interviewer : Please indicate
if the following are mentioned. If not then ask
Yes/No/X
7a. Fever
7b. Chronic cough
7c. Diarrhoea
7d. Weight loss
Duration Yes/No/X 
more than 1 month 
more than 1 month 
more than 1 month 
more than 1 month
For females only (Questions 8-10). For males put X.Tnrerv.iewer, ,,Me wouid like to ask you about the health of your
children."
Have you any children below the age of 2 years? (Make sure the 
child was born since the last visit 2 years ago)Yes/No/X 1---1
If YES to Q 8
I___ 9 Soon after birth, did any of these children have a
thick yellow or green discharge from their eyes?Yes/No/X 1---1
1 0  . During the past two years have child? (Explain stillborn is a
del ivery)
you ever delivered a stillborn 
full term baby who was dead on
Y e s / N o / X  1------- 1
24?
1 1 . Have you had a genital discharge now or during the last 2 years
If
Yes/No 1---1
YBS to Qll,
---12. Think of the most recent episode.How long ago did it start? 1---1
A = Less than 1 week ago B = Less than 1 month ago
C = Less than 1 year ago D = Between 1 and 2 years ago
13 .
14 .
Do you still have it? Yes/No/X
If YBS to Q14,
15. Where did you go for treatment
15a First place 1-- 1
15b Second place 1-- 1
15c Third place 1-- 1
A = Traditional healer 
B = Drugs store/shop C = Disp/Health centre/Hosp 
(Please put code for any govt health unit
I___ I____ I
I___ I____ I
l___ I____ I
used, else X X )
16. Have had any genital ulcer now or during the last 2 year
Yes/No 1---1
If YES to Q16, ask Q17-19
I---- 17. Think of the most recent episode.How long ago did it start? 1---1
A = Less than 1 week ago B = Less than 1 month ago
C = Less than 1 year ago D = Between 1 and 2 years ago
18. Do you still have it? Yes/No/X
19. Did you get treatment for the genital ulcerYes/No/X
If YES to Q19, ask Q20
1-------20. Where did you go for treatment
20a First place 1--1
20b Second place 1--1
20c Third place 1--1
A * Traditional healer 
B = Drugs store/shop C = Disp/Health centre/Hosp 
(Please put code for any govt health unit
I___ I____ I
I____I_____ I
I____I_____ I
used, else X X )
It.any Govt health unit used 
most recent treatment.
21 . Did you get drugs?
22 . were you examined?
23. Did you have to pay a fee?
24. Were you given condoms?
in Q15 or Q20 then ask about the
Yes/No/X 
Yes/No/X 
Yes/No/X
Yes/No/X
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